Page last updated: 2024-09-04

docetaxel anhydrous and Cancer of Stomach

docetaxel anhydrous has been researched along with Cancer of Stomach in 741 studies

Research

Studies (741)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	12 (1.62)	18.2507
2000's	234 (31.58)	29.6817
2010's	405 (54.66)	24.3611
2020's	90 (12.15)	2.80

Authors

Authors	Studies
Mo, DC; Qin, L; Ye, LJ	1
Hirahara, N; Hyakudomi, R; Ishitobi, K; Kaji, S; Matsubara, T; Tajima, Y; Takai, K; Uchida, Y; Yamamoto, T	1
Antonuzzo, L; Brugia, M; De Vita, F; Di Donato, S; Fancelli, S; Formica, V; Fornaro, L; Giommoni, E; Giovanardi, F; Iachetta, F; Lavacchi, D; Pecora, I; Pillozzi, S; Pompella, L; Pozzo, C; Prisciandaro, M; Puzzoni, M; Romagnani, A; Satolli, MA; Sisani, M; Spallanzani, A; Stragliotto, S; Strippoli, A; Tirino, G	1
Chen, Q; Ding, R; Wang, X; Wang, Z	1
Boku, N; Hironaka, S; Iwasa, S; Machida, N; Sadachi, R; Sasako, M; Terashima, M; Yamada, Y; Yoshikawa, T	1
Adenis, A; Khellaf, L; Mazard, T; Mourregot, A; Portales, F; Quesada, S; Samalin, E; Thezenas, S; Ychou, M	1
Aoki, T; Imoto, H; Kamei, T; Kawana, T; Morikawa, T; Ohnuma, S; Sasaki, H; Tanaka, N; Tsuchiya, T; Unno, M; Yamamura, A	1
Alzeeb, G; Arzur, D; Corcos, L; Le Jossic-Corcos, C; Talagas, M; Trichet, V	1
Allum, WH; Bhogal, RH; Chau, I; Chaudry, A; Cunningham, D; Fribbens, C; Gerlinger, M; Kumar, S; Malietzis, G; Moussa, O; Rao, S; Starling, N; Watkins, D	1
Al-Batran, SE; Ettrich, T; Goetze, TO; Gökkurt, E; Hinke, A; Lordick, F; Lorenzen, S; Pauligk, C; Pink, D; Probst, S; Reichardt, P; Sökler, M; Stahl, M; Thuss-Patience, P	1
Ahn, KS; Baek, SH; Hwang, ST; Um, JY; Yang, MH	1
Fan, RY; He, MF; Huang, XE; Li, CY; Shen, LZ; Wang, P; Wei, P; Wu, JQ; Zhai, J	1
Amoroso, D; Barni, S; Bernardini, I; Bilancia, D; Casaretti, R; Cascinu, S; Casolaro, A; Cavanna, L; Cella, CA; Ciarlo, A; Codecà, C; Davite, C; Di Sanzo, A; Labianca, R; Luchena, G; Mosconi, S; Prisciandaro, M; Rosati, G; Silvestris, N; Zoratto, F	1
Brachet, PE; Castera-Tellier, M; Clarisse, B; Corbinais, S; Dorbeau, M; Dos Santos, M; Galais, MP; Guilloit, JM; Le Gallic, C; Leconte, A; Lequesne, J; Parzy, A; Poulain, L; Varatharajah, S; Vaur, D; Weiswald, LB	1
Bartels, A; Brossart, P; Feldmann, G; Giordano, FA; Gonzalez-Carmona, MA; Jafari, A; Kalff, JC; Köksal, M; Lingohr, P; Mahn, R; Mańczak, A; Möhring, C; Monin, M; Sadeghlar, F; Sarria, GR; Strassburg, CP; Timotheou, A; Toma, M; Zhou, T	1
Goto, M; Kawakami, H; Kurokawa, Y; Sakai, D; Satoh, T; Shimokawa, T; Yamaguchi, T	1
Cao, Y; Feng, Z; Li, L; Li, Y; Li, Z; Tu, Y; Zhang, Y	1
Deva, S; Findlay, M; Hitchen, N; Lawrence, B; Waldron, NR	1
Ding, C; Feng, J; Hou, Y; Huang, J; Jiang, D; Li, K; Li, Y; Liu, T; Liu, Y; Ma, F; Qin, J; Qin, Z; Qu, Y; Shen, K; Song, Q; Sujie, A; Tian, S; Wang, B; Wang, Y; Wu, X; Xu, C; Xu, F; Zhang, X; Zhao, JY	1
Ge, D; Hongen, Y; Jian, X; Lishuo, S; Shanshan, L; Taiyuan, C; Wanjia, H; Xiaohui, Z; Xiaoru, L	1
Baheti, A; Bhargava, P; Chaugule, D; Gota, V; Jadhav, S; Jadhav, VK; Mandavkar, S; Mittra, I; Ostwal, V; Peelay, Z; Ramaswamy, A; Shinde, S; Srinivas, S; Tandel, H	1
Jia, SJ; Liu, Q; Song, LY; Wang, C; Zeng, H; Zeng, X	1
Arık, Z; Aydemir, E; Gürler, F; Güven, DC; İnci, BK; Özdemir, N; Özet, A; Sütçüoğlu, O; Yalçın, Ş; Yazıcı, O	1
Chin, K; Doki, Y; Fujitani, K; Fushiki, K; Hironaka, S; Kato, K; Kitagawa, Y; Kojima, T; Kusaba, H; Matsushita, H; Mizusawa, J; Okuno, T; Seki, S; Tomori, A; Tsubosa, Y; Tsushima, T; Ura, T	1
Bruckner, T; Büchler, MW; Crnovrsanin, N; Haag, GM; Jung, JO; Müller-Stich, BP; Nienhueser, H; Schiefer, S; Schmidt, T; Schneider, M; Sisic, L	1
Cai, B; Ma, X; Pu, Y; Yu, P; Zhang, C; Zhu, S	1
Kang, W; Li, J; Ma, M; Zeng, Z; Zheng, Z	1
Cui, Y; Du, Y; Liu, F; Liu, T; Lv, M; Shen, Z; Sun, Y; Wang, X; Wang, Y; Ying, J; Yu, Y; Zheng, S	1
Cao, Y; Gong, J; Kou, F; Li, J; Li, Y; Liu, D; Lu, M; Lu, Z; Shen, L; Wang, X; Wang, Z; Xu, R; Zhang, X; Zhou, J; Zhu, X; Zou, J	1
Akiyama, H; Endo, I; Kasahara, K; Kimura, J; Kondo, H; Kosaka, T; Kunisaki, C; Makino, H; Ono, H; Sato, K; Sato, S; Takahashi, M; Tamura, Y; Tanaka, Y; Tsuchiya, N	1
Chaudhari, K; Doval, DC; Goel, V; Goyal, P; Koyyala, VPB; Maheshwari, U; Patnaik, N; Talwar, V	1
Mehta, R; Shariff, B	1
Belluomini, MA; Catanese, S; Cremolini, C; Fontanini, G; Fornaro, L; Giannini, R; Giordano, M; Lencioni, M; Masi, G; Massa, V; Pallabazzer, G; Pecora, I; Salani, F; Santi, S; Ugolini, C; Vasile, E; Vivaldi, C	1
Fujitani, K; Furukawa, H; Iijima, S; Imamura, H; Kawakami, H; Kimura, Y; Kurokawa, Y; Matsuyama, J; Sakai, D; Satoh, T; Shimokawa, T; Tamura, S; Tsujinaka, T	1
Fujii, M; Ichikawa, W; Kakeji, Y; Kochi, M; Kodera, Y; Sano, T; Sunakawa, Y; Takeuchi, M; Yoshida, K	1
Andreucci, E; Antonuzzo, L; Biagioni, A; Bianchini, F; Calorini, L; Cianchi, F; Lulli, M; Magnelli, L; Massi, D; Messerini, L; Olivo, E; Papucci, L; Pasqualini, E; Peppicelli, S; Peri, S; Ruzzolini, J; Schiavone, N; Staderini, F; Supuran, CT; Versienti, G	1
Akita, H; Hara, H; Haraguchi, N; Hasegawa, S; Kanemura, T; Matsuda, C; Mikamori, M; Miyata, H; Mukai, Y; Nishimura, J; Ohue, M; Omori, T; Shinno, N; Sugase, T; Takeoka, T; Wada, H; Yamamoto, M; Yasui, M	1
Adamczuk, G; Dmoszynska-Graniczka, M; Gawel, K; Grabarska, A; Juszczak, M; Kosheva, N; Kukula-Koch, W; Luszczki, JJ; Rzeski, W; Slawinska-Brych, A; Stepulak, A	1
Chu, Z; Diao, F; Lai, W	1
Abad, M; Al-Abdulla, R; Briz, O; Bujanda, L; Herraez, E; Lozano, E; Macias, RIR; Marin, JJG; Perez-Silva, L; Segues, N	1
Bugano, DDG; Maluf, FC; Rother, ET; Santos, VM; Uson Junior, PLS; Victor, EDS	1
Bando, Y; Fujino, Y; Hirata, M; Kida, Y; Kitamura, S; Mitsui, Y; Miyamoto, H; Muguruma, N; Nakagawa, T; Okamoto, K; Sato, Y; Takayama, T; Tanahashi, T	1
Chen, Y; Guo, Q; Ji, Y; Kang, N; Kang, Z; Zhao, Y	1
Calomino, N; Cherri, S; Farsi, M; Fiaschi, AI; Francini, E; Francini, G; Marrelli, D; Miano, ST; Petrioli, R; Rovello, F; Savelli, V; Vernillo, R	1
Bapat, B; Brown, J; Candrilli, SD; García-Foncillas, J; Kaye, JA; Liepa, AM; Lorenzen, S; Madhwani, S	1
Boku, N; Doki, Y; Katayama, H; Kurokawa, Y; Mizusawa, J; Sato, Y; Tanaka, K; Terashima, M; Yoshikawa, T	1
Jain, A	1
Mini, E; Roviello, F; Roviello, G	1
Adenis, A; Mazard, T; Mourregot, A; Portales, F; Samalin, E; Ychou, M	1
Ji, J; Jia, Y; Li, S; Li, Z; Shan, F; Ying, X; Zhang, L	1
Jung, M; Lee, JH; Lim, SG; Park, YR	1
Antista, M; Corallo, S; Di Bartolomeo, M; Fucà, G; Martinetti, A; Miceli, R; Morano, F; Niger, M; Pagani, F; Pellegrinelli, A; Perrone, F; Pietrantonio, F; Raimondi, A; Randon, G; Tamborini, E	1
Alizadeh, A; Anjom Shoa, M; Ghasemi, S; Rezakhani, L	1
Betel, D; Cleveland, K; Galletti, G; Giannakakou, P; Gjyrezi, A; Powell, S; Shah, MA; Thakkar, PV; Zhang, C; Zhang, J	1
He, Y; Lan, Z; Yang, F	1
Akamaru, Y; Hokkoku, D; Ikeshima, R; Morimoto, O; Munakata, K; Ota, H; Shibata, K; Takiuchi, D; Wada, N; Wada, R	1
Cao, D; Du, T; Jiang, X; Li, H; Song, C; Sun, Q; Yan, D; Yang, Y; Yuan, B; Zhang, S	1
Gao, J; Liu, XL; Lu, HX; Yang, MD; Yang, WH	1
Danandeh Mehr, A; Habibzadeh, A; Molaei, M; Pourghasemian, M	1
Amarantidis, K; Balgkouranidou, I; Biziota, E; Bolanaki, H; Chatzaki, E; Kakolyris, S; Karamitrousis, E; Karayiannakis, A; Kolios, G; Koukaki, T; Lambropoulou, M; Lianidou, E; Trypsianis, G; Xenidis, N	1
Hu, CG; Liu, J; Xue, D; Xue, YF; Yao, B	1
Aguado, G; Arias-Martinez, A; Azkárate, A; Calvo, M; Cano, JM; Carmona-Bayonas, A; Castro Unanua, N; Cerdá, P; Custodio, A; Diez, M; Fernández Montes, A; Gallego, J; Garrido, M; Gil-Negrete, A; Granja, M; Hernández Pérez, C; Hernandez, R; Hurtado, A; Jimenez-Fonseca, P; Limón, ML; Longo, F; López, F; Mangas, M; Martín Carnicero, A; Martín Richard, M; Martínez de Castro, E; Martínez Lago, N; Pericay Pijaume, C; Pimentel, P; Ramchandani, A; Sánchez Cánovas, M; Sauri, T; Vidal Tocino, R; Visa, L	1
Huitema, ADR; Koemans, WJ; van Sandick, JW	1
Fatehi-Agdam, M; Jeddi, F; Najafzadeh, N; Panahizadeh, R; Vatankhah, MA	1
Doyama, H; Kito, Y; Kubo, A; Miyajima, S; Tsuji, K; Ushijima, K; Yonezawa, M	1
Dai, Y; Hu, G; Huang, T; Luo, X; Peng, P; Qiu, H; Wu, B; Yuan, X	1
Chang Lee, R; Hsieh, AH; Moldovan, M; Price, T; Tomita, Y; Townsend, A	1
Li, C; Li, J; Liu, B; Liu, W; Ma, T; Sah, BK; Shi, M; Xu, W; Yan, C; Yan, M; Yuan, F; Zhang, B; Zhang, H; Zhu, Z	1
Nemoto, H; Tanaka, K	1
Aoyama, T; Atsumi, Y; Cho, H; Kano, K; Kazama, K; Maezawa, Y; Masuda, M; Murakami, H; Numata, M; Oshima, T; Rino, Y; Saeki, H; Sato, T; Tamagawa, H; Tsuchida, K; Yamada, T; Yamamoto, Y; Yukawa, N	1
Aizawa, M; Bamba, T; Kakuta, T; Maruyama, S; Matsuki, A; Nakagawa, S; Nogami, H; Nomura, T; Takii, Y; Yabusaki, H	1
Ayari, J; Balti, M; Ben Abdallah, I; Ben Hassen, M; Ben Nasr, S; Doghri, Y; Fendri, S; Haddaoui, A; Trigui, E; Zribi, A	1
Boerma, D; Boot, H; Grootscholten, C; Hartemink, KJ; Kodach, L; Koemans, WJ; Los, M; Sikorska, K; Snaebjornsson, P; van der Kaaij, RT; van Sandick, JW; Veenhof, AAFA; Wassenaar, ECE	1
Ajani, JA; Bhutani, M; Chen, Q; Correa, A; Estrella, JS; Gan, B; Hofstetter, WL; Huo, L; Jin, J; Johnson, RL; Lee, JH; Lei, G; Li, CY; Li, Y; Liu, B; Ma, L; Pizzi, MP; Scott, A; Shanbhag, N; Song, S; Wang, Y; Wei, S; Weston, B; Xiao, L	1
Arigami, T; Kurahara, H; Matsushita, D; Mori, S; Noda, M; Ohtsuka, T; Okubo, K; Sasaki, K; Tanaka, T; Tsuruda, Y	1
Bouvet, M; Fanta, P; Horgan, S; Kelly, KJ; Lowy, AM; Rajabnejad, A; Razzaque, S; Vaida, F; Valasek, M	1
Engel, J; Fagbemi, SO; Li, YH; Onitilo, AA; Shiyanbola, O; Stankowski-Drengler, TJ; Tanimu, S	1
Bria, E; Cintoni, M; Di Salvatore, M; Gasbarrini, A; Genco, E; Manfredi, R; Mele, MC; Pozzo, C; Raoul, P; Rinninella, E; Strippoli, A; Tortora, G; Vivolo, R	1
Fingerhut, A; He, ZR; Hong, HJ; Jiang, TY; Lu, AG; Ma, JJ; Zang, L; Zhang, LY; Zhao, X; Zheng, MH	1
Chen, Y; Gou, H; Hu, J; Leng, W; Ni, L; Qiu, M; Zhang, W	1
Demirag, G; Sullu, Y; Yilmaz, A; Yilmaz, H	1
Ai, Y; Gong, N; Huang, Y; Ju, Z; Li, J; Lu, G; Wu, X; Wu, Y; Xiang, D; Yang, J; Yang, Z; Zeng, B	1
Honda, H; Ishioka, C; Kanbe, M; Kawai, S; Murakawa, Y; Ohori, H; Otsuka, K; Ouchi, K; Saijo, K; Sakamoto, Y; Shimodaira, H; Shindo, Y; Takahashi, H; Takahashi, M; Tanaka, Y; Yamaguchi, T; Yoshioka, T	1
Arik, Z; Gürler, F; Güven, DC; İlhan, A; Kurt İnci, B; Öksüzoğlu, B; Özdemir, N; Özet, A; Sütçüoğlu, O; Turhan, O; Yalçin, Ş; Yazici, O; Yildiz, F	1
Akagunduz, B; Atcı, MM; Demir, M	1
Hayashi, T; Kamiya, A; Katai, H; Otsuki, S; Sekine, S; Wada, T; Yamagata, Y; Yoshikawa, T	1
Fujii, M; Ichikawa, W; Ishiguro, A; Kakeji, Y; Kataoka, M; Kimura, T; Kochi, M; Kodera, Y; Lee, SW; Musha, N; Ojima, H; Sakai, Y; Sano, T; Shibahara, K; Shikano, T; Takase, T; Takeuchi, M; Yoshida, K	1
Gęca, K; Małecka-Massalska, T; Mlak, R; Pelc, Z; Polkowski, WP; Rawicz-Pruszyński, K; Sędłak, K; Skórzewska, M	1
Azuma, M; Higuchi, K; Hosoda, K; Katada, N; Koizumi, W; Komori, S; Mieno, H; Moriya, H; Tanabe, S; Watanabe, M; Yamashita, K; Yoshida, T	1
Chmielowski, B; Dry, SM; Eilber, FC; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kiyuna, T; Li, Y; Murakami, T; Nelson, SD; Russell, TA; Singh, AS; Unno, M	1
Al-Batran, SE; Arnold, D; Bechstein, W; Berkhoff, S; Egger, M; Fischbach, W; Grimm, K; Hartmann, JT; Höffkes, HG; Hofheinz, RD; Homann, N; Illerhaus, G; Jäger, E; Koenigsmann, M; Kraus, TW; Luley, KB; Martens, UM; Mayer, F; Messmann, H; Moehler, M; Mönig, S; Pauligk, C; Post, S; Prasnikar, N; Probst, S; Ronellenfitsch, U; Schmalenberg, H; Stoehlmacher, J	1
Fushida, S; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohta, T; Oyama, K; Saito, H; Tajima, H; Tsukada, T; Yamaguchi, T	1
Aoyama, T; Fujitani, K; Fukunaga, T; Hirabayashi, N; Ito, S; Kimura, Y; Matsui, T; Miki, A; Nemoto, H; Nishikawa, K; Sakamaki, K; Tanabe, K; Yoshikawa, T	1
Aoyagi, E; Kimura, T; Kitamura, S; Mitsui, Y; Miyamoto, H; Muguruma, N; Nakagawa, T; Okamoto, K; Rokutan, K; Takayama, T; Tanahashi, T	1
Al, MJ; Armstrong, N; Blommestein, HM; Büyükkaramikli, NC; Clay, FJ; Kleijnen, J; Riemsma, R; Ross, J; Severens, J; Worthy, G	1
Bai, B; Cao, Y; Cui, D; Gao, J; Li, L; Li, Y; Nie, Z; Yang, L; Ye, L; Zhu, L	1
Ito, J; Kato, H; Kubo, T; Kurayama, E; Miyachi, K; Nakajima, M; Onodera, S; Otsuka, K; Sasaki, K; Satomura, H; Takahashi, M; Yamaguchi, S	1
Boku, N; Iizumi, S; Kawai, S; Matsushima, T; Muro, K; Nagashima, K; Narita, Y; Tajika, M; Takahari, D; Takashima, A; Yasui, H	1
Álvarez Manceñido, F; Arias, D; Azkarate, A; Buxo, E; Cano, JM; Carmona-Bayonas, A; Cerdà, P; Custodio, A; Diaz-Serrano, A; Echavarria, I; Fernández Montes, A; Gallego, J; Garrido, M; Hernández, R; Jiménez Fonseca, P; Lacalle, A; Limón, ML; Longo, F; López, C; Macias, I; Mangas, M; Martin Carnicero, A; Martinez de Castro, E; Pericay, C; Ramchandani, A; Rivera, F; Sánchez Bayona, R; Sánchez Cánovas, M; Vieitez, JM; Visa, L; Viudez, A	1
Grothe, W; Ho, J; Moehler, M; Syn, NL; Tai, BC; Unverzagt, S; Wagner, AD; Yong, WP	1
Ando, T; Fujinami, H; Horikawa, N; Hosokawa, A; Kajiura, S; Kobayashi, Y; Mihara, H; Ogawa, K; Origasa, H; Sugiyama, T; Ueda, A; Yabushita, K; Yoshioka, A; Yoshita, H	1
Eisterer, W; Fridrik, MA; Greil, R; Gruenberger, B; Hejna, M; Huemer, F; Keil, F; Thaler, J; Trommet, V; Ulmer, H; Weiss, L; Wöll, E	1
Jayakumar, R; Mohan, CG; Park, IK; Sarmento, B; Sreeranganathan, M; Uthaman, S	1
Cho, HJ; Choe, YK; Kim, BY; Kim, TW; Lee, HG; Lee, SJ; Lee, YH; Oh, BM; Park, SY; Park, YJ; Park, YS; Yoon, SR	1
Kamiya, J; Kaneko, T; Kawasaki, K; Miura, S; Miyahara, Y; Ogata, A; Takeuchi, D; Yoshimura, K	1
An, Z; Chen, FF; Fang, XD; Ji, FJ; Jiang, JN; Liu, XS; Wu, YY	1
He, MF; Li, CY; Shen, LZ; Tan, AM; Wei, P; Wu, JQ; Zhai, J	1
Cartwright, E; Cunningham, D	1
Fujiwara, T; Hamano, R; Kagawa, S; Kambara, T; Kikuchi, S; Kishimoto, H; Kuroda, S; Kuwada, K; Muraoka, A; Nakayama, H; Nishizaki, M; Noma, K; Shigeyasu, K; Shirakawa, Y; Tanaka, N; Tanakaya, K	1
Doki, Y; Gakuhara, A; Kurokawa, Y; Makino, T; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Tanaka, K; Yamasaki, M	1
Cheong, JH; Chung, HC; Hyung, WJ; Jung, I; Jung, M; Kang, SY; Kim, BS; Kim, HS; Kim, KH; Lee, CK; Lee, KH; Lee, MH; Noh, SH; Rha, SY; Shin, DB; Zang, DY	1
Chen, LT; Chin, YY; Chu, NS; Wu, IC	1
Du, H; Jiao, Z; Ren, Y; Wang, K; Wang, Z; Zhang, G	1
Bozkaya, Y; Demirci, NS; Erdem, GU; Eren, T; Köstek, O; Özdemir, NY; Sezer, S; Yazıcı, O; Zengin, N	1
Cho, H; Ikeda, K; Kano, K; Maezawa, Y; Nakajima, T; Ogata, T; Okubo, Y; Yamada, T; Yoshikawa, T	1
Abudureyimu, A; Ayidu, A; Chao, X; Huang, X; Wang, X; Yang, J; Zhang, F	1
Aieta, M; Conca, R; Multari, AG; Nardone, V; Petrioli, R; Rosellini, P; Roviello, G	1
Bang, SM; Choi, IS; Choi, M; Kang, B; Kim, JH; Kim, JW; Kim, SH; Kim, YJ; Lee, JH; Lee, JO; Lee, JS; Lee, JY; Lee, KW; Suh, KJ	1
Cannita, K; Cortellini, A; De Berardis, B; Ficorella, C; Lanfiuti Baldi, P; Parisi, A; Porzio, G; Venditti, O; Verna, L; Vicentini, R; Vicentini, V	1
Cheng, X; Cui, YH; Hou, J; Ji, Y; Liu, FL; Liu, TS; Shen, ZB; Sun, YH; Wang, Y	1
Al-Batran, SE; Behringer, D; Daum, S; Hacker, U; Ibach, S; Knödler, M; Körfer, J; Kullmann, F; Kunzmann, V; Lindhofer, H; Lordick, F; Schenk, M; Schroll, S; Stahl, M; Trojan, J	1
Deguchi, T; Hanaki, T; Ichikawa, T; Kobayashi, D; Masubuchi, M; Shibata, A; Takase, T; Yaguchi, T	1
Doi, T; Okino, T; Sakamoto, T	1
Berger, MF; Capanu, M; Chou, JF; Chung, V; Desai, A; Epstein, AS; Goldberg, Z; Hechtman, JF; Ilson, DH; Janjigian, YY; Jonsson, P; Kelsen, DP; Ku, GY; Margolis, M; Mondaca, S; Riches, JC; Sanchez-Vega, F; Schultz, N; Shah, MA; Solit, DB; Tuvy, Y; Yu, K	1
Ilson, DH	3
Asghari, F; Baradaran, B; Haghnavaz, N; Kazemi, T; Khaze, V; Shanehbandi, D; Shekari, N	1
Antonuzzo, L; Aprile, G; Avallone, A; Bordonaro, R; Cinieri, S; Di Donato, S; Fanotto, V; Fornaro, L; Gerratana, L; Giampieri, R; Leone, F; Melisi, D; Nichetti, F; Pellegrino, A; Rimassa, L; Rosati, G; Santini, D; Scartozzi, M; Silvestris, N; Stragliotto, S; Tomasello, G; Vasile, E	1
Lordick, F; Smyth, EC	1
Cao, Y; Cui, F; Ding, S; Gao, E; Huang, D; Sun, X; Wang, Y; Xu, S; Zhang, D; Zhang, F; Zhu, A	1
Li, K; Li, P; Liu, S; Qin, Y; Xing, R; Yu, H; Zhang, E	1
Baradaran, B; Darabi, M; Ghasemi, M; Javadian, M; Kazemi, T; Shekari, N	1
Adachi, S; Hayashida, H; Higaki, N; Kawanaka, S; Nezu, R; Oka, Y; Okada, K; Taniguchi, S; Ueshima, S; Yoshioka, S	1
Fujiwara, A; Hama, N; Hamakawa, T; Hirao, M; Kato, S; Kato, T; Maeda, S; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takami, K; Uemura, M	1
Ajani, JA; de Haas, SL; Harle-Yge, ML; Hoersch, S; Kang, YK; Ohtsu, A; Shah, MA; Thuss-Patience, PC; Van Cutsem, E	1
Chon, HJ; Chung, HC; Jung, M; Kang, B; Kim, C; Kim, HS; Kim, JH; Nam, CM; Rha, SY	1
Fujii, M; Ichikawa, W; Ito, S; Kaji, M; Kakeji, Y; Kochi, M; Kodera, Y; Matsui, T; Matsuyama, J; Nagao, N; Nomura, T; Okitsu, H; Sano, T; Takagane, A; Takahashi, M; Takeuchi, M; Watanabe, T; Yamada, M; Yoshida, K; Yoshikawa, T	1
Bian, Y; Cai, J; Liu, B; Qian, H; Qian, K; Wei, J; Yang, J; Yue, W; Zhao, W; Zuo, X	1
Bao, TT; Cao, Y; Chen, D; Chen, W; Hoffman, RM; Jian, T; Li, WB; Liu, HX; Liu, JB; Yang, Z; Yu, C; Yue, C	1
Ali, SK; Mwanzi, S; Nambafu, J; Orare, K	1
Gunji, H; Hanari, N; Hayano, K; Hayashi, H; Kano, M; Matsubara, H; Murakami, K; Ota, S; Toyozumi, T; Uesato, M	1
Cho, H; Kang, YK	1
Fokter-Dovnik, N; Smyth, EC	1
Okabe, H	1
Fujii, M; Kano, H; Kawai, T; Kochi, M; Masuda, S; Matsuno, Y; Nishimaki, H; Shimizu, H; Sugitani, M; Takayama, T; Tamegai, H; Watabe, M	1
Ghasemi, S; Motamedi, M; Razmkhah, F; Rezakhani, L	1
Candamio, S; Carmona, M; Covela, M; Fernández Montes, A; Jorge, M; López, R; Méndez, JC; Quintero Aldana, G; Reboredo, M; Romero, C; Salgado, M; Vázquez Tuñas, L; Vidal Insua, Y	1
Liu, L; Ma, C; Tang, H; Xiong, W; Zhao, Y	1
Aznab, M; Khazaei, M; Khazaei, S; Maleksabet, D; Rezaei, M	1
Baradaran, B; Darabi, M; Ghaffari, S; Javadian, M; Kazemi, T; Shekari, N	1
Xiao, N; Xiao, Y; Zhao, L	1
Cardic, MB; Chao, Y; Chen, LT; Cunningham, D; de Gramont, A; Kang, YK; Kujundzic, M; Lim, HY; Park, SR; Ramos, FJ; Rees, C; Roy, AC; Tabernero, J; Yeh, CG	1
Hamada, K; Imataka, H; Nemoto, H; Sato, A; Takeda, N	1
Dobrovic, A; Ganju, V; Gebski, VJ; Mellor, D; Parry, MM; Pavlakis, N; Strickland, AH; Tebbutt, NC; Van Hazel, GA; Zannino, D	1
Fujimura, T; Fushida, S; Goda, F; Hirono, Y; Kaji, M; Kinoshita, J; Oyama, K; Sudo, Y; Watanabe, Y; Yagi, Y	1
Al-Batran, SE; Hartmann, JT; Hofheinz, RD; Homann, N; Kripp, M; Moehler, M; Pauligk, C; Rosowski, J	1
Shim, KN; Yoon, SY	1
Gao, B; Gao, Z; Gavine, PR; Ji, J; Ji, Q; Kilgour, E; Liu, K; Shen, D; Su, X; Tang, L; Xie, L; Xu, Y; Yin, X; Zhang, J; Zhang, L; Zhang, X; Zhou, M	1
Alici, S; Alkis, N; Altunbas, M; Arpaci, E; Benekli, M; Bilici, A; Buyukberber, S; Dane, F; Demirci, U; Gumus, M; Karaca, H; Ozkan, M; Turk, HM	1
Anagnostopoulos, A; Athanasiadis, A; Boukovinas, I; Georgoulias, V; Kachris, S; Lambrodimou, G; Makrantonakis, P; Polyzos, A; Saridaki, Z; Souglakos, J; Stoltidis, D	1
Al-Batran, SE; Bichev, D; Haller, B; Homann, N; Lordick, F; Lorenzen, S; Luley, K; Pauligk, C; Schumacher, G; Schuster, T; Thuss-Patience, P	1
Chen, JP; Chen, XL; Chen, XZ; Chen, ZX; Hu, JK; Li, H; Li, K; Liao, YB; Wang, L; Yang, C; Yang, K; Zhang, B; Zhou, ZG	1
Cho, JK; Han, T; Hong, JM; Song, SC; Yang, HK	1
Chen, L; Chen, YX; Hao, LH; Jiang, XJ; Li, ZY; Lin, HZ; Song, MQ	1
Dolgikh, SD; Gapbarov, ACh; Polysalov, VN; Veriasova, NN	1
Demirkilic, U; Doganci, S; Erol, G; Gunay, C; Kadan, M; Kaya, E	1
Cho, JY	1
Kim, HJ; Kim, SH; Lee, H; Lee, HJ; Lee, JH; Lee, S; Oh, SY	1
Fujitani, K; Furukawa, H; Iijima, S; Imamura, H; Inoue, K; Kimura, Y; Kobayashi, K; Kurokawa, Y; Matsuyama, J; Shimokawa, T; Tamura, S; Tsuji, T; Tsujinaka, T	1
Dahan, L; Dalban, C; Landi, B; Lepère, C; Mazard, T; Mitry, E; Pernot, S; Rougier, P; Samalin, E; Seitz, JF; Taieb, J; Turki, H; Vaillant, JN; Ychou, M; Zaanan, A	1
Asmar, L; Cohn, A; David McCollum, A; Diab, S; Hecker, LI; Kocs, DM; Richards, D; Spira, AI; Zhan, F	1
Ji, M; Jiang, JT; Li, XD; Wu, CP; Wu, J; Xu, B; Zhang, HY; Zhao, WQ; Zhou, WJ	1
Goto, S; Kamigaki, T; Saito, M; Yano, K	1
Jeong, S; Ki, SH; Kim, HG; Kwon, KS; Lee, DH; Lee, JI; Park, IS; Shin, YW	1
Jiang, XQ; Li, RT; Liu, BR; Liu, Q; Qian, HQ; Qian, XP; Shen, J; Wei, J; Xie, L; Yang, M; Yu, LX	1
Fukumoto, M; Irei, Y; Maruyama, S; Matsuki, A; Nakagawa, S; Nashimoto, A; Nomura, T; Takii, Y; Tsuchiya, Y; Yabusaki, H	1
Amagai, K; Hirai, S; Hironaka, S; Hirose, M; Hyodo, I; Mamiya, T; Matsuda, K; Moriwaki, T; Murashita, T; Nihei, T; Ohkawara, A; Ozeki, M; Sato, M; Soeda, A; Yamaguchi, T	1
Doyama, H; Endo, N; Kadoya, S; Kurumatani, H; Murakami, N; Shimada, M; Tanada, Y; Yamada, T	1
Fujimura, T; Fujita, H; Fushida, S; Hayashi, H; Inokuchi, M; Kinoshita, J; Kitagawa, H; Makino, I; Miyashita, T; Nakagawara, H; Nakamura, K; Nakanuma, N; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Saito, H; Tajima, H; Takamura, H; Tsukada, T	1
Choi, YH; Jung, HY; Kang, HJ; Kang, YK; Kim, BS; Kim, HJ; Kim, KC; Lee, GH; Park, I; Park, YS; Ryu, MH; Yook, JH	1
Du, G; Li, L; Li, X; Xiao, W; Yang, H; Yu, M; Zhang, Z	1
Baek, SK; Kim, HJ; Kim, HS; Kim, SY; Kim, TY; Lee, KW; Nam, BH; Ryu, MH; Zang, DY	1
Akin, S; Al-Batran, SE; Ehninger, G; Goekkurt, E; Heussen, N; Hofheinz, RD; Kramer, M; Lehmann, S; Pauligk, C; Senff, T; Stenholm, L; Stoehlmacher-Williams, J	1
Aishima, S; Ando, K; Kakeji, Y; Kitahara, H; Kounoe, S; Maehara, Y; Oki, E; Saeki, H; Shirabe, K	1
Li, X; Liang, J; Liu, B; Liu, S; Qiu, W; Yao, R; Yao, Y	1
Arnold, D; Geissler, M; Grothe, W; Hofheinz, RD; Moehler, M; Reinacher-Schick, A; Schmoll, HJ; Seufferlein, T; Stein, A; Thuss-Patience, PC	1
Atsumi, Y; Hasegawa, S; Imada, T; Masuda, M; Nemoto, H; Oshima, T; Rino, Y; Sato, T; Tamagawa, H; Uchiyama, M; Yoshikawa, T; Yukawa, N	1
Cai, JC; Luo, QC; Ma, XQ; Wang, LP	1
Bai, Y; Davies, BR; Han, S; Ji, Q; Li, J; Liu, YJ; Tang, L; Wang, H; Xu, Y; Yin, X; Yu, DH; Zhang, J; Zhou, M	1
Guo, H; Liu, L; Liu, T; Liu, Y; Xu, Y; Yang, S; Yao, S; Yao, Z; Yuan, Y; Zhao, Y	1
Horie, T; Ishibashi, Y; Mizumoto, K; Noso, Y; Yamagata, S	1
Liu, Y; Ma, T; Shi, M; Xi, W; Yang, L; Ye, Z; Zhang, J; Zhu, Z	1
Elsing, C; Hannig, CV; Herrmann, C; Herrmann, T; Jäger, D; Stremmel, W	1
Ahn, HK; Cho, EK; Chung, M; Hong, J; Kim, YS; Lee, JH; Lee, WK; Park, I; Park, J; Park, SH; Shin, DB; Sym, SJ	1
Akiyama, H; Endo, I; Fujii, S; Hasegawa, S; Kaida, S; Kosaka, T; Kunisaki, C; Makino, H; Ono, H; Oshima, T; Tamura, S; Wada, T	1
Akao, T; Fukai, Y; Fukuda, T; Ojima, H; Sano, A; Sohda, M; Tanabe, A	1
Akiyama, H; Endo, I; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, H; Takagawa, R	1
Brighenti, M; Curti, A; Donati, G; Lazzarelli, S; Liguigli, W; Martinotti, M; Negri, F; Olivetti, L; Passalacqua, R; Poli, R; Rovatti, M; Tomasello, G	1
Arena, MG; Barba, M; Belli, F; Di Lauro, L; Fattoruso, SI; Giannarelli, D; Maugeri-Saccà, M; Paoletti, G; Pizzuti, L; Sergi, D; Tomao, S; Vici, P	1
Inoue, K; Kobayashi, H; Murata, S; Naitoh, H; Tani, T; Yamamoto, H	1
Amodio, A; Barba, M; Belli, F; Boggia, S; Di Lauro, L; Fattoruso, S; Giannarelli, D; Maugeri-Saccà, M; Pizzuti, L; Sergi, D; Vici, P	1
Park, SH	1
Blazeby, JM; Bridgewater, JA; Chau, I; Cook, N; Coxon, FY; Cunningham, D; Dunn, JA; Falk, S; Ford, HE; Fyfe, D; Janowitz, T; Kareclas, P; Madhusudan, S; Mansoor, W; Marshall, A; Middleton, GW; Swinson, D; Wadsley, J	1
Cui, FB; Ding, H; Hu, WJ; Li, RT; Liu, BR; Liu, Q; Qian, XP; Wu, PY; Yu, LX; Yue, GF	1
Canbay, E; Hirano, M; Ichinose, M; Ishibashi, H; Mizumoto, A; Sako, S; Takao, N; Yonemura, Y	1
Cho, JY; Chung, HC; Fujii, M; Hara, T; Hosaka, H; Imamura, H; Inokuchi, M; Kim, HK; Kim, YH; Koizumi, W; Lee, KH; Nakajima, T; Ogura, M; Okuno, T; Satoh, T; Takagane, A; Takeuchi, M; Tanabe, K; Tsuji, A; Yoshida, K	1
Arase, H; Doi, T; Eriguchi, K; Kawashima, T; Koyama, T; Makidono, K; Miyamoto, K; Ohishi, T; Sakahira, H; Takahashi, O; Ueda, Y	1
Cho, H; Fujikawa, H; Iwasaki, K; Kasahara, A; Masuda, M; Ogata, T; Osaragi, T; Rino, Y; Shirai, J; Sujishi, K; Tsuburaya, A; Yamada, T; Yamamoto, Y; Yoneyama, K; Yoshikawa, T	1
Fushida, S; Kita, I; Mukubo, H; Sato, N; Yasui, T	1
Ebisui, C; Fukuchi, N; Kato, R; Kinuta, M; Makino, S; Murata, K; Okada, K; Okamura, S; Takeoka, T; Wada, Y; Yanagisawa, T; Yokouchi, H	1
Hanada, S; Ichioka, M; Kondo, M; Ochi, J; Okamoto, E; Sakuranaka, H; Shibayama, T; Takagi, K; Tamura, A; Tanaka, M; Tei, S	1
Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H	1
Endo, W; Hamano, R; Nakano, H; Shirakawa, M; Taniguchi, M; Tsujie, M; Watanabe, Y; Yano, H	1
Kanazawa, Y; Uchida, E; Yamada, T; Yokoi, K	1
Bai, L; Su, D	1
Aishima, S; Baba, H; Emi, Y; Hirabayashi, N; Kakeji, Y; Kusumoto, T; Maehara, Y; Morita, M; Oki, E; Orita, H; Sadanaga, N; Saeki, H; Sakaguchi, Y; Sakai, K; Shimokawa, M; Takahashi, I; Yamaguchi, K; Yamamoto, M; Yamanaka, T; Yoshida, K	1
Glimelius, B; Gubanski, M; Lind, PA	1
Li, X; Liang, J; Liu, S; Qi, W; Qiu, W; Yao, R; Yao, Y; Yue, L	1
Deng, W; Gong, JF; Li, J; Li, Y; Lu, M; Lu, ZH; Shen, L; Wang, QW; Zhang, XT; Zhou, J	1
Chang, ZW; Dong, L; Han, ZF; Li, J; Lou, XP; Lu, P; Miao, JH	1
Aitini, E; Amadori, D; Bajetta, E; Bidoli, P; Boni, C; Cantore, M; Carlomagno, C; Casaretti, R; Comella, G; Daniele, B; Di Bartolomeo, M; Di Costanzo, F; Di Fabio, F; Falcone, A; Floriani, I; Labianca, R; Landi, L; Marchet, A; Mini, E; Mosconi, S; Nitti, D; Pinotti, G; Pinto, C; Poli, D; Ravaioli, A; Rosati, G; Santoro, A	1
Enjoji, M; Ishida, T; Ishimaru, S; Kobayashi, K; Murase, H; Obara, M; Oono, R; Ueda, Y	1
Bilici, A	1
Costa, C; Gimenez-Capitan, A; Guan, W; Liu, B; Qian, X; Rosell, R; Sanchez, JJ; Shen, J; Sun, X; Wei, J; Yu, L; Yue, G; Zou, Z	1
Guo, Mg; Yang, Z; Zheng, Q; zhong Di, J	1
Brock, MV; Guo, M; Herman, JG; Lu, Y; Wu, K; Yan, W; Yang, Y; Zhang, Z; Zhou, Y	1
Ades, S; Alcindor, T; Aloraini, A; Asselah, J; Brisson, S; David, M; Ferri, L; Frechette, D; Sudarshan, M; Thirlwell, M; van Huyse, M	1
Abei, M; Endo, S; Hirai, S; Hirose, M; Hyodo, I; Saito, R; Suzuki, H; Ueno, T; Yamato, K	1
Aiello, E; Colarossi, C; Colarossi, L; Espina, V; Iuppa, A; Liotta, L; Memeo, L; Mueller, C	1
Chen, L; Dai, G; Han, Y; Jia, B; Jiao, S; Qin, R; Shi, Y; Wei, B; Wei, L; Wu, Q; Yuan, J	1
Ishibashi, Y; Ito, Y; Omori, K; Wakabayashi, K	1
Kemal, Y; Kut, E; Teker, F; Yilmaz, B; Yucel, I	1
Abali, H; Bostanci, B; Civelek, B; Oguz, D; Oksuzoglu, B; Ozdemir, N; Vural, M; Yalcin, B; Yalcin, S; Zengin, N	1
de Braud, F; Di Bartolomeo, M; Farcomeni, A; Iacovelli, R; Maggi, C; Palazzo, A; Pietrantonio, F; Ricchini, F	1
Iwasaki, W; Kichiraku, T; Kikkawa, M; Kotanagi, H; Kotanagi, K; Muto, O; Ouchi, S; Sato, K; Sawada, T	1
Bilici, A; Demir, N; Dikilitas, M; Oven Ustaalioglu, BB; Selcukbiricik, F; Yildiz, O	1
Boni, C; Clemens, M; Cohn, A; Dane, F; Ecstein-Fraisse, E; Follana, P; Harrison, M; Hitier, S; Massuti, B; Middleton, G; Moiseyenko, V; Pernot, S; Pimentel, FL; Prenen, H; Reichardt, P; Richards, DA; Rougier, P; Tabernero, J; Van Cutsem, E; Zaniboni, A	1
Alsina, M; Aranda, E; Cano, MT; Conde, V; Díaz-Rubio, E; Galán, M; García de Paredes, ML; López, C; Manzano, JL; Martínez Galán, J; Massutí, B; Pachón, V; Reboredo, M; Rivera, F; Salcedo, M; Sastre, J; Serrano, R; Valladares-Ayerbes, M; Yuste Izquierdo, AL	1
Bai, L; Guo, XC; Mao, ZY; Su, D; Wang, LJ; Zhang, TT	1
Chen, F; Ding, GJ; Lu, BQ; Qi, C; Wu, J; Zhu, YJ	1
Hosoda, K; Katada, N; Kikuchi, S; Mieno, H; Moriya, H; Sakuramoto, S; Watanabe, M; Yamashita, K	1
Xu, CD	1
Huang, H; Li, PH; Lu, MD; Qi, DS; Sun, WJ; Wang, FH; You, T; Yu, YJ; Zhang, Y; Zheng, ZQ	1
Ba, Y; Bai, Y; Chen, W; Dai, G; Fan, N; Jiao, S; Li, J; Liu, T; Liu, Y; Ma, D; Qin, S; Shen, L; Shu, Y; Wang, J; Xu, J; Xu, R; Zheng, L	1
Chen, Y; Deng, Y; Gong, J; Lan, P; Li, W; Peng, J; Ren, D; Wang, J; Wang, L; Xiao, J; Zhou, Z	1
Izzo, C	1
Chen, J; Dong, L; Gong, J; Jia, H; Kong, Y; Li, J; Lin, H; Liu, C; Luo, M; Ma, Y; Su, R; Wang, F; Wang, Y; You, L; Yu, J; Zhang, J; Zhang, Z	1
Ito, M; Kunishige, T; Matsumoto, S; Migita, K; Nakade, H; Nakajima, Y; Takayama, T; Tanaka, T; Wakatsuki, K	1
Asao, Y; Furuyama, H; Kadokawa, Y; Kato, S; Machimoto, T; Nishino, H; Nishiuchi, A; Yoshimura, T	1
Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H	1
Aldemir, MN; Bilen, N; Bilici, M; Cayir, K; Makas, I; Simsek, M; Tekin, SB; Turkeli, M; Yildirim, N	1
Bianco, V; Brozzetti, S; Fiaschi, AI; Francini, E; Laera, L; Marrelli, D; Petrioli, R; Rossi, G; Roviello, F; Roviello, G	1
Doki, Y; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Cho, SJ; Choi, IJ; Kim, CG; Kim, MJ; Kim, SK; Kim, YW; Kong, SY; Kook, MC; Lee, JH; Lee, JS; Lee, JY; Lim, HS; Park, SR; Park, YI; Ryu, KW	1
Aoyagi, K; Ashikawa, M; Chiwaki, F; Fujita, T; Fukagawa, T; Katai, H; Komatsu, M; Kushima, R; Nagase, H; Nakagama, H; Narita, M; Sakamoto, H; Sasaki, H; Sawada, Y; Suzuki, M; Suzuki, T; Uezono, Y; Yanagihara, K; Yoshida, T	1
Doki, Y; Hamakawa, T; Kurokawa, Y; Miyata, H; Miyazaki, Y; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Anselmi, E; Banchini, F; Bodini, FC; Capelli, P; Cavanna, L; Michieletti, E; Stroppa, EM; Zangrandi, A	1
Fujino, Y; Goji, T; Kimura, T; Kitamura, S; Miyamoto, H; Miyoshi, J; Muguruma, N; Okahisa, T; Okamoto, K; Sogabe, M; Takayama, T; Taniguchi, T; Tomonari, T	1
Cho, JW; Choi, DR; Han, B; Jung, JY; Kang, YK; Kim, HS; Kim, JH; Kim, MJ; Lim, MS; Park, CK; Ryoo, BY; Ryu, MH; Song, H; Yang, DH; Zang, DY	1
Aizawa, M; Matsuki, A; Migita, K; Nashimoto, A; Yabusaki, H	1
Bae, SH; Baek, JH; Chae, YS; Kang, BW; Kim, JG; Kim, JY; Kim, MK; Lee, KH; Lee, SA; Ryoo, HM; Song, HS; Yoon, S	1
Fushida, S; Kinoshita, J; Makino, I; Miyashita, T; Nakamura, K; Ninomiya, I; Ohta, T; Okamoto, K; Oyama, K; Tajima, H; Takamura, H; Tsukada, T	1
Catino, A; De Ceglie, A; Galetta, D; Logroscino, A; Misino, A; Natalicchio, MI; Simone, G	1
Fujino, Y; Hirakawa, M; Hirata, K; Kagawa, M; Kato, J; Katsuki, S; Kobune, M; Kubo, T; Mitsui, Y; Miyamoto, H; Miyoshi, J; Nobuoka, T; Ohnuma, H; Okuda, T; Osuga, T; Sagawa, T; Sato, Y; Takahashi, Y; Takaoka, T; Takayama, T; Takimoto, R	1
Aoyagi, K; Chiwaki, F; Fujita, T; Fukagawa, T; Ichikawa, H; Katai, H; Komatsu, M; Komatsuzaki, R; Konno, H; Matsusaki, K; Nishimura, T; Ochiya, T; Sakamoto, H; Sasaki, H; Takahashi, RU; Tamaoki, M; Yamada, Y; Yanagihara, K; Yoshida, T	1
Hotopp, T; Müller, H; Tofeili, A; Wutke, K	1
Skoropad, VY	1
Alvarez, E; Campos Balea, B; Casal, J; Castellanos, J; Fernández, A; Gallardo, E; González, P; Grande, C; Jorge, M; López, C; López, R; Quintero-Aldana, G; Salgado, M; Varela, S; Villanueva, MJ	1
Cai, J; Ding, H; Gu, X; Huang, H; Li, M; Wang, Q; Wang, Y; Xu, P; Yang, L; Yang, Q; Zhang, S; Zhu, J	1
Hoshi, K; Hosoda, K; Katada, N; Kikuchi, S; Mieno, H; Moriya, H; Ushiku, H; Watanabe, M; Yamashita, K	1
Bronsert, P; Glatz, T; Hoeppner, J; Hopt, UT; Kulemann, B; Makowiec, F; Marjanovic, G; Schäfer, M; Sick, O; Zirlik, K	1
Cui, Y; Feng, Y; Guo, M; Li, Q; Li, W; Liu, T; Wang, Y; Yu, Y; Zhuang, R	1
Allani, B; Ayadi, M; Bahloul, R; Ben Nasr, S; Chrait, N; Guesmi, S; Mezlini, A; Rais, H; Rifi, H	1
Capanu, M; Henderson, C; Janjigian, YY; Kelsen, DP; Kemeny, M; Krishnamurthi, S; Mehrotra, B; Ocean, A; Ritch, P; Shah, MA; Shibata, S; Stoller, R; Su, YB	1
Bang, YJ; Kim, TY; Oh, DY	1
Choi, M; Kim, R; Mahipal, A	1
Hasegawa, T; Himuro, N; Hirata, K; Ishikawa, K; Kato, J; Kawano, Y; Kobune, M; Kubo, T; Miyanishi, K; Mori, M; Murase, K; Nobuoka, T; Sato, T; Sato, Y; Sugita, S; Takada, K; Takayama, T; Takimoto, R	1
Hayashi, T; Horii, N; Inoue, H; Kimura, J; Kunisaki, C; Maezawa, Y; Makino, H; Masuda, M; Ohnishi, H; Ohshima, T; Rino, Y; Suzuki, Y; Takagawa, R; Tsuburaya, A; Yamamoto, J	1
Du, N; Kang, HR; Li, XS; Ma, J; Yao, FF; Yao, S	1
Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Legdeur, MC; Meulendijks, D; Schellens, JH	1
Chang, YJ; Cheng, WL; Huang, CY; Hung, CS; Tu, CC; Uyanga, B; Wei, PL	1
Brower, V	1
Beeker, A; Beerepoot, LV; Beijnen, JH; Boers, JE; Boot, H; Cats, A; de Groot, JW; de Jong, RS; Goey, SH; Kuiper, M; Los, M; Meulendijks, D; Polee, MB; Portielje, JE; Schellens, JH; Sikorska, K; Tesselaar, ME; Vanhoutvin, SA	1
Andreoni, B; Bernhard, J; Biffi, R; Brauchli, P; Chiappa, A; Crosta, C; de Braud, F; Fazio, N; Goldhirsch, A; Hayoz, S; Huber, O; Luca, F; Maibach, R; Morant, R; Renne, G; Roth, AD; Stupp, R; Thierstein, S; Zampino, MG	1
Du, C; Guo, C; Wang, J; Xu, Q; Zhou, A	1
Cui, J; Gao, J; Guo, M; Huang, J; Li, W; Lin, B; Lin, S; Lu, Y; Pan, Y; Shen, L; Wang, JM; Xing, R; Zhao, Y; Zhu, M	1
Meng, ZJ; Tao, K	1
Fujii, Y; Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Miura, S; Morioka, E; Nakano, Y; Noguchi, M; Ohonishi, T; Ohono, Y; Sakata, N; Tomita, Y; Ueda, N	1
Kunisaki, C; Masuda, M; Ohshima, T; Rino, Y; Suzuki, Y; Tsuburaya, A; Yukawa, N	1
Akiyama, H; Endo, I; Kimura, J; Kunisaki, C; Makino, H; Minami, Y; Suzuki, Y; Takagawa, R; Tsuburaya, A; Yazawa, K	1
Hiratsuka, M; Ishibashi, Y; Ito, Y; Morita, A; Omori, K; Saito, H; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K	1
Ito, M; Kitano, M; Kunishige, T; Matsumoto, S; Migita, K; Nakade, H; Nakajima, Y; Nakatani, M; Tanaka, T; Wakatsuki, K	1
Chao, Y; Chen, LT; Chen, MH; Chen, YC; Hsiao, CF; Li, CP; Lin, J; Liu, TW; Shan, YS	1
Cooray, P; Ferraro, DA; Ganju, V; Gebski, V; Hall, M; Pavlakis, N; Price, TJ; Shannon, JA; Sjoquist, KM; Strickland, A; Tebbutt, NC; Underhill, C; Varma, SC; Veillard, AS; Wong, N; Young, R	1
Datta, A; Goh, LK; Koh, V; Liem, N; Padmanabhan, N; So, J; Subhash, VV; Tan, IB; Tan, P; Tan, SH; Tan, WL; Wong, FY; Wong, WK; Xie, C; Yan, FL; Yap, CT; Yeo, MS; Yong, WP	1
Ajani, J; Baker, J; Blum Murphy, MA; Elimova, E; Ho, L; Mewada, N; Phan, A; Qiao, W; Takashi, T; Wadhwa, R	1
Geetha, P; Gopi Mohan, C; Jayakumar, R; Sivaram, AJ	1
Beeker, A; Beerepoot, LV; Beijnen, JH; Boers, JE; Cats, A; de Groot, JW; de Jong, RS; Goey, SH; Grootscholten, C; Kuiper, M; Los, M; Meulendijks, D; Pluim, D; Polee, MB; Portielje, JE; Schellens, JH; Sikorska, K; Tesselaar, ME; Vanhoutvin, SA	1
Bottini, A; Francini, E; Generali, D; Marano, L; Marrelli, D; Petrioli, R; Polom, K; Roviello, F; Roviello, G; Zanotti, L	1
Batlett, D; Canbay, E; Coccolini, F; Deraco, M; Elias, D; Glehen, O; Gonzaletz-Moreno, S; Ishibashi, H; Li, Y; Mahtem, H; Mizumoto, A; Moran, B; Morris, D; Piso, P; Sugarbaker, PH; Verwaal, V; Yonemura, Y	1
Chaudhry, NA; Coman, R; Zahid, K; Zhang, Q	1
Huang, CQ; Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yang, XJ; Zhang, Q	1
Chung, HY; Kang, BW; Kim, JG; Kwon, OK; Yu, W	1
Arigami, T; Baba, K; Ishigami, S; Kita, Y; Maemura, K; Matsushita, D; Mori, S; Natsugoe, S; Okumura, H; Tsuruda, Y; Uchikado, Y; Uenosono, Y; Yanagita, S	1
Al-Fakeeh, A; Al-Ruzug, I; Alcindor, T; Doerksen, T; Ferri, L; Mulla, N; Santos, F	1
Kato, T; Nakamura, Y; Nakayama, H; Okamura, R; Yoh, T	1
Lu, M; Wang, J; Wang, T	1
Abramovich, A; Amit, L; Brenner, B; Gordon, N; Idelevich, E; Kundel, Y; Medalia, G; Purim, O; Sadeh Gonik, U; Sarfaty, M; Sulkes, A	1
Bonnetain, F; Borg, C; Cléau, D; Fein, F; Fiteni, F; Foubert, A; Fratté, S; Jacquin, M; Jary, M; Kim, S; Lakkis, Z; Lamfichekh, N; Mariette, C; Mathieu, P; Messager, M; Nguyen, T; Paget-Bailly, S; Sakek, N	1
Akiyama, H; Arisaka, S; Endo, I; Furuya, M; Ichikawa, Y; Kosaka, R; Kunisaki, C; Ohashi, K	1
Arbea, L; Cano, D; Ceniceros, L; Chopitea, A; Diaz-Gonzalez, JA; Hernandez, JL; Iragorri, Y; Legaspi, J; Martin-Romano, P; Martínez-Regueira, F; Ponz-Sarvise, M; Rodríguez, J; Sola, JJ; Subtil, JC	1
Barni, S; Ghidini, M; Passalacqua, R; Petrelli, F; Tomasello, G	1
Cho, H; Hayashi, T; Ikeda, K; Kano, K; Maezawa, Y; Masuda, M; Nakajima, T; Ogata, T; Ohshima, T; Rino, Y; Sato, T; Segami, K; Yamada, T; Yamamoto, N; Yoshikawa, T; Yukawa, N	1
Cheng, SY; Du, J; Li, J; Li, KC	1
Beijnen, JH; Cats, A; Deenen, MJ; Joerger, M; Meulendijks, D; Rozeman, EA; Schellens, JHM; Sikorska, K	1
Hanyu, T; Hishiki, M; Ichikawa, H; Ishikawa, T; Kameyama, H; Kobayashi, T; Kosugi, S; Muneoka, Y; Nagahashi, M; Otani, T; Sakai, T; Sakata, J; Usui, K; Wakai, T	1
Abou, M; Cacheux, W; Fernandez, E; Frossard, JL; Huber, O; Koessler, T; Moniez, M; Puppa, G; Roth, A	1
Takahari, D	1
Chen, H; Chen, T; Chen, X; Chen, Y; Chen, Z; He, X; Hu, Y; Hu, Z; Li, X; Liu, Y; Tu, W; Xu, Y; Yan, G; Yao, S; Zhang, T; Zhao, G	1
Bozkaya, Y; Demirci, NS; Doğan, M; Erdem, GU; Yazıcı, O; Zengin, N	1
Hu, S; Jiang, Y; Sun, Y; Xue, L; Xue, X; Yang, L; Yue, J; Zhu, Y	1
Fujii, M	1
Ahn, JB; Chung, HC; Jeung, HC; Noh, SH; Rha, SY; Roh, JK; Shin, SJ; Yoo, NC	1
Barone, C; Pozzo, C	1
Ajani, JA	4
Al-Batran, SE; Atmaca, A; Clemens, MR; Fritz, M; Hartmann, JT; Hofheinz, R; Homann, N; Jäger, E; Mahlberg, R; Pauligk, C; Probst, S; Rethwisch, V; Seipelt, G; Sievert, M; Stoehlmacher, J	1
Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Nishimura, K; Saigenji, K; Sasaki, T; Takagi, S; Tanabe, S	1
Hang, X; Ma, S; Sun, Q; Wang, D; Yang, Y; Ying, JE; Yong, D; Zhang, Y; Zhong, B; Zhong, H	1
Bekaii-Saab, T; Haghighat, P	1
Chen, Z; Guo, J; Li, CZ; Liu, B; Liu, J; Sheng, LJ; Wang, QC; Wang, ZH; Zhang, EN; Zhou, DG	1
Kim, JH; Lee, YC	1
Cheng, Z; Feng, CN; Guo, MG; Wang, Y; Yang, Z; Zheng, Q	1
Fukushima, M; Konishi, K; Okada, M; Sanada, Y; Tsutani, Y; Wada, Y; Yoshida, K	1
Chang, MH; Ji, SH; Jun, HJ; Kang, WK; Kim, HS; Kim, KH; Lee, J; Lim, DH; Lim, HY; Park, JO; Park, MJ; Park, SH; Park, YS; Uhm, J; Yi, SY	1
Ishikawa, T; Isozaki, Y; Kiyota, K; Kokura, S; Matsuyama, R; Nagao, Y; Okita, M; Oyamada, H; Suzuki, K; Yoshikawa, T	1
Liu, BR; Qian, XP; Wang, TT; Wei, J; Yu, LX	1
Doki, Y; Fujiwara, Y; Miyata, H; Nakajima, K; Nishida, T; Takiguchi, S; Yamazaki, M	1
Blaszkowsky, LS; Clark, JW; Earle, CC; Enzinger, PC; Fidias, P; Fuchs, CS; Kulke, MH; Mayer, RJ; Meyerhardt, JA; Muzikansky, A; Ryan, DP; Vincitore, MM; Zhu, AX	1
Gennatas, C; Gennatas, S; Michalaki, V	1
Han, T; Hwang, SW; Jang, KM; Jung, JY; Kim, HJ; Kim, HS; Kim, HY; Kim, JH; Kim, MJ; Kwon, JH; Park, S; Song, HH; Yang, DH; Yoo, KS; Zang, DY	1
Berglund, A; Byström, P; Frödin, JE; Glimelius, B; Johansson, B; Letocha, H; Nygren, P; Pedersen, D	1
Arena, MG; Di Lauro, L; Fattoruso, SI; Giacinti, L; Giannarelli, D; Lopez, M; Sergi, D	1
Chikazawa, N; Iijima, H; Ikebe, M; Jo, E; Kameda, C; Katano, M; Morisaki, T; Nagai, S; Nakamura, M; Sato, N; Sekine, F; Shoda, M; Suzuki, H; Tanaka, H; Tasaka, T; Wada, J; Yamasaki, A	1
Fujimura, T; Fushida, S; Kinoshita, J; Ohta, T; Oyama, K; Yagi, Y	1
Egashira, A; Emi, Y; Kakeji, Y; Maehara, Y; Morita, M; Oki, E; Sadanaga, N; Takahashi, I	1
Kameda, A; Minami, K; Miyahara, E; Noso, Y; Ohara, M; Suzuki, T; Tsutani, Y	1
Choi, IJ; Kim, NK; Kim, YW; Kong, SY; Kook, MC; Lee, JH; Lee, JS; Lim, HS; Nam, BH; Park, SR; Park, YI; Ryu, KW	1
Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD	1
Fujita, M; Matsuura, O; Morohashi, H; Yamada, K; Yamazaki, S	1
Abali, H; Budakoglu, B; Güler, T; Odabaşi, H; Oksüzoğlu, B; Ozdemir, NY; Uncu, D; Zengin, N	1
Fujitani, K; Hirao, M; Kurokawa, Y; Tsujinaka, T; Yamasaki, H; Yoshida, K	1
Endou, Y; Hirano, M; Ichinose, M; Ikeda, M; Ikeda, S; Kimura, H; Masuda, S; Matsuda, T; Matsuki, N; Miura, M; Mizumoto, A; Mizuno, M; Nakajima, G; Sasaki, T; Shinbo, M; Takao, N; Yonemura, J; Yonemura, Y; Yuuba, T	1
Fujii, S; Fukahori, M; Imada, T; Kunisaki, C; Makino, H; Masuda, M; Nagano, Y; Oshima, T; Rino, Y; Sato, T; Yamamoto, N	1
Futagawa, S; Kitajima, M; Konishi, N; Marusasa, T; Nishimura, K; Ochiai, T; Satoh, G; Watanabe, T	1
Inokuchi, M; Kawano, T; Kojima, K; Otsuki, S; Sugihara, K; Sugita, H; Yamada, H	1
Artale, S; Bardelli, A; Barone, C; Cascinu, S; Di Fabio, F; Falcone, A; Giannetta, L; Giaquinta, S; Martoni, AA; Mutri, V; Pinto, C; Rojas Llimpe, FL; Schinzari, G; Siena, S; Stella, G	1
Bazin, IS; Garin, AM; Kanagavel, D; Nasyrova, RIu; Tiuliandin, SA	1
Teng, KY; Xu, RH	1
Alici, S; Benekli, M; Buyukberber, S; Camci, C; Coskun, U; Dane, F; Gumus, M; Kalender, ME; Kaya, AO; Ozturk, B; Sevinc, A; Uncu, D; Yaman, E; Yildiz, R	1
Ban, T; Fujiwara, K; Hayashi, K; Hori, Y; Iwasaki, H; Kurimoto, T; Nemoto, A; Nishiwaki, H; Orito, E; Shiroko, J; Tachi, K; Umemura, S; Yamada, T; Yamakawa, Y	1
Fujii, S; Hiroshima, Y; Kimura, J; Kunisaki, C; Makino, H; Nagano, Y; Oshima, T; Takagawa, R	1
Doki, Y; Fujiwara, Y; Miyata, H; Mori, M; Nakajima, K; Nishida, T; Takiguchi, S; Yamamoto, K; Yamasaki, M	1
Fukushima, M; Konishi, K; Okada, M; Osada, S; Sanada, Y; Shigematsu, H; Takahashi, T; Wada, Y; Yoshida, K	1
Ma, Y; Qin, H; Wang, Y; Wang, Z; Yang, Z; Zheng, Q	1
Nishiyama, M; Wada, S	1
Chang, HM; Kang, HJ; Kang, YK; Kim, BS; Kim, TW; Lee, JL; Lee, SS; Oh, ST; Ryu, MH; Sym, SJ; Yook, JH	2
Chang, HM; Kang, YK; Kim, BS; Kim, TW; Lee, JL; Oh, ST; Ryu, MH; Sym, SJ; Yook, JH	1
Yu, JM; Yu, YH; Zhang, Y	1
Bu, ZD; Ji, JF; Li, SX; Li, ZY; Ren, H; Shan, F; Tang, L; Wu, AW; Wu, Q; Wu, XJ; Zhang, LH; Zhang, XP; Zong, XL	1
Akiya, T; Hosaka, H; Kon, Y; Motegi, K; Nogawa, H; Tagaya, R	1
Amadori, D; Arienti, C; Brigliadori, G; Fabbri, F; Leonetti, C; Passardi, A; Scarsella, M; Silvestrini, R; Tesei, A; Ulivi, P; Zoli, W; Zupi, G	1
Fukuda, K; Ikeguchi, M; Kuroda, H; Matsunaga, T; Saito, H; Tatebe, S	1
Ami, K; Ando, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kawasaki, N; Nagahama, T; Ohara, T; Tei, S	1
Fukunaga, M; Furukawa, H; Imamura, H; Kawabata, R; Kishimoto, T; Ohzato, H	1
Ami, K; Andou, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kurokawa, T; Nagahama, T; Ohara, T; Tei, S	1
Hirata, K; Kato, J; Kida, M; Kobune, M; Miyanishi, K; Niitsu, Y; Ohnuma, H; Ohta, H; Okubo, S; Sagawa, T; Sato, T; Sato, Y; Shintani, N; Takahashi, Y; Takayama, T; Takimoto, R; Tanaka, S; Yamaguchi, K	1
Hataya, K; Kimura, M; Kobayashi, O; Koizumi, W; Nabeshima, K; Sato, A; Shimada, K; Takahashi, M; Tsuburaya, A; Yoshikawa, T; Yoshizawa, Y	1
Cummins, MM; Ganju, V; Gebski, V; Gibbs, D; Sourjina, T; Stockler, M; Strickland, A; Tebbutt, NC; Van Hazel, G; Zalcberg, J	1
Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K	1
Abbruzzese, JL; Ajani, J; Ho, L; Jhamb, J; Kazmi, SM; Lin, E; Overman, MJ; Phan, A; Yao, JC	1
Fujimura, T; Fujita, H; Fushida, S; Harada, S; Kayahara, M; Kinoshita, J; Makino, I; Nakamura, K; Ninomiya, I; Ohta, T; Oyama, K	1
Bamias, A; Bobos, M; Christodoulou, Ch; Dimopoulos, MA; Fountzilas, G; Karina, M; Kostopoulos, I; Papakostas, P; Pectasides, D; Pentheroudakis, G; Samantas, E; Vourli, G	1
Andreoni, B; Biffi, R; Bonomo, G; Chiappa, A; Crosta, C; Fazio, N; Fiori, G; Huber, O; Luca, F; Orsi, F; Roth, A; Schuller, JC; Zampino, MG	1
Bazin, IS; Fedyanin, MY; Garin, AM; Kanagavel, D; Narimanov, MN; Pokataev, IA; Tjulandin, SA; Tryakin, AA; Yakovleva, ES	1
Emi, M; Hamai, Y; Hihara, J; Okada, M; Suzuki, T; Tanabe, K; Taomoto, J; Yoshida, K	1
Kaiho, T; Miyazaki, M; Nishimura, M; Nobumoto, D; Nomura, S; Okamoto, R; Shinmura, K; Togawa, A; Tsuchiya, S; Yanagisawa, S	1
Chao, Y; Kuo, JY; Lee, RC; Li, AF; Li, CP; Luo, JC; Yang, KC	1
Corn, BW; Geva, R	1
Brighenti, M; Buti, S; Dalla Chiesa, M; Donati, G; Lazzarelli, S; Passalacqua, R; Rovere, RK; Tomasello, G	1
Aneiros-Cachaza, J; Aneiros-Fernandez, J; Arias-Santiago, S; Escobar Gómez-Villalva, F; Husein-ElAhmed, H; Nicolae, A; O'Valle Ravassa, F	1
Allegrini, G; Andreuccetti, M; Cascinu, S; Cortesi, E; Falcone, A; Fontana, E; Fornaro, L; Granetto, C; Loupakis, F; Masi, G; Mentuccia, L; Merlano, M; Salvatore, L; Vasile, E	1
Fleig, WE; Grothe, W; Grothey, A; Haerting, J; Kleber, G; Unverzagt, S; Wagner, AD	1
Almhanna, K; Bekai-Saab, T; Dawson, S; El-Rayes, BF; Hammad, N; Heilbrun, LK; Patel, B; Philip, PA; Shields, AF; Smith, D; Urba, S; Vaishampayan, U; Zalupski, M	1
Liu, Y; Ma, T; Ye, ZB; Zhang, J; Zhu, ZG	1
Maehara, Y; Matsuda, H; Nagata, S; Ueda, N; Yoshida, Y	1
Hantel, A; Hwang, J; Javle, M; Khorana, AA; Kiefer, G; Lo, SS; Rajasenan, K; Ramanathan, RK; Schmotzer, A; Shayne, M; Simon, S; Wang, H	1
Andersen, M; Jensen, HA; Pfeiffer, P; Schønnemann, KR; Vestermark, LW; Yilmaz, M	1
Ansari, RH; Benson, AB; Catalano, P; O'Dwyer, PJ; Powell, M; Sun, W	1
Ohdan, H; Suzuki, T; Tanabe, K; Tokumoto, N; Yamamoto, H; Yoshida, K	1
Li, K; Park, J	1
Doki, Y; Fujiwara, Y; Miyata, H; Moon, JH; Mori, M; Nakajima, K; Nishida, T; Takiguchi, S; Yamamoto, K; Yamasaki, M	1
Aggarwal, S; Goel, G; Jauhri, M; Negi, A	1
Allali, M; Bergmann, U; Kummer, G; Riebeling, J; Schultheis, B; Sendler, A; Sendler, U; Strumberg, D; Tannapfel, A	1
Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T	1
Kito, F; Kunisaki, C; Matsuda, S; Mochizuki, Y; Takahashi, M; Watanabe, J; Yabuno, T	1
Doi, T; Horiuchi, A; Ishida, N; Sato, K; Sugishita, H; Watanabe, Y; Yoshida, M	1
Chen, G; Ding, Y; Liu, B; Qian, X; Wei, J; Xie, L; Yu, L	1
Hachisuka, T; Hattori, K; Kinoshita, T; Miyauchi, M; Mori, T; Shikano, T; Shinohara, M; Yamamoto, T	1
Ansari, RH; Choong, NW; Ferguson, MK; Fishkin, PA; Haraf, DC; Hoffman, PC; Kesler, KA; Kocherginsky, M; Krauss, SA; Mauer, AM; Posner, MC; Sandler, AB; Sciortino, DF; Szeto, L; Vokes, EE; Wade, J	1
Akiyama, H; Endo, I; Fujii, S; Kameda, K; Kimura, J; Kito, F; Kosaka, T; Kunisaki, C; Makino, H; Morita, S; Ono, HA; Oshima, T; Takagawa, R; Takahashi, M	1
Chang, HM; Kang, YK; Kim, BS; Kim, TW; Oh, ST; Ryu, MH; Yoo, C; Yook, JH	1
Berglund, A; Fernebro, E; Flygare, P; Glimelius, B; Gubanski, M; Johnsson, A; Kadar, L; Karlberg, I; Lind, PA	1
Bernal, P; Byrd, J; Malik, I	1
Hasegawa, I; Joh, T; Kajino, S; Kato, A; Nukaya, H; Tanaka, Y; Tokuda, H	1
Breithaupt, K; Thuss-Patience, PC	1
Hosono, S; Ito, H; Ito, S; Kawai, H; Kawase, T; Matsuo, K; Muro, K; Sawaki, A; Shibata, T; Shitara, K; Tajima, K; Takahari, D; Tanaka, H; Ura, T; Watanabe, M; Yatabe, Y; Yokota, T	1
Andersen, M; Pfeiffer, P; Schønnemann, KR; Yilmaz, M	1
Han, B; Kang, WK; Kim, JA; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS	1
Chao, Y; Chen, JS; Chen, LT; Lee, KD; Li, CP; Lin, PC; Lu, CH; Su, WP; Tsai, HJ; Yen, CJ	1
Arai, H; Hirakata, A; Kawamoto, M; Maruyama, H; Matsushita, A; Matsutani, T; Sasajima, K; Suzuki, S; Uchida, E; Umakoshi, M; Wakabayashi, H; Yokoyama, T	1
Hwang, IG; Kang, JH; Kang, WK; Kim, HS; Kwon, JM; Lee, HY; Lee, SC; Lim, DH; Lim, HY; Oh, SY; Park, KW; Park, SH	1
de Vries, A; Gastl, G; Lukas, P; Mühlmann, G; Öfner, D; Pluschnig, U; Spizzo, G; Steger, G; Widder, J; Zabernigg, A; Zacherl, J	1
Atsukawa, K; Honda, T; Hoshino, G; Imai, S; Imajyo, K; Kanai, T; Kumamoto, Y; Nagase, T; Nakagawa, M; Nonaka, T; Ogawa, Y; Sakaguchi, T; Shiba, T; Wada, O	1
Horiuchi, A; Kikuchi, S; Kojima, Y; Kuwabara, J; Matsuno, Y; Morimoto, M; Sato, K; Sato, M; Sugishita, H; Watanabe, Y; Yamamoto, Y; Yoshida, M	1
Capanu, M; Ilson, DH; Jhawer, M; Kelsen, DP; Lefkowitz, RA; Robinson, E; Shah, MA	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Moon, JH; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M	1
Amagasa, H; Ami, K; Ando, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kawasaki, N; Kurokawa, T; Nagahama, T; Ohhara, T; Watayo, Y	1
Egawa, T; Hayashi, S; Inaba, Y; Irino, T; Ito, Y; Kenmochi, T; Mihara, K; Nagashima, A; Ohashi, M; Okamura, A	1
Asami, S; Idani, F; Kin, H; Komoto, S; Kubo, S; Kubota, T; Kumano, K; Kurose, Y; Muro, M; Nojima, H; Sasaki, H; Takakura, N; Yoshioka, T	1
Amagasa, H; Ami, K; Ando, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kawasaki, N; Kurokawa, T; Nagahama, T; Watayo, Y	1
Chika, N; Dan, N; Goto, H; Hosokawa, T; Kakimoto, M; Kato, H; Koshiishi, H; Masuda, T; Matsuyama, T; Mitsuhashi, Y; Nishida, K; Okamura, T; Sakamoto, K; Tokita, H; Yoshimura, T	1
Ashley, S; Charalambous, H; Chau, I; Cunningham, D; Hawkes, E; Koukouma, A; Okines, AF; Papamichael, D; Rao, S	1
Hu, Y; Li, W; Sun, D; Wang, S; Wu, H; Xin, Y; Zhao, J	1
Contreras Ibáñez, JA; Díaz Gómez, L; Navas García, N	1
Antimonik, NIu; Beliak, NP; Manikhas, GM	1
Amano, S; Fujii, S; Fukahori, M; Godai, T; Imada, T; Kunisaki, C; Makino, H; Masuda, M; Numata, M; Oshima, T; Rino, Y; Sato, T	1
Hosojima, Y; Miura, T; Nakamura, J; Nakazawa, Y; Ozeki, Y; Takahashi, T; Yamada, S; Yamazaki, H; Yanagi, M	1
Daimon, Y; Kito, F; Mochizuki, Y; Takahashi, M; Watanabe, J; Yabuno, T; Yoshida, S	1
Akiyama, H; Endo, I; Fujii, S; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Nagano, Y; Ono, HA; Takagawa, R	1
Danno, K; Imaoka, S; Iwazawa, T; Kagara, N; Kanoh, T; Kimura, Y; Monden, T; Nakano, Y; Ohnishi, T; Taniguchi, H; Tono, T; Yano, H	1
Danno, K; Imaoka, S; Imasato, M; Kanoh, T; Kimura, Y; Monden, T; Nakano, Y; Ohnishi, T; Taniguchi, H; Tono, T; Yano, H	1
Dai, H; Liu, JW; Yan, D	1
Ahn, JB; Chung, HC; Im, CK; Jeung, HC; Noh, SH; Rha, SY; Roh, JK; Shin, SJ; Yang, WI	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Okada, K; Takiguchi, S; Yamasaki, M	1
Abali, H; Aksoy, S; Budakoglu, B; Kos, FT; Odabaş, H; Oksuzoglu, B; Ozdemir, N; Uncu, D; Zengin, N	1
Al-Batran, SE; Altmannsberger, HM; Atmaca, A; Bruch, HP; Homann, N; Jäger, E; Luley, K; Noack, F; Pauligk, C; Werner Kraus, T	1
Kim, DN; Lee, SK; Shin, HJ	1
Chen, JS; Chen, PT; Chen, YY; Hsu, HC; Huang, JS; Lin, YC; Shen, WC; Wang, HM; Yeh, KY	1
Ba-Ssalamah, A; Bojic, M; Datler, P; Hejna, M; Maresch, J; Pluschnig, U; Schoppmann, SF; Thallinger, CM; Zacherl, J	1
Fujitani, K; Furukawa, H; Iijima, S; Imamura, H; Inoue, K; Kimura, Y; Kobayashi, K; Kurokawa, Y; Matsuyama, J; Tamura, S; Tsuji, T	1
Huang, XE; Huo, JG; Li, CG; Li, Y; Xu, JW	1
Bichev, D; Blau, I; Breithaupt, K; Dogan, Y; Grieser, C; Grothoff, M; Kretzschmar, A; Reichardt, P; Rothmann, F; Schwaner, I; Thuss-Patience, PC	1
Ae, T; Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Naruke, A; Nishimura, K; Sasaki, T; Takagi, S; Tanabe, S	1
Amarantidis, K; Chamalidou, E; Chelis, L; Deftereos, S; Dimopoulos, P; Kakolyris, S; Karanikas, M; Karayiannakis, A; Michailidis, P; Tentes, A; Xenidis, N	1
Bonetti, A; Durante, E; Mercanti, A; Piacentini, P; Trolese, A	1
Benlloch, S; Chen, H; Costa, C; Ding, Y; Gimenez-Capitan, A; Liu, B; Meng, F; Moran, T; Qian, X; Rosell, R; Sanchez, JJ; Taron, M; Wei, J; Yu, L; Zou, Z	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M	1
Abe, K; Iwazawa, T; Morita, S; Nakabori, T; Osa, A; Takimoto, T; Terada, H; Watanabe, A	1
Fujita, K; Imamura, I; Kakeji, Y; Kubo, N; Maehara, Y; Morita, M; Ohgaki, K; Oki, E; Sadanaga, N; Shibahara, K; Tsujitani, S	1
Homma, K; Maruyama, S; Matsuki, A; Nakagawa, S; Nashimoto, A; Nomura, T; Takii, Y; Tsuchiya, Y; Usuda, A; Yabusaki, H	1
Fujimura, T; Fujita, H; Fushida, S; Hayashi, H; Kinoshita, J; Kitagawa, H; Makino, I; Nakagawara, H; Nakamura, K; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Tani, T	1
Buhr, HJ; Fusi, A; Hotz, B; Hotz, HG; Keilholz, U	1
Bayraktar, S; Bayraktar, UD; Chen, E; Hosein, P; Koniaris, LG; Montero, AJ; Rocha-Lima, CM	1
Ades, S; Alcindor, T; Artho, G; Chasen, M; Ferri, LE; Hickeson, M; Marcus, V; Thirlwell, MP	1
Chi, Y; Cui, CX; Li, JL; Ren, JH; Wang, JW; Yang, L	1
Chae, SW; Choi, JM; Choi, SJ; Cui, JX; Jadhav, VB; Jun, YJ; Kim, IS; Lee, HJ; Min, JH; Sohn, YS	1
Aono, H; Maehara, T; Naohara, T; Sato, K; Sato, M; Sugishita, H; Watanabe, Y; Yamamoto, Y; Yoshida, M	1
Cho, H; Fukunaga, T; Ito, S; Kunisaki, C; Matsui, T; Morita, S; Nishikawa, K; Sakuramoto, S; Taguri, M; Tanabe, K; Tsuburaya, A; Yoshikawa, T	1
Al-Batran, SE; Altmannsberger, HM; Atmaca, A; Hartmann, JT; Hofheinz, RD; Homann, N; Jäger, E; Pauligk, C; Schmalenberg, H; Steinmetz, K; Werner, D; Wirtz, R	1
Ajani, JA; Beddar, AS; Briere, TM; Chakravarty, T; Crane, CH; Das, P; Delclos, ME; Krishnan, S; Mansfield, PF; Mok, H; Reed, VK	1
Fujimura, T; Fukushima, N; Fushida, S; Kawachi, Y; Kuwabara, S; Musha, N; Nashimoto, A	1
Fu, S; Jiang, R; Liu, T; Lu, JJ; Peng, L; Tey, J; Xiong, F; Yang, Z; Zhang, Q	1
Fujitani, K; Hirao, M; Kodama, Y; Mano, M; Tsujinaka, T	1
Goh, PG; Jeong, HY; Kim, ES; Kim, SH; Kim, YJ; Lee, BS; Lee, ES; Lee, SY; Moon, HS; Sung, JK	1
Cho, DH; Ha, YJ; Jeon, YJ; Kim, BS; Kim, HJ; Kim, JC; Kim, SY; Kim, YS; Roh, SA; Yoon, SN	1
Dok, Y; Hamakawa, T; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Egawa, T; Eto, E; Hayashi, S; Inaba, Y; Irino, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Okamura, A; Segami, K	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Okada, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Leistner, Y; Ludewig, S; Rauchfuss, F; Settmacher, U; Zanow, J	1
Alessandroni, P; Baldelli, AM; Casadei, V; Catalano, V; D'Emidio, S; Fiorentini, G; Giordani, P; Graziano, F; Luzi Fedeli, S; Rossi, D; Santini, D; Schiavon, G; Tonini, G; Vincenzi, B	1
Ben Aharon, I; Brenner, B; Brenner, R; Gordon, N; Kundel, Y; Purim, O; Sulkes, A	1
Hashizume, E; Narita, T; Suzuki, A; Yajima, M	1
Inal, A; Isikdogan, A; Kaplan, MA; Kucukoner, M	1
Ando, T; Fujinami, H; Horikawa, N; Hosokawa, A; Itaya, Y; Kajiura, S; Kobayashi, T; Nishikawa, J; Note, M; Ogawa, K; Sugiyama, T; Tsukioka, Y; Ueda, A; Yabushita, K	1
Chan, HC; Jiang, X	1
Wu, H; Xiao, Y; Xin, Y; Zhao, J	1
Ju, AH; Lin, J; Sun, XC	1
Hwang, IG; Kang, JH; Kang, WK; Kwon, HC; Lee, J; Lee, SC; Lee, SI; Lim, DH; Lim, HY; Nam, E; Oh, SY; Park, JO; Park, KW; Park, SH; Park, YS; Shin, DB	1
Koroleva, IA; Mochalova, AS	1
Ishiguro, A; Itoh, J; Kawasaki, H; Kijima, H; Kudoh, Y; Matsumoto, Y; Saijo, Y; Shimaya, S; Takahata, T; Tanaka, S	1
Li, XL; Liu, BR; Qian, XP; Wang, TT; Wei, J; Yu, LX; Zou, ZY	1
Kang, WK; Lee, J; Lim, HY; Park, JO; Park, SH; Park, YS; Yi, JH; Yim, DS	1
Ebi, M; Hirata, Y; Joh, T; Kamiya, T; Kataoka, H; Kitagawa, M; Mizoshita, T; Mizushima, T; Shimura, T; Tanida, S; Yamada, T; Yoshida, M	1
Lu, H; Wang, F; Xia, L; Xing, L; Yu, H; Yu, J; Yu, X; Zhang, J	1
Hayakawa, T; Hirakata, A; Hosone, M; Katayama, H; Maruyama, H; Matsushita, A; Matsutani, T; Sasajima, K; Takao, Y; Uchida, E; Umakoshi, M; Yokoyama, T; Yoshida, H	1
Hasegawa, H; Kubo, H; Miyahara, M; Nishiyama, M; Tada, K; Yamashita, Y	1
Boku, N; Ito, S; Katayama, H; Mizusawa, J; Sano, T; Sasako, M; Takahari, D; Terashima, M; Tsuburaya, A	1
Chen, J; Liu, B; Qian, X; Wang, T; Wei, J; Xie, L; Yu, L; Zou, Z	1
Lordick, F	1
Buonadonna, A; Corona, G; Frustaci, S; Lo Re, G; Miolo, G; Tabaro, G; Toffoli, G; Torrisi, E; Tumolo, S; Turchet, E	1
Enomoto, K; Ito, M; Matsumoto, S; Migita, K; Nakajima, Y; Takayama, T; Tanaka, T; Wakatsuki, K	1
Arnold, D; Bichev, D; Breithaupt, K; Daum, S; Florschütz, A; Gahn, B; Glanemann, M; Hofheinz, RD; Kneba, M; Kretzschmar, A; Mantovani-Löffler, L; Reichardt, P; Schlattmann, P; Schumacher, G; Thuss-Patience, PC	1
Adenis, A; Adler, G; Aparicio, J; Barcelo, JR; Canon, JL; Cassinello, J; Castanon, C; Cunningham, D; D'Hondt, L; Fonseca, E; Garcia Giron, C; Hawkins, R; Hossfeld, DK; Kerger, J; Lofts, F; Lopez-Vivanco, G; Misset, JL; Mousseau, M; Nicolson, M; Rixe, O; Rodriguez, R; Roy, A; Schalhorn, A; Schoffski, P; Sörbye, H	1
Asukai, K; Hasegawa, I; Horiguchi, N; Koguchi, H; Matsunaga, S; Miura, A; Ohno, T; Sakakibara, K; Shimizu, S; Togawa, S	1
Ba, Y; Bai, M; Deng, T; Huang, DZ; Li, HL; Wang, X; Zhou, LK	1
Aoki, Y; Emi, M; Hamai, Y; Hihara, J; Kushitani, K; Okada, M; Tanabe, K	1
Akiyama, H; Endo, I; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, HA; Oshima, T; Takagawa, R; Takahashi, M	1
Bilici, A; Ercan, S; Gumus, M; Orcun, A; Seker, M; Ustaalioglu, BB; Yilmaz, BE	1
Hu, LM; Hu, ZB; Huang, MD; Shen, HB; Shu, YQ; Wang, ZW; Xu, JL; Yin, ZQ	1
Hirata, Y; Itagaki, T; Kameda, A; Miyahara, E; Okamura, K; Sasaki, T; Teramoto, S; Ukon, K	1
Aoki, Y; Higashiguchi, T; Iwakura, S; Kunimoto, H; Nakase, T; Shimada, K; Shimamoto, T	1
Choi, SR; Han, JS; Hsing, CT; Jang, JS; Kim, DC; Roh, MH; Ryu, SH; Woo, SM	1
Baek, JH; Cho, SH; Choi, YH; Chung, IJ; Hong, YS; Jeung, HC; Kang, HJ; Kim, BS; Kim, JS; Nam, SH; Oh, SC; Song, EK; Yang, SH; Yim, CY	1
Akyol, M; Bayoglu, IV; Can, A; Demir, L; Dirican, A; Erten, C; Kucukzeybek, Y; Medeni, M; Somali, I; Tarhan, MO	1
Chi, Y; Cui, CX; Li, YS; Lü, N; Song, Y; Sun, YK; Wang, JW; Yang, L; Yuan, XH; Zhang, W; Zhou, AP	1
Dimitroulis, D; Felekouras, E; Griniatsos, J; Karatzas, T; Karavokyros, J; Kontzoglou, K; Mantas, D; Nikiteas, N; Polyzos, A; Polyzos, K; Syrigos, K; Tsavaris, N; Vafiadis, I	1
Al-Batran, SE; Hozaeel, W; Jäger, E	1
Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Nakamura, Y; Okada, K; Takahashi, T; Takiguchi, S; Yamasaki, M	1
Aydogan, F; Aykan, F; Disci, R; Ekenel, M; Keskin, S; Kilic, L; Saglam, S; Sakar, B; Sen, F; Yıldız, I	1
Ito, S; Kawai, H; Kondoh, C; Mizota, A; Muro, K; Nomura, M; Sawaki, A; Shitara, K; Takahari, D; Ura, T; Yokota, T	1
Chen, Y; Cui, Y; Feng, Y; Li, Q; Liu, T; Wang, Y; Yu, Y	1
Fujii, Y; Kihara, K; Komai, Y; Noguchi, N; Waseda, Y; Yano, A	1
Akman, T; Oztop, I; Salman, T; Unal, OU; Unek, IT; Yilmaz, U	1
Guven, M; Inal, A; Işikdogan, A; Kaplan, MA; Kuçukoner, M; Nas, N; Urakci, Z; Yunce, M	1
Abd-Allah, D; El-Shazly, W; Khedr, G; Rostom, Y; Zaghloul, H	1
Harita, S; Kiguchi, T; Kimura, K; Kubo, T; Mannami, T; Masunari, T; Nakata, Y; Ninomiya, K; Okada, T; Seno, S; Sezaki, N; Sonobe, H; Suzuki, Y; Tamura, T	1
Akiyama, H; Endo, I; Fujii, S; Hasegawa, S; Izumisawa, Y; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, HA; Oshima, T; Takagawa, R; Tokuhisa, M	1
Bae, WK; Cho, CS; Cho, SH; Chung, IJ; Hwang, JE; Kim, DE; Ko, HM; Lee, JH; Park, IK; Park, MS; Shim, HJ	1
Hirayama, M; Kato, J; Kawano, Y; Kobune, M; Kuroiwa, G; Miyanishi, K; Sato, T; Sato, Y; Takada, K; Takahashi, S; Takimoto, R	1
Amakata, Y; Amano, I; Hashimoto, H; Horimoto, R; Kato, R; Matsumoto, J; Mizuno, C; Mizuno, M; Nishiwaki, M; Okanoue, T; Oya, H; Sawai, N; Seki, K; Shaura, Y; Shima, T; Tanaka, I	1
Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY; Xiang, J; Xu, X; Ye, LH; Zhan, YP	1
Cinar, V; Erdik, B; Oyan, B; Ozturk, MA; Ozveren, O	1
Egawa, T; Etoh, E; Inaba, Y; Irino, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Okamura, A; Segami, K	1
Ades, S; Alcindor, T; Andalib, A; Artho, G; Chasen, M; Ferri, LE; Hickeson, M; Marcus, V; Thirlwell, MP	1
Abdel-Latif, RM; Anter, AH	1
Fujii, M; Funada, T; Jinno, D; Kaiga, T; Kanamori, N; Kochi, M; Mihara, Y; Shimizu, H; Takayama, T; Tamegai, H	1
Al-Batran, SE; Homann, N; Jäger, E; Lorenzen, S; Pauligk, C; Schmalenberg, H	1
Harada, K; Hayashi, T; Hirakawa, M; Hirata, K; Hirayama, M; Kato, J; Katsuki, S; Kobune, M; Maeda, M; Miyamoto, H; Miyanishi, K; Nobuoka, T; Ohnuma, H; Ono, M; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takahashi, M; Takahashi, Y; Takayama, T; Takimoto, R	1
Fujiwara, T; Gochi, A; Kagawa, S; Kimura, T; Kishimoto, H; Ninomiya, M; Nishizaki, M; Nonaka, Y; Shigeyasu, K; Takahata, T; Uno, F	1
Akiyama, H; Endo, I; Fukushima, T; Hasegawa, S; Izumisawa, Y; Kimura, J; Kosaka, T; Kunisaki, C; Makino, H; Ono, HA; Oshima, T; Ota, M; Takagawa, R; Takahashi, M; Tokuhisa, M; Tsuchida, K	1
Arnold, D; Brenner, B; Galle, PR; Gockel, I; Klautke, G; Lang, H; Moehler, M; Rödel, C; Roessler, HP; Schimanski, CC; Schmidberger, H; Thomaidis, T; Trarbach, T	1
Ideguchi, K; Ikeda, Y; Mori, T; Nakagawa, K; Okamoto, K; Sakata, K; Yasumitsu, T	1
Bang, YJ; Boudraa, Y; Daglish, B; Heo, DS; Jacques, C; Kang, WK; Kang, YK; Kim, HC; Kim, NK; Kim, WS; Zuber, E	1
Asaumi, Y; Hara, T; Hirano, M; Kikkawa, H; Kikuchi, T; Murakami, N; Nozawa, H; Takizawa, M; Uno, Y	1
Campos, B; Carrete, N; Constenla, M; Garcia-Arroyo, R; Lorenzo, I; Palacios, P	1
Hyodo, I; Katsu, K; Mitachi, Y; Miyata, Y; Ohtsu, A; Sairenji, M; Saitoh, S; Sakata, Y; Sato, T; Suwa, T	1
Chang, JY; Chen, LT; Chung, TR; Jan, CM; Liu, JM; Liu, TW; Shiah, HS; Whang-Peng, J; Wu, CW	1
Fujimura, T; Fushida, S; Kinami, S; Miwa, K; Miyamoto, K; Nao, F; Ninomiya, I; Nishimura, G; Ohta, T; Yokogawa, K	1
Kurihara, M; Matsukawa, M; Nakamachi, M; Sato, A; Shimada, K; Ushio, J; Yamamoto, W	1
Amadori, D; De Paola, F; Frassineti, GL; Milandri, C; Ricotti, L; Tesei, A; Ulivi, P; Zoli, W	1
Dörken, B; Krenn, V; Kretzschmar, A; Reichardt, P; Thuss-Patience, PC	1
Saitoh, S; Sakata, Y	1
Roth, AD	1
Alberts, SR; Cha, SS; Goldberg, RM; Jatoi, A; Kardinal, CG; Mailliard, JA; Morton, RF; Nair, S; Rowland, KM; Sargen, D; Stella, PJ; Tirona, MT	1
Ajani, J; Roth, AD	1
Motwani, M; Rizzo, C; Schwartz, GK; She, Y; Sirotnak, F	1
Sawabu, N	1
Gao, H; Gu, B; Li, M; Lü, H; Wan, Y; Wu, D	1
Gamoh, M; Kanamaru, R; Mitachi, Y; Saitoh, S; Sakata, Y; Sekikawa, K; Terashima, M; Yoshioka, T	1
Chung, JH; Kim, SA; Lee, HJ; Park, YH; Ryoo, BY	1
Baba, E; Katano, M; Matsunaga, H; Morisaki, T; Nakahara, C; Nakamura, K; Noshiro, H; Tanaka, M; Wada, M; Yamanaka, N	1
Baba, H; Kakeji, Y; Maehara, Y; Oki, E; Tokunaga, E; Ushiro, S; Watanabe, M	1
Hihara, J; Minami, K; Ohta, K; Tanabe, K; Toge, T; Yamaguchi, Y; Yoshida, K	1
Akiyama, N; Arai, F; Funakoshi, K; Inayoshi, J; Kato, T; Motoyama, H; Tasaki, A	1
Depisch, D; Hejna, M; Kornek, GV; Lang, F; Lenauer, A; Raderer, M; Scheithauer, W; Schmid, K; Schüll, B	1
Kobayashi, M; Konishi, N; Kusunoki, M; Mohri, Y; Ohmori, Y; Tanaka, K; Tonouchi, H	1
Chow, W; Chu, D; Doroshow, JH; Frankel, P; Leong, L; Lim, D; Lin, P; Margolin, K; Morgan, RJ; Paz, B; Schwarz, R; Shibata, S; Somlo, G; Stalter, S; Synold, T; Twardowski, P; Yen, Y	1
Alimonti, A; Carlini, P; Cognetti, F; Di Cosimo, S; Fazio, N; Felici, A; Ferretti, G; Gelibter, A; Papaldo, P; Silvestris, N	1
Endo, T; Fujita, M; Hosokawa, M; Imai, K; Itoh, F; Kikuchi, T; Kojima, T; Kusano, M; Mita, H; Ogi, K; Sasaki, Y; Satoh, A; Suzuki, H; Tokino, T; Toyota, M; Yamashita, T	1
Sasako, M; Ushijima, T	1
Akiba, Y; Hibi, T; Hosoe, N; Ishii, H; Izumiya, M; Mori, S; Nagata, H; Suzuki, J; Takaishi, H; Ueda, T; Yamagishi, Y	1
Choi, SJ; Kim, HT; Park, YH; Ryoo, BY	1
Bonsignori, M; Marcucci, F; Massacesi, C; Mazzanti, P; Pilone, A; Rocchi, MB	1
Borner, MM; de Braud, F; Fazio, N; Goldhirsch, A; Herrmann, R; Maibach, R; Morant, R; Roth, AD; Sessa, C; Stupp, R	1
Van Cutsem, E	1
Boige, V; Ducreux, M; Roth, A	1
Bando, E; Endou, Y; Kawamura, T; Kimura, M; Kuno, K; Miyamoto, K; Sasaki, T; Shimada, T; Sugarbaker, PH; Yonemura, Y	1
Im, YH; Jung, CW; Kang, WK; Kim, HY; Kim, JH; Kim, K; Lee, MH; Lee, SH; Lee, SI; Park, J; Park, JO; Park, K; Park, YS	1
Sulkes, A	1
Kitajima, M; Kubota, T; Kumai, K; Maeda, S; Otani, Y; Saikawa, Y; Sugiura, T	1
Ajani, JA; Andrassy, RJ; Blakely, ML; Harting, MT; Herzog, CE; Lally, KP	1
Hong, YS; Kang, JH; Kim, GY; Lee, KS; Lee, MA; Shim, KH; Woo, IS	1
Fujita, S; Inoue, Y; Katsura, H; Nomura, M; Sakao, J; Souda, S; Yokotani, H	1
Gotoh, M; Hoshino, M; Hoshino, Y; Kanzaki, N; Kashimura, S; Kogure, M; Matsuyama, S; Ogata, T; Ohto, H; Otani, S; Soeta, N; Terashima, M	1
Handa, R; Iijima, S; Kato, T; Kikkawa, N; Kurokawa, E; Naoi, Y; Ohshima, S; Tsujie, M; Yamamoto, H	1
Fujiki, H; Kadotani, Y; Kumano, T; Mitsuo, M; Morita, S; Oda, T; Sonoyama, Y; Yasuoka, R	1
Iishi, H; Narahara, H; Sugimoto, N; Tatsuta, M	1
Toge, T; Yoshida, K	1
Chiba, M; Kawaguch, A; Mekata, E; Morii, H; Naitoh, H; Tan, T; Yamamoto, H	1
Chung, CW; Im, YH; Kang, WK; Kim, K; Kim, WS; Lee, HR; Lee, KE; Lee, MH; Lee, SH; Park, CH; Park, J; Park, JO; Park, K; Park, SH	1
Georgoulias, V; Panopoulos, C; Polyzos, A; Potamianou, A; Stergiou, J; Syrigos, K; Vamvakas, L	1
Goto, M; Katsu, K; Kawabe, S; Ohta, S; Takiuchi, H	1
Choi, CW; Choi, IK; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, JH; Shin, SW; Yoon, SY	1
Dai, DJ; Lu, CD; Meng, H; Sun, YL; Tanigawa, N	1
Li, YS	1
Kawasaki, H; Kobori, H; Maruyama, M; Sasaki, M; Seino, K; Shibata, S; Sugiyama, Y; Yamada, K	1
Bae, JM; Choi, IJ; Choi, JY; Chun, JH; Hwangbo, B; Kim, CG; Kim, HK; Kim, YW; Lee, HG; Lee, JS; Park, SR; Ryu, KW	1
Colucci, G; Dejaco, H; Grones, A; Marsoner, H; Thaler, W	1
Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K	1
Deguchi, Y; Doi, H; Higuchi, A; Komai, Y; Sakai, M; Shioya, M; Takenaka, K	1
Arena, MG; Belli, F; Carpano, S; Di Lauro, L; Giannarelli, D; Lopez, M; Paoletti, G	1
Caponigro, F; Facchini, G; Iaffaioli, RV; Nasti, G	1
Bang, YJ; Heo, DS; Joh, Y; Kim, DW; Kim, NK; Kim, TY; Kwon, JH; Lee, JJ; Oh, DY	1
Emi, Y; Fukushima, M; Kakeji, Y; Maehara, Y; Takahashi, I; Uchida, J	1
Baek, JH; Jung, HY; Kim, DH; Kim, JG; Kim, TB; Lee, KB; Park, JY; Sohn, SK; Sung, WJ; Yu, W	1
Philip, PA	1
Bang, SM; Cho, EK; Chung, M; Lee, JH; Lee, WK; Park, SH; Shin, DB	1
Hamai, Y; Hihara, J; Tanabe, K; Toge, T; Ukon, K; Yoshida, K	1
Hirakawa, K; Ishikawa, T; Komoto, M; Nakata, B; Nomura, S; Ohira, M; Sawada, T; Takashima, T	1
Akerman, P; Barnett, JM; Berkenblit, A; Harrington, D; Iannitti, D; Maia, C; Miner, T; Nadeem, A; Rathore, R; Roye, D; Safran, H; Stuart, K; Tsai, JY	1
Chan, CH; Chang, JY; Chen, LT; Liu, TW; Whang-Peng, J	1
Ajani, JA; Assadourian, S; Cabral Filho, S; Chao, Y; Fodor, MB; Majlis, A; Moiseyenko, VM; Tjulandin, SA; Van Cutsem, E	1
Androulakis, N; Georgoulias, V; Kalykaki, A; Kentepozidis, N; Kouroussis, Ch; Saridaki, Z; Spiridonakou, S; Vamvakas, L; Xiropoulou, E	1
Bae, JM; Choi, IJ; Chun, JH; Kim, CG; Kim, HK; Kim, YW; Lee, JH; Lee, JS; Park, SR	1
Bando, E; Endou, Y; Kawamura, T; Miyamoto, K; Sasaki, T; Shimada, T; Tanaka, M; Tochiori, S; Yonemura, Y	1
Bang, SJ; Cho, HR; Kim, DH; Kim, GY; Kim, H; Min, YJ; Park, JH	1
Doki, Y; Fujiwara, Y; Kim, SJ; Miyata, H; Miyoshi, Y; Monden, M; Noguchi, S; Takiguchi, S; Urano, N; Yano, M; Yasuda, T	1
Aoki, T; Enomoto, M; Katayanagi, S; Miyazawa, K; Ohyashiki, K; Sudo, H; Takagi, Y; Tokita, H; Tsuchida, A	1
Bang, SM; Cho, EK; Chung, M; Han, SH; Lee, JH; Lee, WK; Lee, Y; Park, SH; Shin, DB	1
Chung, HC; Jeung, HC; Kim, YT; Noh, SH; Rha, SY; Roh, JK	1
André, T; Bennamoun, M; Carola, E; Flesch, M; Gamelin, E; Louvet, C; Nguyen, S; Rebischung, C; Van Ongeval, J; Ychou, M	1
Endo, Y; Fujiwara, T; Hioki, M; Ikeda, Y; Kagawa, S; Kishimoto, H; Sakai, R; Tanaka, N; Urata, Y	1
Kimura, H; Koyama, F	1
Alberts, SR; Dakhil, SR; Flynn, PJ; Foster, N; Giordano, KF; Jatoi, A; Mailliard, JA; Nikcevich, DA; Stella, PJ; Tschetter, LK	1
Bafaloukos, D; Bamias, A; Fountzilas, G; Janinis, D; Kalofonos, HP; Kosmidis, P; Papakostas, P; Sakantamis, A; Skarlos, D; Tsavdaridis, D; Xiros, N	1
Fukushima, M; Konishi, K; Mizuiri, H; Sakata, Y; Suzuki, T; Tanabe, K; Ukon, K; Wada, Y; Yoshida, K	1
Bandou, E; Endou, Y; Sasaki, T; Sawa, T; Sugarbaker, PH; Yonemura, Y; Yoshimitsu, Y	1
Bae, JM; Choi, IJ; Chun, JH; Kim, CG; Kim, HK; Kim, YW; Lee, JH; Lee, JS; Park, SR; Ryu, KW; Yu, MS	1
Besova, NS; Borisova, TA; Gorbunova, VA; Markovich, AA; Orel, NF; Zaguzina, NN	1
Ahn, JS; Im, YH; Kang, JH; Kang, WK; Lee, J; Lee, SI; Lim, HY; Park, JO; Park, K; Park, KW; Park, YS	1
Gotoh, M; Hirabayashi, N; Ninomiya, M; Nishiyama, M; Sakamoto, J; Sato, Y; Takakura, N; Takiyama, W; Terashima, M; Todo, S; Yoshida, K	1
Lago, S; Murad, AM; Pecego, R; Skare, NG; Vinholes, J	1
Akiya, T; Doi, T; Esaki, T; Hyodo, I; Kato, T; Kinjo, F; Koizumi, W; Komatsu, Y; Maeda, Y; Miyata, Y; Munakata, M; Nakano, S; Narahara, H; Saitoh, S; Sakata, Y; Shimamura, T; Takiuchi, H; Yamaguchi, K	1
Aurilio, G; Carlomagno, C; Catalano, G; Ciardiello, F; De Placido, S; De Vita, F; Galizia, G; Lieto, E; Martinelli, E; Orditura, M; Vecchione, L	1
Hihara, J; Tanabe, K; Ukon, K; Wada, Y; Yoshida, K	1
Egashira, A; Kakeji, Y; Maehara, Y; Morita, M; Oki, E; Takahashi, I	1
Attarpour, M; Balcer-Kubiczek, EK; Jiang, J; Kennedy, AS; Suntharalingam, M	1
Cejka, D; Crevenna, R; Losert, D; Monia, BP; Selzer, E; Sieghart, W; Strommer, S; Wacheck, V	1
Kretzschmar, A; Reichardt, P; Thuss-Patience, PC	1
Ajani, JA; Boni, C; Chao, Y; Constenla, M; Fodor, M; Majlis, A; Moiseyenko, VM; Risse, ML; Rodrigues, A; Tjulandin, S; Van Cutsem, E; Voznyi, E	1
Mohagheghi, MA; Montazeri, A; Sadighi, S; Sadighi, Z	1
Geng, M; Ji, YB; Jiang, JS; Li, H; Lou, GY; Ma, T; Xi, WQ; Xia, HQ; YeE, ZB	1
Doi, M; Egawa, T; Hayashi, S; Ito, Y; Kitano, M; Nagashima, A; Shimizu, M; Yoshii, H	1
Fujino, K; Ishikubo, T; Shimamura, T; Tada, M; Yamaguchi, K	1
Miyade, Y; Ninomiya, M; Ohtani, S; Shimizu, Y; Sugiyama, S	1
Arai, T; Fujimori, K; Gomyou, Y; Nakatsuji, Y; Okamoto, K; Shigeno, T; Shimizu, F; Suzuki, A; Tsuchiya, T	1
Yoshida, S	1
Matsukawa, M; Sato, A	1
Ichinari, H; Kawano, F; Matsuda, S; Mine, K; Taneda, Y; Yonei, A	1
Aoki, T; Hibi, Y; Hoshino, S; Ito, K; Katayanagi, S; Suda, T; Sudo, H; Takagi, Y; Tsuchida, A	1
Cho, JY; Lew, W; Roh, MR	1
Banba, M; Hidaka, K; Ikeda, E; Katayama, M; Kawahara, T; Nishikawa, A; Okajima, T; Shigematsu, T; Tanaka, M	1
Doki, Y; Fujiwara, Y; Miyata, H; Monden, M; Takiguchi, S; Yasuda, T	1
López-Brea, MF; Rivera, F; Vega-Villegas, ME	1
Amiconi, G; Blasio, AD; Candeloro, G; Cesta, A; Necozione, S; Rea, S; Recchia, F; Saggio, G	1
Ember, A; Esik, O; Horváth, OP; Kalmár, K; Papp, A; Yousuf, AF	1
Langner, C; Ott, A	1
Amarantidis, K; Chatzaki, E; Houhouli, K; Kakolyris, S; Lyrantzopoulos, N; Matthaios, D; Miloussis, A; Papatheodorou, K; Tentes, A; Tsaroucha, A	1
Chang, HM; Chun, YJ; Kang, YK; Kim, BS; Kim, M; Kim, TW; Lee, JL; Lee, JS; Oh, ST; Ryu, MH; Yook, JH	1
Bueno Muiño, C; Díaz-Rubio, E; García Miralles, N; García-Sáenz, JA; Martín, M; Puente Vázquez, J; Sánchez-Pernaute, A; Sastre Valera, J	1
Höffken, K; Kuss, O; Wagner, AD; Wedding, U	1
Astone, A; Barone, C; Basso, M; Cassano, A; D'Argento, E; Pozzo, C; Quirino, M; Schinzari, G; Trigila, N	1
Bilancia, D; Dinota, A; Germano, D; Manzione, L; Reggiardo, G; Romano, R; Rosati, G	1
Hamai, Y; Oue, N; Sentani, K; Suzuki, T; Wada, Y; Yasui, W; Yoshida, K	1
Chen, XH; Cheng, HY; Lei, LN; Ma, R; Tang, LP; Wang, J; Zhang, QF; Zhu, L	1
Haberl, C; Heinemann, V; Hentrich, M; Lordick, F; Lorenzen, S; Peschel, C; Roethling, N; Schuster, T; Seroneit, T	1
Ajani, JA; Boni, C; Chao, Y; Constenla, M; Fodor, M; Majlis, A; Marabotti, C; Moiseyenko, VM; Rodrigues, A; Tjulandin, S; Van Cutsem, E; Voznyi, E	1
Ajani, JA; Awad, L; Boni, C; Chao, Y; Constenla, M; Fodor, M; Majlis, A; Moiseyenko, VM; Rodrigues, A; Tjulandin, S; Van Cutsem, E; Voznyi, E	1
Bernhard, J; Borner, MM; de Braud, F; Falk, S; Fazio, N; Glynne-Jones, R; Köberle, D; Leslie, M; Maibach, R; Roth, AD; Rufibach, K; Saletti, P; Seymour, M; Stupp, R; Wernli, M; Widmer, L	1
Arena, MG; Di Lauro, L; Foggi, P; Lopez, M; Nunziata, C; Sperduti, I	1
Fujimori, Y; Hiraguri, M; Ishizone, S; Kumeda, S; Maruta, F; Miyagawa, S; Shimizu, F	1
Kitajima, M; Kiyota, T; Kubota, T; Kumagai, K; Kumai, K; Nakamura, R; Ohashi, M; Saikawa, Y; Yoshida, M	1
Deeks, ED; Scott, LJ	1
Wilson, D	1
Murad, AM	1
Akerman, P; Evans, D; Jean, M; Kennedy, T; Millis, R; Miner, T; Safran, H	1
Hirata, K; Kato, J; Kuroiwa, G; Matsunaga, T; Miyanishi, K; Nagashima, H; Niitsu, Y; Ohnuma, H; Okamoto, T; Sagawa, T; Sato, Y; Takahashi, Y; Takayama, T; Takimoto, R; Yamaguchi, K	1
Agostana, B; Aitini, E; Ardizzoia, A; Ardizzoni, A; Bajetta, E; Bochicchio, AM; Bordonaro, R; Botta, M; Buzzoni, R; Cicero, G; Comella, G; Di Bartolomeo, M; Duro, M; Fagnani, D; Ferrario, E; Gevorgyan, A; Katia, D; Kildani, B; Mantovani, G; Mariani, L; Marini, G; Massidda, B; Mozzana, R; Oliani, C; Palazzo, S; Pinotti, G; Reguzzoni, G; Schieppati, G; Villa, E; Zilembo, N	1
Aravantinos, G; Fountzilas, G; Gogas, H; Kalofonos, HP; Klouvas, G; Kosmidis, P; Makatsoris, T; Papakostas, P; Pectasides, D; Tsavdaridis, D; Xanthakis, I	1
Shi, LR; Wu, AZ; Zhao, JM	1
Akerman, P; Berkenblit, A; Chauhan, B; Cruff, D; Evans, D; Habr, F; Harrington, D; Iannitti, D; Kennedy, T; Maia-Acuna, C; Miner, T; Safran, H; Sears, D; Stuart, K	1
Goh, PG; Hwang, SW; Jeong, HY; Kang, HM; Kang, SH; Kang, YS; Kim, JI; Kim, SH; Kwon, DS; Lee, BS; Moon, HS; Nam, KW; Seong, JK	1
Asmar, L; Boehm, KA; McCollum, D; Richards, D; Sborov, M; Wilfong, L; Zhan, F	1
Itoh, J; Kawasaki, H; Kijima, H; Matsuya, H; Miyamoto, K; Sasaki, M; Shibata, S	1
Abe, S; Honda, K; Kondo, H; Makino, K; Mizushima, T; Oura, K; Sumiyoshi, T; Tamura, F; Tanaka, S; Tsuji, Y; Tsushima, T; Yoshizaki, N	1
Assmann, M; Deist, T; Fahlke, J; Hribaschek, K; Keilholz, U; Kettner, E; Lippert, H; Quietzsch, D; Ridwelski, K; Schmidt, C; Stuebs, P	1
Ye, S; Zhang, AM	1
Gao, H; Wang, HB; Wang, HZ	1
Ding, Y; Li, X; Liu, B; Qian, X; Shen, Z; Yang, M; Yu, L	1
Haines, IE	1
Cho, JH; Han, JS; Hong, SK; Kim, EY; Kim, JM; Kwon, OJ; Kwon, SJ; Lee, KS; Park, CH; Park, SY	1
Chang, HM; Jo, JC; Kang, YK; Kim, TW; Lee, JL; Lee, JS; Lee, SS; Ryu, MH; Sym, SJ	1
Bae, SH; Baek, JH; Chae, YS; Chung, HY; Do, YR; Hyun, MS; Kim, JG; Kim, MK; Kwon, KY; Lee, KH; Lee, WS; Park, KU; Ryoo, HM; Sohn, SK; Song, HS; Yu, W	1
Doki, Y; Fujiwara, Y; Miyata, H; Monden, M; Nishida, T; Takiguchi, S; Yamazaki, M	1
Fujimura, T; Fukushima, N; Fushida, S; Goda, F; Hirono, Y; Imano, M; Kaji, M; Kurita, A; Kurita, N; Nashimoto, A; Ohta, T; Tanemura, H; Tsujitani, S; Watanabe, Y; Yamaguchi, K	1
Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Miyazaki, M; Nakamori, S; Ohmura, Y; Takami, K; Tsujinaka, T; Yamasaki, H; Yasui, M	1
Abbrederis, K; Lordick, F; Lorenzen, S; Peschel, C; Rothling, N; Schuster, T; Vehling-Kaiser, U; von Weikersthal, LF	1
Ding, Y; Liu, B; Qian, X; Wang, T; Wei, J; Yu, L	1
Akiyama, N; Arai, F; Funakoshi, K; Ikarashi, S; Ito, H; Kato, T; Motoyama, H; Sasaki, S	1
Cho, JY; Choi, SH; Lee, DK; Lee, KS; Lee, SI; Lee, SJ; Lim, JY; Paik, YH; Park, HJ; Yoon, DS	1
Carcereny, E; Casado, E; Fernández-Llamazares, J; Font, A; Gallego, R; Guix, M; Manzano, JL; Maurel, J; Ramirez, JL; Rosell, R; Salazar, R; Tabernero, J; Taron, M	1
Guo, Y; Hong, X; Li, J; Wang, B; Zhang, W	1
Bae, SH; Hyun, MS; Kim, MK; Lee, KH; Ryoo, HM; Sin, JI	1
Bae, JM; Choi, IJ; Kim, CG; Kim, HK; Kim, NK; Kim, YW; Lee, JH; Lee, JS; Park, SR; Ryu, KW	1
Bae, JM; Choi, IJ; Kim, CG; Kim, HK; Kim, YW; Kook, MC; Lee, JH; Lee, JS; Park, SR; Ryu, KW	1
Ba-Ssalamah, A; Brodowicz, T; Hejna, M; Pluschnig, U; Püspök, A; Raderer, M; Schmidinger, M; Zacherl, J; Zielinski, CC	1
Ran, FW; Shi, YK; Wu, F; Zhang, HG; Zhang, XR	1
Fujimura, T; Funaki, H; Fushida, S; Kayahara, M; Kinami, S; Kinoshita, J; Ninomiya, I; Nishimura, G; Ohta, T; Yagi, Y	1
Hwang, SW; Jang, KM; Jung, JY; Kim, HJ; Kim, JH; Kim, MJ; Kwon, JH; Lee, BH; Lee, HW; Park, CK; Park, SR; Song, HH; Yang, DH; Zang, DY	1
Jeen, YT; Kim, HK; Kim, YH; Seo, HY; Shim, BY; Yang, J	1
Aamdal, S; Catimel, G; Sternberg, C; Sulkes, A; van Hoesel, Q; Verweij, J; Wolff, I	1
Dirix, LY; Franklin, H; Kaye, S; LeBail, N; Sessa, C; Smyth, J; Sulkes, A; Vermorken, JB; Verweij, J; Wanders, J	1
Taguchi, T	1
Obata, T; Sasaki, T; Tanaka, M	1
Rougier, P	1
Benson, AB; Einzig, AI; Karp, DD; Neuberg, D; O'Dwyer, PJ; Remick, SC; Stewart, JA	1
Hirabayashi, N; Kanamaru, R; Kurihara, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T	1
Armand, JP; Couteau, C	1
Furue, H; Hirabayashi, N; Kanamaru, R; Kurihara, M; Mai, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T	1
Inoue, H; Kim, R; Ohi, Y; Toge, T	1
Choy, H	1
Kobayashi, T; Maeda, Y; Okamoto, R; Omuro, Y; Sasaki, T; Takeda, N	1
Aapro, MS; Alberto, P; Borner, MM; Castiglione, M; Cavalli, F; Fazio, N; Goldhirsch, A; Herrmann, R; Honegger, H; Maibach, R; Martinelli, G; Morant, R; Pagani, O; Roth, AD	1
Fujii, H; Igarashi, T; Imoto, S; Ishizawa, K; Ito, K; Kubota, K; Minami, H; Saeki, T; Sasaki, Y; Takashima, S	1
Agelaki, S; Androulakis, N; Georgoulias, V; Hatzidaki, D; Kakolyris, S; Kalbakis, K; Kourousis, C; Mavroudis, D; Sarmonis, G; Sarra, E; Souglakos, J; Vardakis, N	1
Kubota, T	1
Ohtsu, A; Tahara, M	1
Baldelli, AM; Battelli, N; Cascinu, S; Catalano, G; Catalano, V; Giordani, P; Graziano, F; Lai, V; Testa, E	1
Kim, R; Minami, K; Nishimoto, N; Toge, T	1
Köhne, CH; Wilke, HJ; Wils, JA	1
Baldelli, AM; Barni, S; Casaretti, R; Cascinu, S; Catalano, G; Catalano, V; Comella, G; Frontini, L; Graziano, F; Labianca, R	1
Gu, B; Li, M; Lü, H; Wu, D	1
Eichelmann, K; Fahlke, J; Gebauer, T; Kettner, E; Kröning, H; Lippert, H; Meyer, F; Ridwelski, K	1
Ohtsu, A; Yoshida, M	1
Haller, DG; Misset, JL	1

Reviews

78 review(s) available for docetaxel anhydrous and Cancer of Stomach

Article	Year
Docetaxel and fluorouracil as first-line therapy for gastric cancer with bone marrow metastasis and disseminated intravascular coagulation. Future oncology (London, England), 2022, Volume: 18, Issue:35 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Clinical Trials as Topic; Disseminated Intravascular Coagulation; Docetaxel; Fluorouracil; Humans; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2022
FLOT or CROSS for gastroesophageal junction cancers-is the debate over yet? Chinese clinical oncology, 2023, Volume: 12, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Leucovorin; Neoadjuvant Therapy; Oxaliplatin; Stomach Neoplasms	2023
Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023, Volume: 26, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Gastrectomy; Humans; Neoplasm Staging; Stomach Neoplasms; Tegafur	2023
Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors. Scientific reports, 2019, 11-01, Volume: 9, Issue:1 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Esophageal Neoplasms; Humans; Perioperative Care; Stomach Neoplasms	2019
[Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?] Bulletin du cancer, 2020, Volume: 107, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Perioperative Care; Randomized Controlled Trials as Topic; Stomach Neoplasms	2020
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITA The oncologist, 2020, Volume: 25, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Humans; Microsatellite Instability; Prognosis; Stomach Neoplasms; Tumor Microenvironment	2020
Salvage systemic therapy for advanced gastric and oesophago-gastric junction adenocarcinoma. The Cochrane database of systematic reviews, 2020, 11-19, Volume: 11 Topics: Adenocarcinoma; Antineoplastic Agents; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Humans; Immunotherapy; Irinotecan; Neoplasm Recurrence, Local; Paclitaxel; Placebos; Progression-Free Survival; Quality of Life; Randomized Controlled Trials as Topic; Salvage Therapy; Stomach Neoplasms	2020
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 2017, Volume: 35, Issue:12 Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Humans; Models, Economic; Paclitaxel; Quality-Adjusted Life Years; Ramucirumab; Stomach Neoplasms; Taxoids; Technology Assessment, Biomedical	2017
Chemotherapy for advanced gastric cancer. The Cochrane database of systematic reviews, 2017, 08-29, Volume: 8 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Fluorouracil; Humans; Irinotecan; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids	2017
The Role of Systemic Therapy in Resectable Gastric and Gastro-oesophageal Junction Cancer. Current treatment options in oncology, 2017, 11-16, Volume: 18, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2017
Advances in the treatment of gastric cancer. Current opinion in gastroenterology, 2018, Volume: 34, Issue:6 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Gastrectomy; Humans; Nivolumab; Oxonic Acid; Stomach Neoplasms; Tegafur	2018
Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis. PloS one, 2013, Volume: 8, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Disease Progression; Docetaxel; Fluorouracil; Humans; Palliative Care; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
[A case of gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Adenosquamous; Cisplatin; Docetaxel; Drug Combinations; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2013
Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:11 Topics: Antineoplastic Agents; Camptothecin; Clinical Trials, Phase III as Topic; Docetaxel; Fluorouracil; Humans; Irinotecan; Neoplasm Recurrence, Local; Neoplasm Staging; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids	2013
[A case of liver metastasis from gastric cancer responding completely to S-1/docetaxel chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hepatectomy; Humans; Liver Neoplasms; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[Curative resection of a case of advanced gastric cancer with peritoneal dissemination responding well to combination chemotherapy of docetaxel,cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:9 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer with carcinomatous lymphangitis of the lung treated with docetaxel and S-1 combination chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymphangitis; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World journal of gastroenterology, 2014, Apr-14, Volume: 20, Issue:14 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Docetaxel; Epirubicin; Fluorouracil; Humans; Medical Oncology; Neoplasm Metastasis; Palliative Care; Pyrimidines; Quality of Life; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab; Treatment Outcome; Vascular Endothelial Growth Factor A	2014
Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies. PloS one, 2014, Volume: 9, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Databases, Factual; Docetaxel; Humans; Neoplasm Staging; Ramucirumab; Stomach Neoplasms; Survival Rate; Taxoids	2014
[Curative resection for Stage IV advanced gastric cancer that responded to combination chemotherapy with docetaxel, cisplatin, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2014
[Adjuvant treatment for esophagogastric junction cancer]. Nihon Geka Gakkai zasshi, 2015, Volume: 116, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asia; Capecitabine; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Digestive System Surgical Procedures; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophagogastric Junction; Europe; Fluorouracil; Humans; Lymph Node Excision; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Taxoids; Tegafur	2015
[CURRENT STATE OF ADJUVANT TREATMENT FOR GASTRIC CANCER AFTER RADICAL SURGERY WITH EXTENDED LYMPH NODE DISSECTION]. Voprosy onkologii, 2015, Volume: 61, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Drug Combinations; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymph Node Excision; Multicenter Studies as Topic; Oxaloacetates; Oxonic Acid; Paclitaxel; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2015
Capecitabine for the treatment of gastric cancer. Expert review of gastroenterology & hepatology, 2015, Volume: 9, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids	2015
Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand? Journal of the National Comprehensive Cancer Network : JNCCN, 2015, Volume: 13, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asian People; Camptothecin; Docetaxel; Humans; Irinotecan; Neoplasm Staging; Pyridines; Ramucirumab; Stomach Neoplasms; Taxoids; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2015
[Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2015
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis. Critical reviews in oncology/hematology, 2016, Volume: 102 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Epirubicin; Humans; Neoplasm Staging; Stomach Neoplasms; Taxoids; Treatment Outcome	2016
A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytoreduction Surgical Procedures; Docetaxel; Drug Combinations; Humans; Hyperthermia, Induced; Infusions, Parenteral; Multivariate Analysis; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Taxoids; Tegafur	2016
Taxanes in the Treatment of Advanced Gastric Cancer. Molecules (Basel, Switzerland), 2016, May-17, Volume: 21, Issue:5 Topics: Apoptosis; Cell Division; Cell Proliferation; Docetaxel; Humans; Neoplasm Staging; Paclitaxel; Stomach Neoplasms; Taxoids	2016
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicity. Anti-cancer drugs, 2017, Volume: 28, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids	2017
[A Case of Simultaneous Multiple Gastric Cancers Showing Differences of Response after Neoadjuvant Chemotherapy with Docetaxel, CDDP, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2016
Second-line chemotherapy for patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017, Volume: 20, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Everolimus; Humans; Molecular Targeted Therapy; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Receptor, ErbB-2; STAT3 Transcription Factor; Stomach Neoplasms; Taxoids; Vascular Endothelial Growth Factor A	2017
Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer, 2008, Sep-01, Volume: 113, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Docetaxel; Esophagogastric Junction; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2008
An update on biochemotherapy of advanced gastric and gastroesophageal adenocarcinoma. Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:9 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Capecitabine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Drug Combinations; ErbB Receptors; Esophagogastric Junction; Fluorouracil; Humans; Irinotecan; Oxonic Acid; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Tegafur; Vascular Endothelial Growth Factor A	2008
The role of capecitabine in the management of tumors of the digestive system. Reviews on recent clinical trials, 2009, Volume: 4, Issue:1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Colonic Neoplasms; Deoxycytidine; Digestive System Neoplasms; Docetaxel; Esophageal Neoplasms; Fluorouracil; Gallbladder Neoplasms; Humans; Irinotecan; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Rectal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A	2009
[Docetaxel in the treatment of metastatic gastric cancer]. Vestnik Rossiiskoi akademii meditsinskikh nauk, 2009, Issue:8 Topics: Antineoplastic Agents; Docetaxel; Humans; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Treatment Outcome	2009
[Progress in chemotherapy for advanced gastric cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2009, Volume: 28, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Drug Combinations; Fluorouracil; Gefitinib; Humans; Irinotecan; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Paclitaxel; Quinazolines; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Trastuzumab	2009
Docetaxel: its role in current and future treatments for advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2009, Volume: 12, Issue:3 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Clinical Trials as Topic; Docetaxel; Humans; Stomach Neoplasms; Taxoids; Treatment Outcome	2009
Chemotherapy for advanced gastric cancer. The Cochrane database of systematic reviews, 2010, Mar-17, Issue:3 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Fluorouracil; Humans; Irinotecan; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids	2010
[Metastatic gastric cancer: does second-line chemotherapy make sense?]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:38 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Clinical Trials, Phase III as Topic; Disease Progression; Docetaxel; Humans; Irinotecan; Neoplasm Staging; Palliative Care; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Retreatment; Stomach Neoplasms; Survival Rate; Taxoids	2010
[Three cases of advanced gastric cancer successfully treated by combination therapy of biweekly S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Humans; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2011
Surgical resection following combination chemotherapy with oral S-1 and biweekly docetaxel in a patient with advanced gastric cancer and a prior coronary artery bypass graft with the right gastroepiploic artery: report of a case. Surgery today, 2011, Volume: 41, Issue:11 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Coronary Artery Bypass; Coronary Disease; Docetaxel; Drug Combinations; Follow-Up Studies; Gastrectomy; Gastroepiploic Artery; Humans; Infusions, Intravenous; Male; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Preoperative Care; Risk Assessment; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2011
Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2013, Volume: 24, Issue:1 Topics: Amiodarone; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Combined Modality Therapy; Coronary Angiography; Diagnostic Errors; Docetaxel; Electric Countershock; Fatal Outcome; Fluorouracil; Gastrectomy; Humans; Irinotecan; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Myocardial Infarction; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Takotsubo Cardiomyopathy; Taxoids; Ventricular Fibrillation	2013
Docetaxel for gastric and esophageal carcinomas. Oncology (Williston Park, N.Y.), 2002, Volume: 16, Issue:6 Suppl 6 Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Clinical Trials as Topic; Docetaxel; Esophageal Neoplasms; Humans; Paclitaxel; Stomach Neoplasms; Taxoids	2002
Docetaxel-based chemotherapy in the treatment of gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14 Suppl 2 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Europe; Fluorouracil; Humans; Multicenter Studies as Topic; Paclitaxel; Research Design; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
[Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2003, Volume: 100, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Drug Combinations; Drug Delivery Systems; Fluorouracil; Humans; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2003
[Chemotherapy for gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Meta-Analysis as Topic; Neoadjuvant Therapy; Oxonic Acid; Paclitaxel; Pyridines; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2003
Docetaxel in advanced gastric cancer--review of the main clinical trials. Acta oncologica (Stockholm, Sweden), 2003, Volume: 42, Issue:7 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Docetaxel; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2003
Focus on gastric cancer. Cancer cell, 2004, Volume: 5, Issue:2 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Cadherins; Camptothecin; Carcinogens; Docetaxel; Fluorouracil; Gerbillinae; Herpesvirus 4, Human; Humans; Irinotecan; Lymphatic Metastasis; Mice; Mice, Transgenic; Models, Animal; Mutation; Neoplasm Staging; Neoplasms, Experimental; Rats; Stomach Neoplasms; Taxoids	2004
The treatment of advanced gastric cancer: new findings on the activity of the taxanes. The oncologist, 2004, Volume: 9 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Risk Assessment; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2004
[Docetaxel and gastric cancer]. Bulletin du cancer, 2004, Volume: 91, Issue:3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Doxorubicin; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2004
Chemotherapy in gastric cancer: a brief chronicle with emphasis on recent developments. The Israel Medical Association journal : IMAJ, 2004, Volume: 6, Issue:7 Topics: Antineoplastic Agents; Camptothecin; Carcinoma; Chemotherapy, Adjuvant; Docetaxel; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pyrimidines; Stomach Neoplasms; Taxoids	2004
[CPT-11 combined chemotherapy for metastatic gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Mitomycin; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2004
[Combination chemotherapy of TS-1 and docetaxel on advanced and recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2004
[Second-line chemotherapy in gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Quality of Life; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Rate; Taxoids	2005
[Chemotherapy of advanced stomach cancer]. Zhonghua yi xue za zhi, 2004, Dec-17, Volume: 84, Issue:24 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Irinotecan; Stomach Neoplasms; Taxoids	2004
Colonic rupture in a patient on combination chemotherapy for metastasized carcinoma of the esophagogastric junction. Case report and review of the literature. Onkologie, 2005, Volume: 28, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cecal Diseases; Cisplatin; Colonic Diseases; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Intestinal Perforation; Middle Aged; Rupture; Stomach Neoplasms; Taxoids; Treatment Outcome	2005
Gastric cancer. Treatment of advanced disease and new drugs. Frontiers in bioscience : a journal and virtual library, 2005, Sep-01, Volume: 10 Topics: Antineoplastic Agents; Camptothecin; Docetaxel; Drug Therapy; Humans; Hydroxamic Acids; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2005
Experience with docetaxel in the treatment of gastric cancer. Seminars in oncology, 2005, Volume: 32, Issue:2 Suppl 4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Doxorubicin; Epirubicin; Fluorouracil; Gemcitabine; Humans; Irinotecan; Stomach Neoplasms; Taxoids	2005
Chemotherapy for advanced gastric or gastroesophageal cancer: defining the contributions of docetaxel. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Monitoring; Esophageal Neoplasms; Fluorouracil; Humans; Patient Selection; Stomach Neoplasms; Taxoids; Treatment Outcome	2006
[Combination chemotherapy of S-1 plus biweekly docetaxel for advanced and recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 1 Topics: Animals; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Combinations; Humans; Leukopenia; Neoplasm Transplantation; Neutropenia; Oxonic Acid; Quality of Life; Randomized Controlled Trials as Topic; Rats; Rats, Nude; Stomach Neoplasms; Stomatitis; Taxoids; Tegafur	2006
Docetaxel in the treatment of gastric cancer. Future oncology (London, England), 2006, Volume: 2, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Epirubicin; Fluorouracil; Humans; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Rate; Taxoids	2006
[Chemotherapy in advanced gastric cancer--to ensure timely and appropriate switch to subsequent treatment options]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Leucovorin; Methotrexate; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2007
[Basic strategies on first- and second-line chemotherapy for advanced gastric cancers]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Irinotecan; Stomach Neoplasms; Survival Rate; Taxoids	2007
[Clinical development of chemotherapy for advanced gastric cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2007, Volume: 104, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2007
Chemotherapy of advanced gastric cancer. Cancer treatment reviews, 2007, Volume: 33, Issue:4 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Drug Combinations; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Uracil	2007
Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007, Volume: 9, Issue:5 Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Chemotherapy, Adjuvant; Disease Progression; Docetaxel; Humans; Male; Neoadjuvant Therapy; Stomach Neoplasms; Taxoids	2007
Docetaxel: in gastric cancer. Drugs, 2007, Volume: 67, Issue:13 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2007
Docetaxel delivers new management opportunities for gastrointestinal carcinomas. Anti-cancer drugs, 1995, Volume: 6 Suppl 4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids	1995
Chemotherapy for gastric carcinoma: new and old options. Oncology (Williston Park, N.Y.), 1998, Volume: 12, Issue:10 Suppl 7 Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Capecitabine; Deoxycytidine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Etoposide; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids; Tegafur; Uracil	1998
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas]. Bulletin du cancer, 1998, Volume: Spec No Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome	1998
Taxanes in combined-modality therapy for solid tumors. Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:10 Suppl 5 Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Neoplasms; Paclitaxel; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids	1999
[New combination therapies for gastrointestinal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colorectal Neoplasms; Docetaxel; Fluorouracil; Humans; Irinotecan; Leucovorin; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Analysis; Taxoids	2000
[Evidence for Taxotere treatment with solid tumors]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:8 Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Evidence-Based Medicine; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Ovarian Neoplasms; Paclitaxel; Stomach Neoplasms; Taxoids	2000
[Recent advance in gastric cancer chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Mitomycin; Paclitaxel; Prognosis; RNA, Messenger; Stomach Neoplasms; Taxoids; Thymidylate Synthase	2000
[Latest progress on chemotherapy for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:13 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Irinotecan; Oxonic Acid; Paclitaxel; Pyridines; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2000
Developments in the treatment of gastric cancer in Europe. Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:12 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Fluorouracil; Humans; Infusions, Intravenous; Irinotecan; Neoplasm Metastasis; Paclitaxel; Randomized Controlled Trials as Topic; Stomach Neoplasms; Survival Analysis; Taxoids	2000
[New drugs for unresectable or recurrent gastric cancer--paclitaxel and docetaxel]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59 Suppl 4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Docetaxel; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome	2001
Docetaxel in advanced gastric cancer. Anti-cancer drugs, 2002, Volume: 13, Issue:5 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Humans; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome	2002

Trials

255 trial(s) available for docetaxel anhydrous and Cancer of Stomach

Article	Year
Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer. BMC cancer, 2021, Oct-01, Volume: 21, Issue:1 Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fatigue; Feasibility Studies; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Oxonic Acid; Patient Compliance; Stomach Neoplasms; Tegafur	2021
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - results from the phase II RAMIRIS Study of the German Gastric Can European journal of cancer (Oxford, England : 1990), 2022, Volume: 165 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Neoplasms, Second Primary; Paclitaxel; Ramucirumab; Stomach Neoplasms	2022
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022, Volume: 25, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Docetaxel; Epirubicin; Fluorouracil; Humans; Oxaliplatin; Stomach Neoplasms; Treatment Outcome	2022
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR). BMC cancer, 2022, May-12, Volume: 22, Issue:1 Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Leucovorin; Neoadjuvant Therapy; Oxaliplatin; Stomach Neoplasms; Tumor Microenvironment	2022
Protocol of OGSG 1901: a phase II trial of ramucirumab plus irinotecan for patients with early relapsed gastric cancer during or after adjuvant docetaxel plus S - 1 therapy. BMC cancer, 2022, Jul-15, Volume: 22, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Docetaxel; Humans; Irinotecan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Prospective Studies; Ramucirumab; Stomach Neoplasms	2022
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study). Medical oncology (Northwood, London, England), 2022, Nov-13, Volume: 40, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Copper; Docetaxel; Female; Humans; Male; Middle Aged; Prospective Studies; Reactive Oxygen Species; Resveratrol; Stomach Neoplasms	2022
Economic evaluation of FLOT and ECF/ECX perioperative chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma. BMJ open, 2022, 11-14, Volume: 12, Issue:11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cost-Benefit Analysis; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2022
Early tumor shrinkage and depth of response in patients with metastatic esophageal cancer treated with 2-weekly docetaxel combined with cisplatin plus fluorouracil: an exploratory analysis of the JCOG0807. Esophagus : official journal of the Japan Esophageal Society, 2023, Volume: 20, Issue:2 Topics: Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Kaplan-Meier Estimate; Stomach Neoplasms; Treatment Outcome	2023
Pyrotinib alone or in combination with docetaxel in refractory HER2-positive gastric cancer: A dose-escalation phase I study. Cancer medicine, 2023, Volume: 12, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Neutropenia; Receptor, ErbB-2; Stomach Neoplasms	2023
Study of Efficacy and Toxicity of Capecitabine Maintenance After Response to Docetaxel, Cisplatin, and 5-Fluracil-Based Chemotherapy in Advanced Carcinoma Stomach. The Gulf journal of oncology, 2023, Volume: 1, Issue:42 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Cisplatin; Docetaxel; Fluorouracil; Humans; Prospective Studies; Stomach Neoplasms	2023
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023, Volume: 26, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Gastrectomy; Humans; Neoplasm Staging; Proportional Hazards Models; Stomach Neoplasms	2023
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704). Future oncology (London, England), 2020, Volume: 16, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Protocols; Docetaxel; Drug Combinations; Female; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Oxaliplatin; Oxonic Acid; Postoperative Care; Preoperative Care; Stomach Neoplasms; Tegafur	2020
Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 07-15, Volume: 26, Issue:14 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cell Line, Tumor; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastric Mucosa; Humans; Kaplan-Meier Estimate; Kinesins; Male; Microtubules; Middle Aged; Pilot Projects; Progression-Free Survival; Stomach Neoplasms; Tubulin	2020
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer. Nature communications, 2020, 11-30, Volume: 11, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Docetaxel; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Morbidity; Neoadjuvant Therapy; Oxaliplatin; Patients; Postoperative Complications; Stomach; Stomach Neoplasms; Treatment Outcome	2020
Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer. Japanese journal of clinical oncology, 2021, Mar-03, Volume: 51, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Postoperative Complications; Preoperative Care; Stomach Neoplasms; Tegafur; Time Factors	2021
Efficacy and safety of ramucirumab plus paclitaxel therapy for advanced gastric cancer patients treated previously with docetaxel-containing chemotherapy. International journal of clinical oncology, 2021, Volume: 26, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Paclitaxel; Ramucirumab; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2021
Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial. Journal of surgical oncology, 2021, Volume: 123, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytoreduction Surgical Procedures; Docetaxel; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Hyperthermic Intraperitoneal Chemotherapy; Male; Middle Aged; Oxaliplatin; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate	2021
Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut, 2021, Volume: 70, Issue:12 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Disease Models, Animal; Docetaxel; Esophageal Neoplasms; Female; Gossypol; Humans; Male; Mice; Middle Aged; Neoplastic Stem Cells; Pilot Projects; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms	2021
A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas. Medicine, 2021, Apr-30, Volume: 100, Issue:17 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Oxaliplatin; Oxaloacetates; Progression-Free Survival; Stomach Neoplasms; Survival Rate	2021
Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203). The Tohoku journal of experimental medicine, 2021, Volume: 254, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Progression-Free Survival; Stomach Neoplasms; Trastuzumab	2021
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022, Volume: 25, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Humans; Neoplasm Staging; Stomach Neoplasms	2022
Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial. JAMA oncology, 2017, Sep-01, Volume: 3, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Esophagogastric Junction; Fluorouracil; Gastrectomy; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Metastasectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Young Adult	2017
Early results of a randomized two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S-1 and docetaxel/cisplatin/S-1 as neoadjuvant chemotherapy for locally advanced gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2017, Aug-01, Volume: 28, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2017
Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes. Oncology, 2017, Volume: 93, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Microarray Analysis; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome	2017
Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancer. Medical oncology (Northwood, London, England), 2017, Volume: 34, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2017
Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer. American journal of clinical oncology, 2018, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur	2018
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3. Anticancer research, 2017, Volume: 37, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Austria; Bevacizumab; Camptothecin; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2017
A multi-institution phase II study of docetaxel and S-1 in combination with trastuzumab for HER2-positive advanced gastric cancer (DASH study). Cancer chemotherapy and pharmacology, 2018, Volume: 81, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxonic Acid; Progression-Free Survival; Prospective Studies; Receptor, ErbB-2; Stomach Neoplasms; Tegafur; Trastuzumab	2018
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial. Cancer research and treatment, 2019, Volume: 51, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Oxonic Acid; Republic of Korea; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome	2019
Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study. Medicine, 2018, Volume: 97, Issue:20 Topics: Adenocarcinoma; Administration, Intravenous; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Receptor, ErbB-2; Stomach; Stomach Neoplasms; Taxoids; Trastuzumab	2018
Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer. British journal of cancer, 2018, Volume: 119, Issue:3 Topics: Adult; Aged; Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; CD3 Complex; Docetaxel; Epithelial Cell Adhesion Molecule; Female; Fluorouracil; Gastrectomy; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms	2018
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019, Volume: 22, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Progression-Free Survival; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab	2019
Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019, Volume: 22, Issue:4 Topics: Ado-Trastuzumab Emtansine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Docetaxel; Esophagogastric Junction; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Polymorphism, Genetic; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Survival Rate; Young Adult	2019
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer. European journal of cancer (Oxford, England : 1990), 2019, Volume: 112 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bridged-Ring Compounds; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Paclitaxel; Prospective Studies; Stomach Neoplasms; Taxoids	2019
Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 05-20, Volume: 37, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Medication Adherence; Middle Aged; Neoplasm Staging; Oxonic Acid; Postoperative Care; Stomach Neoplasms; Tegafur	2019
Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis. Annals of surgical oncology, 2019, Volume: 26, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Prognosis; Propensity Score; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur	2019
First-line panitumumab plus docetaxel and cisplatin in advanced gastric and gastro-oesophageal junction adenocarcinoma: results of a phase II trial. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2020, Volume: 22, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Panitumumab; Prospective Studies; Stomach Neoplasms	2020
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Camptothecin; Docetaxel; Drug Carriers; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Irinotecan; Male; Middle Aged; Nanocapsules; Stomach Neoplasms; Survival Rate; Taxoids	2013
Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial. British journal of cancer, 2013, Mar-05, Volume: 108, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Esophageal Neoplasms; Esophagogastric Junction; Humans; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids	2013
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2013
Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Leucovorin; Male; Quality of Life; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Survival; Survival Rate; Taxoids; Vitamin B Complex	2013
Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer. The Korean journal of internal medicine, 2013, Volume: 28, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Protocols; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Republic of Korea; Salvage Therapy; Stomach Neoplasms; Taxoids	2013
Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Prognosis; Prospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Time Factors	2014
Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: results of a randomised Phase 2 study. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:13 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mutation; Organoplatinum Compounds; Oxaliplatin; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome; United States	2013
Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer. Onkologie, 2013, Volume: 36, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; China; Cisplatin; DNA-Binding Proteins; Docetaxel; Female; Fluorouracil; Genetic Markers; Glutathione S-Transferase pi; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Outcome Assessment, Health Care; Polymorphism, Single Nucleotide; Prevalence; Prognosis; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome; X-ray Repair Cross Complementing Protein 1	2013
A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Young Adult	2014
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma. Cancer chemotherapy and pharmacology, 2013, Volume: 72, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Disease Progression; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2013
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study. Acta oncologica (Stockholm, Sweden), 2014, Volume: 53, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Stomach Neoplasms; Taxoids	2014
Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Docetaxel; Drug Combinations; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Prospective Studies; Stomach Neoplasms; Taxoids; Tegafur	2014
Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Nausea; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Collagen; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2014
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids	2014
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Young Adult	2014
Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer. Annals of surgical oncology, 2014, Volume: 21, Issue:7 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Preoperative Care; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2014
Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin). Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Camptothecin; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Quality of Life; Stomach Neoplasms; Surveys and Questionnaires; Taxoids; Treatment Outcome	2014
Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. The Journal of international medical research, 2014, Volume: 42, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Irinotecan; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prospective Studies; Recurrence; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2014
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Leucovorin; Stomach Neoplasms; Taxoids	2014
Efficacy and safety of docetaxel or epirubicin, combined with cisplatin and fluorouracil (DCF and ECF), regimens as first line chemotherapy for advanced gastric cancer: a retrospective analysis from Turkey. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:16 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Turkey	2014
Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Turkey	2014
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Endpoint Determination; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome; Weight Loss	2015
Clinical study of nimotuzumab combined with chemotherapy in the treatment of late stage gastric cancer. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:23 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer. World journal of gastroenterology, 2014, Dec-28, Volume: 20, Issue:48 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Diagnostic Imaging; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Karnofsky Performance Status; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2014
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2016
Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids	2015
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience. Cancer chemotherapy and pharmacology, 2015, Volume: 75, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2015
A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytochrome P-450 CYP2A6; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Oxonic Acid; Perioperative Care; Pharmacogenetics; Postoperative Care; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2016
Phase II study of docetaxel, oxaliplatin, and S-1 therapy in patients with metastatic gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:2 Topics: Adenocarcinoma; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2016
Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer. Anticancer research, 2015, Volume: 35, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2015
Trastuzumab in combination with docetaxel/cisplatin/S-1 (DCS) for patients with HER2-positive metastatic gastric cancer: feasibility and preliminary efficacy. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Cisplatin; Docetaxel; Drug Combinations; ErbB Receptors; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Trastuzumab	2015
Phase II study of first-line biweekly docetaxel and cisplatin combination chemotherapy in advanced gastric cancer. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Monitoring; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Palliative Care; Spain; Stomach Neoplasms; Survival Analysis; Taxoids	2015
Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma. Medical oncology (Northwood, London, England), 2015, Volume: 32, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Young Adult	2015
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Nov-20, Volume: 33, Issue:33 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Proportional Hazards Models; Risk Assessment; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome; United States	2015
BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016, Volume: 19, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; bcl-2 Homologous Antagonist-Killer Protein; Biomarkers, Tumor; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Non-Randomized Controlled Trials as Topic; Oxonic Acid; Peptide Fragments; Prognosis; Proto-Oncogene Proteins; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Young Adult	2016
Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer: A Randomized, Controlled Study. Medicine, 2015, Volume: 94, Issue:42 Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma; Disease-Free Survival; Docetaxel; Female; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Stomach Neoplasms; Taxoids	2015
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction. Cancer chemotherapy and pharmacology, 2015, Volume: 76, Issue:6 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Genetic Predisposition to Disease; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Single Nucleotide; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study. Investigational new drugs, 2016, Volume: 34, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab	2016
Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Fluorouracil; Gastrectomy; Humans; Middle Aged; Neoadjuvant Therapy; Perioperative Period; Postoperative Period; Stomach Neoplasms; Taxoids; Treatment Outcome	2016
A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial. Medicine, 2016, Volume: 95, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2016
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial. British journal of cancer, 2016, Mar-01, Volume: 114, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Fluorouracil; Humans; Infections; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Panitumumab; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting	2016
A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction. American journal of clinical oncology, 2018, Volume: 41, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Oxaliplatin; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate	2018
Bevacizumab combined with docetaxel, oxaliplatin, and capecitabine, followed by maintenance with capecitabine and bevacizumab, as first-line treatment of patients with advanced HER2-negative gastric cancer: A multicenter phase 2 study. Cancer, 2016, 05-01, Volume: 122, Issue:9 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Neoplastic Cells, Circulating; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Receptor, ErbB-2; Stomach Neoplasms; Taxoids	2016
A pilot trial of FLOT neoadjuvant chemotherapy for resectable esophagogastric junction adenocarcinoma. Medical oncology (Northwood, London, England), 2016, Volume: 33, Issue:7 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Pilot Projects; Quality of Life; Stomach Neoplasms; Taxoids	2016
Effects of paclitaxel liposome and capecitabine in the treatment of advanced gastric cancer by clinical observation. International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Liposomes; Male; Middle Aged; Paclitaxel; Remission Induction; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2016
A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer. PloS one, 2016, Volume: 11, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Taxoids	2016
Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma. American journal of clinical oncology, 2018, Volume: 41, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Stomach Neoplasms; Survival Rate; Young Adult	2018
Chemotherapy for advanced gastric cancer: ongoing phase III study of S-1 alone versus S-1 and docetaxel combination (JACCRO GC03 study). International journal of clinical oncology, 2008, Volume: 13, Issue:3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2008
Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer. Cancer letters, 2008, Nov-08, Volume: 270, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Marrow Cells; Cell Line, Tumor; Cell Movement; Cell Survival; Cells, Cultured; Disease-Free Survival; Docetaxel; Endothelial Cells; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Stem Cells; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2008
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2008
A multicenter, phase I dose-escalating study of docetaxel, cisplatin and S-1 for advanced gastric cancer (KDOG0601). Oncology, 2008, Volume: 75, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2008
[Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:5 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Taxoids; Vomiting; Young Adult	2008
A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Feasibility Studies; Female; Humans; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2009
[Clinical trials of neo-adjuvant chemotherapy for advanced gastric cancer with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2008
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Esophageal Neoplasms; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids	2009
An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Camptothecin; Digestive System Neoplasms; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Treatment Outcome; Vitamin B Complex	2010
Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma. Journal of experimental & clinical cancer research : CR, 2009, Mar-09, Volume: 28 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Survival Rate; Taxoids	2009
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases. Anti-cancer drugs, 2009, Volume: 20, Issue:8 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Liver; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Stomach; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2009
Phase II study of biweekly docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Oncology, 2009, Volume: 77, Issue:1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome; Young Adult	2009
Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer. Pharmacogenomics, 2009, Volume: 10, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Docetaxel; Drug Combinations; Female; Genome-Wide Association Study; Humans; Male; Middle Aged; Oxonic Acid; Pilot Projects; Polymorphism, Genetic; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome; Young Adult	2009
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study). British journal of cancer, 2009, Oct-20, Volume: 101, Issue:8 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids	2009
Induction chemotherapy with docetaxel, 5-FU and CDDP (DFP) for advanced gastric cancer. Anticancer research, 2009, Volume: 29, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Taxoids	2009
Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:2 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids; Young Adult	2010
Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer. Annals of surgical oncology, 2010, Volume: 17, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2010
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neutropenia; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome	2010
A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2009, Volume: 12, Issue:4 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Female; Floxuridine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2009
Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. British journal of cancer, 2010, Feb-02, Volume: 102, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids	2010
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diarrhea; Docetaxel; ErbB Receptors; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Tissue Array Analysis; Treatment Outcome	2010
Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer. World journal of gastroenterology, 2010, Feb-21, Volume: 16, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Endosonography; Europe; Feasibility Studies; Female; Fluorouracil; Gastrectomy; Humans; Laparoscopy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Stomach Neoplasms; Taxoids; Time Factors; Tomography, Spiral Computed; Treatment Outcome	2010
A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2010
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: results of a phase II trial. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Polyethylene Glycols; Recombinant Proteins; Stomach Neoplasms; Taxoids; Treatment Outcome	2011
Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers. Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Docetaxel; Esophagogastric Junction; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2010
[Efficacy and safety evaluation of docetaxel plus oxaliplatin and capecitabine in the treatment of advanced gastric adenocarcinoma: a single center non-controlled phase II clinical trial]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2010, Volume: 13, Issue:3 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2010
A phase II study of weekly docetaxel in combination with capecitabine in advanced gastric and gastroesophageal adenocarcinomas. Oncology, 2010, Volume: 78, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Outpatients; Patient Selection; Stomach Neoplasms; Survival Analysis; Taxoids; Young Adult	2010
Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer. Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
Phase II study of sorafenib in combination with docetaxel and cisplatin in the treatment of metastatic or advanced gastric and gastroesophageal junction adenocarcinoma: ECOG 5203. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jun-20, Volume: 28, Issue:18 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Cisplatin; Docetaxel; Esophagogastric Junction; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2010
Feasibility study of S-1 and intraperitoneal docetaxel combination chemotherapy for gastric cancer with peritoneal dissemination. Anticancer research, 2010, Volume: 30, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Feasibility Studies; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2010
Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma. Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Taxoids	2010
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Japan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2010
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Medical oncology (Northwood, London, England), 2011, Volume: 28 Suppl 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Taxoids; Time Factors; Treatment Outcome	2011
Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2011
Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Taxoids; Young Adult	2011
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2010, Volume: 13, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Statistics as Topic; Stomach Neoplasms; Surveys and Questionnaires; Survival Analysis; Taxoids; Time Factors; Vitamin B Complex	2010
A phase I study of docetaxel, oxaliplatin, & capecitabine (DOC) as first-line therapy of patients with locally advanced or metastatic adenocarcinoma of stomach and GE junction. Cancer investigation, 2010, Volume: 28, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Fatigue; Fluorouracil; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Vomiting	2010
Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2011
A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer. British journal of cancer, 2010, Oct-26, Volume: 103, Issue:9 Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids; Tegafur; Uracil	2010
Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study. Annals of surgical oncology, 2011, Volume: 18, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Preoperative Care; Radiotherapy Dosage; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2011
Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Mar-01, Volume: 29, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2011
A phase I study of bi-weekly docetaxel for recurrent or advanced gastric cancer patients whose disease progressed by prior chemotherapy. Japanese journal of clinical oncology, 2011, Volume: 41, Issue:6 Topics: Adult; Aged; Alanine Transaminase; Anemia; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Patient Selection; Salvage Therapy; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2011
A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy. Cancer, 2011, May-15, Volume: 117, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Middle Aged; Osteonectin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2011
A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012, Volume: 15, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2012
Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Drug Combinations; Feasibility Studies; Female; Gastrectomy; Humans; Infusions, Intravenous; Lymph Node Excision; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Prospective Studies; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2011
Ubenimex capsule improves general performance and chemotherapy related toxicity in advanced gastric cancer cases. Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Capsules; Cisplatin; Docetaxel; Female; Hemoglobins; Humans; Killer Cells, Natural; Leucine; Leukocytes; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; T-Lymphocytes; Taxoids; Tegafur	2011
Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts. British journal of cancer, 2011, Aug-09, Volume: 105, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cohort Studies; Deoxycytidine; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2011
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601). Cancer chemotherapy and pharmacology, 2012, Volume: 69, Issue:2 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2012
Docetaxel plus oxaliplatin in combination with capecitabine as first-line treatment for advanced gastric cancer. Oncology, 2011, Volume: 80, Issue:5-6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2011
Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Perioperative Period; Stomach Neoplasms; Taxoids; Tumor Burden; Young Adult	2012
Phase II clinical study on the modified DCF regimen for treatment of advanced gastric carcinoma. Chinese medical journal, 2011, Volume: 124, Issue:19 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids	2011
A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized ph Japanese journal of clinical oncology, 2012, Volume: 42, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2012
Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Combinations; Feasibility Studies; Female; Gastrectomy; Humans; Infusions, Intravenous; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Patient Selection; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome	2012
Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2012
The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience. Anti-cancer drugs, 2012, Volume: 23, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2012
Docetaxel and Cisplatin Plus Fluorouracil compared with Modified Docetaxel, Cisplatin, and 5-Fluorouracil as first-line therapy for advanced gastric cancer: a retrospective analysis of single institution. Neoplasma, 2012, Volume: 59, Issue:2 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome; Young Adult	2012
Efficacy of weekly paclitaxel in patients with advanced gastric cancer refractory to docetaxel-based chemotherapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012, Volume: 15, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Treatment of Borrmann type IV gastric cancer with a neoadjuvant chemotherapy combination of docetaxel, cisplatin and 5-fluorouracil/leucovorin. The Journal of international medical research, 2011, Volume: 39, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Taxoids; Treatment Outcome	2011
Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, May-01, Volume: 30, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Platinum Compounds; Proportional Hazards Models; Prospective Studies; Pyrimidines; Republic of Korea; Risk Assessment; Risk Factors; Salvage Therapy; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2012
Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum. British journal of cancer, 2012, Apr-24, Volume: 106, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Female; Fluorouracil; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Platinum; Pyrroles; Salvage Therapy; Stomach Neoplasms; Sunitinib; Survival Rate; Taxoids; Tissue Distribution; Treatment Outcome; Young Adult	2012
Phase I study of docetaxel, cisplatin and concurrent radiotherapy for locally advanced gastric adenocarcinoma. Neoplasma, 2012, Volume: 59, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2012
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome	2012
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients. International journal of clinical oncology, 2013, Volume: 18, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2013
Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO){dagger}. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study. British journal of cancer, 2012, Jul-24, Volume: 107, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Disease Progression; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Stomach Neoplasms; Taxoids	2012
A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Korea; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2012
[Phase II clinical trial of docetaxel, platinum and S-1 for advanced gastric cancer]. Zhonghua yi xue za zhi, 2012, Jun-26, Volume: 92, Issue:24 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Platinum; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2012
Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study. Anticancer research, 2012, Volume: 32, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids	2012
Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NADP); Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2013
Docetaxel-based preoperative chemoradiation in localized gastric cancer: impact of pathological complete response on patient outcome. Journal of gastrointestinal cancer, 2013, Volume: 44, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Low-dose docetaxel and cisplatin combination chemotherapy for stage II/III gastric cancer showing resistance to S-1 adjuvant chemotherapy: a phase I study. Journal of chemotherapy (Florence, Italy), 2012, Volume: 24, Issue:6 Topics: Aged; Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Dehydration; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2012
Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2013
The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial. Medical oncology (Northwood, London, England), 2013, Volume: 30, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2013
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer. British journal of cancer, 2013, Feb-19, Volume: 108, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Perioperative Care; Prognosis; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids	2013
A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Combined Modality Therapy; DNA Repair; DNA-Binding Proteins; Docetaxel; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Endonucleases; Endosonography; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Tomography, X-Ray Computed; Treatment Outcome	2013
Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneum; Stomach Neoplasms; Taxoids; Tegafur	2013
Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer. Anticancer research, 2013, Volume: 33, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Oxonic Acid; Proportional Hazards Models; Stomach Neoplasms; Taxoids; Tegafur	2013
Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction. BMC cancer, 2013, Feb-11, Volume: 13 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Esophagogastric Junction; Female; Germany; Humans; Israel; Kaplan-Meier Estimate; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2013
Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial. Japanese journal of clinical oncology, 2002, Volume: 32, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Docetaxel; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids	2002
Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Incidence; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taxoids; Time Factors; Treatment Outcome	2002
Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5, Issue:3 Topics: Adult; Aged; Alkyl and Aryl Transferases; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Japan; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taxoids; Transferases (Other Substituted Phosphate Groups); Treatment Outcome	2002
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer. Oncology, 2002, Volume: 63, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids	2002
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion. Onkologie, 2003, Volume: 26, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Spleen; Splenic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5 Suppl 1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome	2002
European experience of docetaxel and cisplatin in advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5 Suppl 1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Taxoids	2002
A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia. International journal of gastrointestinal cancer, 2002, Volume: 32, Issue:2-3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cardia; Docetaxel; Dose-Response Relationship, Drug; Esophageal Neoplasms; Female; Humans; Hypotension; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Nausea; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting	2002
Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Irinotecan; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Taxoids	2003
Effective combination chemotherapy with bimonthly docetaxel and cisplatin with or without hematopoietic growth factor support in patients with advanced gastroesophageal cancer. Oncology, 2003, Volume: 65, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Therapy, Combination; Erythropoietin; Esophageal Neoplasms; Esophagogastric Junction; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Maximum Tolerated Dose; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2003
Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Dec-01, Volume: 9, Issue:16 Pt 1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2003
A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer. British journal of cancer, 2004, Apr-05, Volume: 90, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Factors predicting docetaxel-related toxicity: experience at a single institution. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Health Status; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Regression Analysis; Stomach Neoplasms; Taxoids; Vomiting	2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer. British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Male; Middle Aged; Neutropenia; Palliative Care; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2004
Docetaxel plus cisplatin as second-line therapy in metastatic or recurrent advanced gastric cancer progressing on 5-fluorouracil-based regimen. American journal of clinical oncology, 2004, Volume: 27, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma. Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:5 Topics: Adult; Aged; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neutropenia; Stomach Neoplasms; Survival Rate; Taxoids	2005
Docetaxel (Taxotere), cisplatin, UFT, and leucovorin combination chemotherapy in advanced gastric cancer. British journal of cancer, 2005, Mar-14, Volume: 92, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome; Uracil	2005
Weekly docetaxel in combination with capecitabine in patients with metastatic gastric cancer. American journal of clinical oncology, 2005, Volume: 28, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids	2005
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids	2005
Docetaxel + 5-fluorouracil + cisplatin 3-day combination chemotherapy as a first-line treatment in patients with unresectable gastric cancer. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids	2005
Phase II study of docetaxel and capecitabine in patients with metastatic or recurrent gastric cancer. Oncology, 2005, Volume: 68, Issue:2-3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2005
Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer. BMC cancer, 2005, Jul-22, Volume: 5 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cohort Studies; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids; Time Factors	2005
Phase I study of docetaxel, capecitabine, and carboplatin in metastatic esophagogastric cancer. American journal of clinical oncology, 2005, Volume: 28, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Carboplatin; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Nausea; Neutropenia; Stomach Neoplasms; Taxoids	2005
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2005
Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors. Oncology, 2005, Volume: 69, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liposomes; Male; Middle Aged; Neoplasms; Neoplasms, Unknown Primary; Polyethylene Glycols; Prostatic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2005
Phase II study of low-dose docetaxel/fluorouracil/cisplatin in metastatic gastric carcinoma. American journal of clinical oncology, 2005, Volume: 28, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids	2005
A phase II study of docetaxel and cisplatin in patients with gastric cancer recurring after or progressing during 5-FU/platinum treatment. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:12 Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Gastrectomy; Humans; Leukopenia; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2005
Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil. Anti-cancer drugs, 2006, Volume: 17, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2006
A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancer. Oncology, 2006, Volume: 70, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Epirubicin-docetaxel in advanced gastric cancer: two phase II studies as second and first line treatment. Bulletin du cancer, 2006, Volume: 93, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Epirubicin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids	2006
Combination docetaxel (Taxotere), fluorouracil, and leucovorin (TFL), as first-line chemotherapy in advanced gastric cancer: a Hellenic Cooperative Oncology Group phase II study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2006, Volume: 9, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Maximum Tolerated Dose; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids	2006
Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma. British journal of cancer, 2006, May-22, Volume: 94, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids	2006
[Study on efficacy and toxicity of new combined regimen "taxoter + cisplatin + 5-fluorouracil" in disseminated and locally-spread stomach cancer. Comparative analysis of tolerance and efficacy in patients younger and older than 65 years]. Advances in gerontology = Uspekhi gerontologii, 2006, Volume: 18 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Invasiveness; Stomach Neoplasms; Taxoids; Treatment Outcome	2006
Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer. Cancer chemotherapy and pharmacology, 2007, Volume: 59, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; Disease Progression; Docetaxel; Female; Humans; Male; Middle Aged; Nausea; Neoplasm Metastasis; Neutropenia; Palliative Care; Stomach Neoplasms; Taxoids; Vomiting	2007
Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-01, Volume: 12, Issue:11 Pt 1 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2006
Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2006, Volume: 9, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Rate; Taxoids	2006
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer. British journal of cancer, 2006, Jun-19, Volume: 94, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Oxonic Acid; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2006
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Disease Progression; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Taxoids	2006
[Combination chemotherapy of S-1 and docetaxel on advanced and recurrent gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33 Suppl 1 Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2006
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Nov-01, Volume: 24, Issue:31 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2006
Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF). BMC cancer, 2006, Dec-05, Volume: 6 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids	2006
A dose escalation study of docetaxel plus capecitabine in combination with gemcitabine in patients with advanced solid tumors. Oncology research, 2006, Volume: 16, Issue:6 Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Pancreatic Neoplasms; Patient Compliance; Stomach Neoplasms; Taxoids; Treatment Outcome	2006
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Disease Progression; Docetaxel; Drug Delivery Systems; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Failure	2008
Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2007, Volume: 10, Issue:2 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids	2007
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18 Suppl 6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Palliative Care; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids	2007
Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Stomach Neoplasms; Taxoids	2007
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2007
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cisplatin; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Statistics, Nonparametric; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2007
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Quality of Life; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma. British journal of cancer, 2007, Sep-03, Volume: 97, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Diarrhea; Disease Progression; Docetaxel; Esophagogastric Junction; Female; Fever; Humans; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Mucositis; Neoplasm Metastasis; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome; Vomiting	2007
A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Floxuridine; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids	2007
A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer. American journal of clinical oncology, 2007, Volume: 30, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer. British journal of cancer, 2007, Oct-08, Volume: 97, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Immunoenzyme Techniques; Intestinal Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Vascular Endothelial Growth Factor A	2007
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial. Oncology, 2006, Volume: 71, Issue:5-6 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Mitomycin; Neutropenia; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome	2006
Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer: a Hellenic Cooperative Oncology Group (HeCOG) phase II study. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:3 Topics: Adenocarcinoma; Adjuvants, Immunologic; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Male; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2007
[Clinical observation on treatment of advanced gastric cancer by combined use of Shenqi Fuzheng injection, docetaxel, flurouracil and calcium folinate]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluorouracil; Humans; Injections; Leucovorin; Male; Middle Aged; Phytotherapy; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study. Cancer investigation, 2007, Volume: 25, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carboplatin; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Analysis; Taxoids	2007
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Dexamethasone; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Gastrointestinal Diseases; Humans; Magnesium Sulfate; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Premedication; Stomach Neoplasms; Taxoids; Treatment Outcome	2008
A multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer. Chemotherapy, 2007, Volume: 53, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2007
[Weekly dosage of docetaxel combined with cisplatin and 5-fluorouracil in the treatment of advanced gastric cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007, Volume: 27, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
[Clinical observation on treatment of 34 advanced gastric carcinoma patients by chemotherapy of DCF regimen combined with Fuzheng Hewei Decoction]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2007, Volume: 27, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluorouracil; Humans; Male; Middle Aged; Phytotherapy; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. British journal of cancer, 2008, Feb-12, Volume: 98, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Analysis; Taxoids	2008
[Neoadjuvant chemotherapy for gastric cancer with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2007
[A multi-centric phase I/II study of intraperitoneal docetaxel combined with S-1 for patients with peritoneal dissemination of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Infusions, Parenteral; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2007
Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer. Results of a phase II study in elderly patients or patients with impaired performance status. Critical reviews in oncology/hematology, 2008, Volume: 66, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Esophagogastric Junction; Female; Humans; Male; Prospective Studies; Stomach Neoplasms; Taxoids	2008
A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer. Cancer chemotherapy and pharmacology, 2008, Volume: 63, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Camptothecin; Disease Progression; Docetaxel; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Irinotecan; Male; Middle Aged; Remission Induction; Stomach Neoplasms; Survival Analysis; Taxoids	2008
Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer. Oncology, 2007, Volume: 73, Issue:1-2 Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Platinum Compounds; Salvage Therapy; Severity of Illness Index; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Cisplatin plus weekly CPT-11/docetaxel in advanced esophagogastric cancer: a phase I study with pharmacogenetic assessment of XPD, XRCC3 and UGT1A1 polymorphisms. Cancer chemotherapy and pharmacology, 2008, Volume: 62, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Diarrhea; Disease Progression; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; Docetaxel; Drug Resistance, Neoplasm; Esophageal Neoplasms; Female; Genotype; Glucuronosyltransferase; Humans; Irinotecan; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Polymorphism, Single Nucleotide; Stomach Neoplasms; Survival Analysis; Taxoids; Xeroderma Pigmentosum Group D Protein	2008
Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2009
Phase I/II study of S-1 combined with weekly docetaxel in patients with metastatic gastric carcinoma. British journal of cancer, 2008, Apr-22, Volume: 98, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2008
Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer, 2008, Volume: 112, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Endosonography; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Preoperative Care; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tomography, X-Ray Computed	2008
Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally advanced esophagogastric cancer previously untreated with chemotherapy for advanced disease: results of the Central European Cooperative Oncology Group Stud Anti-cancer drugs, 2008, Volume: 19, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Erythropoietin; Esophageal Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Survival Rate; Taxoids	2008
Phase I/II trial with docetaxel and S-1 for patients with advanced or recurrent gastric cancer with consideration to age. Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2009
Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Oxonic Acid; Prospective Studies; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2009
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group. European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A Suppl 4 Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged; Neoplasms; Paclitaxel; Sarcoma; Stomach Neoplasms; Taxoids	1995
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. British journal of cancer, 1994, Volume: 70, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Taxoids	1994
[An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:14 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids	1994
Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Medical oncology (Northwood, London, England), 1996, Volume: 13, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Paclitaxel; Remission Induction; Stomach Neoplasms; Survival Rate; Taxoids	1996
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12 Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting	1998
[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting, Anticipatory	1999
Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Paclitaxel; Stomach Neoplasms; Survival Analysis; Taxoids	2000
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Confidence Intervals; Disease Progression; Docetaxel; Female; Fever; Follow-Up Studies; Gastrectomy; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Male; Middle Aged; Neutropenia; Paclitaxel; Remission Induction; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2000
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:10 Topics: Aged; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Paclitaxel; Salvage Therapy; Stomach Neoplasms; Taxoids	2000
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. British journal of cancer, 2001, Volume: 84, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Fatigue; Female; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leucovorin; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome	2001
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diarrhea; Docetaxel; Female; Humans; Leukopenia; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2001

Other Studies

408 other study(ies) available for docetaxel anhydrous and Cancer of Stomach

Article	Year
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 12-01, Volume: 39, Issue:34 Topics: Docetaxel; Esophagogastric Junction; Humans; Neoadjuvant Therapy; Oxaliplatin; Stomach Neoplasms	2021
Results of the observational prospective RealFLOT study. BMC cancer, 2021, Oct-08, Volume: 21, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Feasibility Studies; Female; Fluorouracil; Humans; Italy; Male; Microsatellite Instability; Middle Aged; Neutropenia; Oxaliplatin; Prognosis; Prospective Studies; Stomach Neoplasms	2021
Intelligent Algorithm-Based CT Imaging for Evaluation of Efficacy of Docetaxel Combined with Fluorouracil on Patients with Gastric Cancer. Journal of healthcare engineering, 2021, Volume: 2021 Topics: Algorithms; Docetaxel; Fluorouracil; Humans; Stomach Neoplasms; Tomography, X-Ray Computed	2021
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013. Japanese journal of clinical oncology, 2022, Jan-03, Volume: 52, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Kidney; Stomach Neoplasms; Taxoids	2022
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma. Anticancer research, 2022, Volume: 42, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Carcinoembryonic Antigen; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Perioperative Period; Proportional Hazards Models; Stomach Neoplasms	2022
[A Case of Remnant Gastric Cancer with Mesojejunal Lymph Node Metastasis]. Gan to kagaku ryoho. Cancer & chemotherapy, 2021, Volume: 48, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dissection; Docetaxel; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms	2021
Gastric cancer cell death analyzed by live cell imaging of spheroids. Scientific reports, 2022, 01-27, Volume: 12, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cancer-Associated Fibroblasts; Cell Culture Techniques, Three Dimensional; Cell Line, Tumor; Docetaxel; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Intravital Microscopy; Lovastatin; Spheroids, Cellular; Stomach Neoplasms	2022
Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study. BJS open, 2022, 01-06, Volume: 6, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cohort Studies; Docetaxel; Epirubicin; Esophageal Neoplasms; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Perioperative Care; Propensity Score; Stomach Neoplasms; Treatment Outcome	2022
Corilagin exhibits differential anticancer effects through the modulation of STAT3/5 and MAPKs in human gastric cancer cells. Phytotherapy research : PTR, 2022, Volume: 36, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Glucosides; Humans; Hydrolyzable Tannins; Mitogen-Activated Protein Kinases; STAT3 Transcription Factor; Stomach Neoplasms	2022
Docetaxel and 5-FU enhanced the inhibitory effects of apatinib and ramucirumab on growth and migration of gastric cancer. Life sciences, 2022, May-01, Volume: 296 Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Cell Proliferation; Docetaxel; Embryo, Nonmammalian; Fluorouracil; Humans; Proto-Oncogene Proteins c-akt; Pyridines; Ramucirumab; Stomach Neoplasms; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish	2022
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter? Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:5 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2023
A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer. Bioscience reports, 2022, 09-30, Volume: 42, Issue:9 Topics: Cisplatin; Docetaxel; Gene Expression Regulation, Neoplastic; Humans; RNA, Long Noncoding; RNA, Messenger; Stomach Neoplasms	2022
Real-world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first-line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma. Asia-Pacific journal of clinical oncology, 2023, Volume: 19, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Febrile Neutropenia; Gemcitabine; Humans; Middle Aged; Palliative Care; Pancreatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Treatment Outcome	2023
Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. Nature communications, 2022, 09-29, Volume: 13, Issue:1 Topics: Docetaxel; Humans; Phosphatidylinositol 3-Kinases; Proteome; Proteomics; Proto-Oncogene Proteins c-akt; Receptors, Antigen, T-Cell; Stomach Neoplasms; Transketolase; Trastuzumab	2022
Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma. Turkish journal of medical sciences, 2022, Volume: 52, Issue:5 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Retrospective Studies; Stomach Neoplasms; Taxoids	2022
Perioperative chemotherapy with 5-FU, leucovorin, oxaliplatin, and docetaxel (FLOT) for esophagogastric adenocarcinoma: ten years real-life experience from a surgical perspective. Langenbeck's archives of surgery, 2023, Feb-10, Volume: 408, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fluorouracil; Humans; Leucovorin; Neoadjuvant Therapy; Oxaliplatin; Retrospective Studies; Stomach Neoplasms	2023
Efficacy and safety evaluation of PSOX, DOF and SOX regimens as neoadjuvant chemotherapy for advanced gastric cancer. Future oncology (London, England), 2022, Volume: 18, Issue:40 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Neoadjuvant Therapy; Oxaliplatin; Paclitaxel; Retrospective Studies; Stomach Neoplasms	2022
Integrated analysis from multicentre studies identities m7G-related lncRNA-derived molecular subtypes and risk stratification systems for gastric cancer. Frontiers in immunology, 2023, Volume: 14 Topics: Cisplatin; Docetaxel; Humans; Risk Assessment; RNA, Long Noncoding; Stomach Neoplasms; Tumor Microenvironment	2023
Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA). BMC cancer, 2023, Apr-04, Volume: 23, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Docetaxel; Humans; Neoadjuvant Therapy; Oxaliplatin; Prospective Studies; Stomach Neoplasms	2023
Long-term Outcomes of Neoadjuvant Chemotherapy With Docetaxel, Cisplatin and S-1 for Stage III Gastric Cancer. Anticancer research, 2023, Volume: 43, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Retrospective Studies; Stomach Neoplasms	2023
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy. Oncology, 2023, Volume: 101, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Fluorouracil; Humans; Leucovorin; Stomach Neoplasms; Tumor Microenvironment	2023
The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs. Cancer letters, 2023, 09-01, Volume: 571 Topics: Antigens, Neoplasm; Antineoplastic Agents; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Cell Line; Cell Line, Tumor; Docetaxel; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms; Taxoids	2023
Adjuvant Chemotherapy With S-1 Plus Docetaxel Anticancer research, 2023, Volume: 43, Issue:11 Topics: Adjuvants, Immunologic; Chemotherapy, Adjuvant; Docetaxel; Humans; Oxaliplatin; Retrospective Studies; Stomach Neoplasms	2023
Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel. International journal of molecular sciences, 2023, Oct-24, Volume: 24, Issue:21 Topics: Adenocarcinoma; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Stomach Neoplasms; Zebrafish	2023
S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer. Cancer communications (London, England), 2019, 10-26, Volume: 39, Issue:1 Topics: Docetaxel; Humans; Oxonic Acid; Stomach Neoplasms; Tegafur	2019
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters. Biochemical pharmacology, 2020, Volume: 171 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Cell Line, Tumor; Diclofenac; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Male; Mice, Nude; Middle Aged; Multidrug Resistance-Associated Proteins; Sorafenib; Stomach Neoplasms; Xenograft Model Antitumor Assays	2020
JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020, Volume: 23, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carrier Proteins; Cell Proliferation; Cisplatin; Docetaxel; Drug Combinations; Gene Expression Regulation, Neoplastic; Humans; Jumonji Domain-Containing Histone Demethylases; Oxonic Acid; Prognosis; Stomach Neoplasms; Tegafur; Tumor Cells, Cultured	2020
Atractylenolide III Enhances the Anti-Neoplastic Efficacy of Docetaxel in Gastric Cancer Cell by Inhibiting Fibroblast Growth Factor Receptors 1, -2, and -4 Expression. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2019, Volume: 38, Issue:3 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Docetaxel; Gene Expression; Humans; Lactones; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 4; Sesquiterpenes; Stomach Neoplasms	2019
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer. Anti-cancer drugs, 2020, Volume: 31, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Prospective Studies; Stomach Neoplasms	2020
Clinical management patterns of advanced and metastatic gastro-oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom. European journal of cancer care, 2020, Volume: 29, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease Progression; Docetaxel; Emergency Service, Hospital; Epirubicin; Esophagogastric Junction; Female; Fluorouracil; France; Germany; Guideline Adherence; Hospice Care; Hospitalization; Humans; Irinotecan; Male; Middle Aged; Nutritional Support; Oxaliplatin; Palliative Care; Practice Guidelines as Topic; Practice Patterns, Physicians'; Receptor, ErbB-2; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Failure; United Kingdom	2020
Perioperative chemotherapy for gastric cancer in FLOT4. Lancet (London, England), 2020, 01-11, Volume: 395, Issue:10218 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2020
Perioperative chemotherapy for gastric cancer in FLOT4. Lancet (London, England), 2020, 01-11, Volume: 395, Issue:10218 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2020
The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020, Volume: 23, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Platelets; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Hemoglobins; Humans; Inflammation; Lymph Node Excision; Lymphocytes; Male; Middle Aged; Neoadjuvant Therapy; Neutrophils; Nomograms; Oxaliplatin; Paclitaxel; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate	2020
Gene regulatory network analysis with drug sensitivity reveals synergistic effects of combinatory chemotherapy in gastric cancer. Scientific reports, 2020, 03-03, Volume: 10, Issue:1 Topics: Aged; Cell Movement; Cisplatin; Databases, Genetic; Docetaxel; Drug Synergism; Female; Fluorouracil; Gene Regulatory Networks; Humans; Male; Middle Aged; Stomach Neoplasms	2020
Frequency of CD44 positive cells in MKN45 cell line after treatment with docetaxel in two and three-dimensional cell cultures. Tissue & cell, 2020, Volume: 63 Topics: Animals; Cell Culture Techniques; Cell Line, Tumor; Docetaxel; Extracellular Matrix; Gene Expression Regulation, Neoplastic; Humans; Hyaluronan Receptors; Intestines; Rats; Stomach Neoplasms	2020
Gastric squamous cell carcinoma presenting in ascites: Negative to P63 and P40 after one course of chemotherapy. Diagnostic cytopathology, 2020, Volume: 48, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Gastroscopy; Gene Expression; Humans; Keratins; Lymphatic Metastasis; Membrane Proteins; Middle Aged; NF-KappaB Inhibitor alpha; Stomach; Stomach Neoplasms; Tomography, X-Ray Computed	2020
[Case of Gastric Cancer with Para-Aortic Lymph Node Metastases Successfully Treated with S-1/Docetaxel Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Oxonic Acid; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tegafur	2020
FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer. Canadian journal of gastroenterology & hepatology, 2020, Volume: 2020 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Gastrectomy; Humans; Laparoscopy; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Oxaliplatin; Stomach Neoplasms; Treatment Outcome; Young Adult	2020
[Summary of clinical research progression of apatinib combined with docetaxel in second-line treatment of advanced gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2020, Jul-23, Volume: 42, Issue:7 Topics: Antineoplastic Agents; Disease Progression; Docetaxel; Humans; Pyridines; Stomach Neoplasms	2020
Outcome of FOLFOX and Modified DCF Chemotherapy Regimen in Patients with Advanced Gastric Adenocarcinoma. Asian Pacific journal of cancer prevention : APJCP, 2020, Aug-01, Volume: 21, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Sectional Studies; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate	2020
Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer. Clinical chemistry and laboratory medicine, 2020, 09-01, Volume: 59, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Capecitabine; DNA Methylation; Docetaxel; Gene Expression Regulation; Humans; Oxaliplatin; Promoter Regions, Genetic; SOXF Transcription Factors; Stomach Neoplasms; Tumor Suppressor Proteins	2020
Correlation between microRNA-766 expression in patients with advanced gastric cancer and the efficacy of platinum-containing chemotherapy. European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:17 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; MicroRNAs; Middle Aged; Neoplasm Staging; Oxaliplatin; Paclitaxel; Stomach Neoplasms; Treatment Outcome; Tumor Burden	2020
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit? Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Clinical Trials as Topic; Docetaxel; Female; Humans; Male; Middle Aged; Platinum Compounds; Product Surveillance, Postmarketing; Progression-Free Survival; Prospective Studies; Pyrimidines; Registries; Stomach Neoplasms; Survival Rate; Treatment Outcome; Young Adult	2021
Reply to: Comments on "Systemic exposure of oxaliplatin and docetaxel in gastric patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy". European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2020, Volume: 46, Issue:12 Topics: Docetaxel; Humans; Hyperthermic Intraperitoneal Chemotherapy; Oxaliplatin; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms	2020
Efficacy of Metformin and Chemotherapeutic Agents on the Inhibition of Colony Formation and Shh/Gli1 Pathway: Metformin/Docetaxel Versus Metformin/5-Fluorouracil. Drug research, 2021, Volume: 71, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Docetaxel; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Metformin; Signal Transduction; Stomach Neoplasms; Tumor Stem Cell Assay; Zinc Finger Protein GLI1	2021
Docetaxel-induced fluid retention during adjuvant chemotherapy with S-1 plus docetaxel. Clinical journal of gastroenterology, 2021, Volume: 14, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Humans; Japan; Neoplasm Recurrence, Local; Stomach Neoplasms	2021
Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells. Oncology reports, 2020, Volume: 44, Issue:6 Topics: Acrylamides; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemoradiotherapy; Docetaxel; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Radiation Tolerance; Radiation-Sensitizing Agents; Receptor, ErbB-2; Stomach Neoplasms; Xenograft Model Antitumor Assays	2020
[Long-Term Follow-Up of Patients Who Received Chemotherapy with S-1 and Docetaxel after Relatively Curative Surgery for Advanced Gastric Cancer Including Non-Curative Factors]. Gan to kagaku ryoho. Cancer & chemotherapy, 2020, Volume: 47, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Follow-Up Studies; Gastrectomy; Humans; Neoplasm Recurrence, Local; Patients; Stomach Neoplasms	2020
Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases. Bulletin du cancer, 2021, Volume: 108, Issue:3 Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Digestive System Diseases; Docetaxel; Fatigue; Female; Fluorouracil; Hematologic Diseases; Humans; Male; Middle Aged; Nail Diseases; Nervous System Diseases; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tunisia	2021
Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study. Oncology, 2021, Volume: 99, Issue:6 Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nutrition Assessment; Oxonic Acid; Practice Guidelines as Topic; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Tegafur; Treatment Outcome	2021
Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer. Journal of surgical oncology, 2021, Volume: 123, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxaliplatin; Retrospective Studies; Stomach Neoplasms	2021
Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC). Clinical medicine & research, 2021, Volume: 19, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Stomach Neoplasms; Taxoids	2021
Body Composition Changes in Gastric Cancer Patients during Preoperative FLOT Therapy: Preliminary Results of an Italian Cohort Study. Nutrients, 2021, Mar-16, Volume: 13, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Body Composition; Body Mass Index; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Italy; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Oxaliplatin; Retrospective Studies; Sarcopenia; Stomach Neoplasms; Tomography, X-Ray Computed	2021
Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction. Journal of surgical oncology, 2021, Volume: 123 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Humans; Infusions, Intravenous; Laparoscopy; Leucovorin; Lymph Nodes; Male; Middle Aged; Neoplasm Grading; Omentum; Oxaliplatin; Retrospective Studies; Stomach Neoplasms	2021
Predictive Significance of Ki-67 and Platelet Lymphocyte Ratio in Patients with Gastric Cancer Receiving Neoadjuvant FLOT Chemotherapy. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2021, Volume: 30, Issue:5 Topics: Docetaxel; Fluorouracil; Humans; Ki-67 Antigen; Leucovorin; Lymphocytes; Neoadjuvant Therapy; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms; Turkey	2021
The impact of recent chemotherapy on immunity in 2 COVID-19 cases with gastrointestinal tumors: A case report. Medicine, 2021, May-28, Volume: 100, Issue:21 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Cyclobutanes; Docetaxel; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung; Male; Middle Aged; Organoplatinum Compounds; RNA, Viral; SARS-CoV-2; Sorafenib; Stomach Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2021
Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment. Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Hematologic Diseases; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Survival Analysis	2022
Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT. Journal of gastrointestinal cancer, 2022, Volume: 53, Issue:3 Topics: Docetaxel; Fluorouracil; Humans; Leucovorin; Nutritional Status; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms	2022
Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2022, Volume: 48, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biomarkers; Capecitabine; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Irinotecan; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oxaliplatin; Oxonic Acid; Proportional Hazards Models; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Trastuzumab	2022
Union is strength: Textbook outcome with perioperative chemotherapy compliance decreases the risk of death in advanced gastric cancer patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2022, Volume: 48, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Docetaxel; Epirubicin; Female; Fluorouracil; Gastrectomy; Guideline Adherence; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Outcome and Process Assessment, Health Care; Oxaliplatin; Perioperative Care; Postoperative Complications; Practice Guidelines as Topic; Stomach Neoplasms; Survival Rate	2022
Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer. Surgery today, 2017, Volume: 47, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Pancreaticoduodenectomy; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2017
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model. Cell cycle (Georgetown, Tex.), 2017, Jun-03, Volume: 16, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Proliferation; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Imaging, Three-Dimensional; Leiomyosarcoma; Luminescent Proteins; Mice, Nude; Mice, Transgenic; Neoplasm Invasiveness; Red Fluorescent Protein; Stomach Neoplasms; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays	2017
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study. BMC cancer, 2017, 04-27, Volume: 17, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Oxonic Acid; Platelet Aggregation; Preoperative Care; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2017
Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells. Anti-cancer drugs, 2017, Volume: 28, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Delayed-Action Preparations; Docetaxel; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplastic Stem Cells; Polyethylene Glycols; Polyglactin 910; Pyrans; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2017
Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur	2017
Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry. British journal of cancer, 2017, Sep-05, Volume: 117, Issue:6 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chile; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Odds Ratio; Receptor, ErbB-2; Registries; Spain; Stomach Neoplasms; Taxoids; Treatment Outcome	2017
In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts. International journal of nanomedicine, 2017, Volume: 12 Topics: Animals; Antibodies, Monoclonal; Cell Cycle; Cell Death; Cell Line, Tumor; Cetuximab; Chromatography, High Pressure Liquid; Computer Simulation; Docetaxel; Endocytosis; ErbB Receptors; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Nanomedicine; Nanoparticles; Polyglutamic Acid; Stomach Neoplasms; Taxoids; Tissue Distribution; Xenograft Model Antitumor Assays	2017
Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:10 Topics: Apoptosis; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; Cell Survival; Chromosomal Proteins, Non-Histone; Docetaxel; GTP Phosphohydrolases; Humans; Mitochondria; Mitochondrial Proteins; Mitophagy; Neisseria gonorrhoeae; Phosphoric Monoester Hydrolases; Reactive Oxygen Species; RNA, Small Interfering; Stomach Neoplasms; Taxoids; Tensins	2017
[A Case of Advanced Gastric Cancer Responding to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil, Leading to a Pathological Complete Response]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Gastrectomy; Humans; Neoadjuvant Therapy; Stomach Neoplasms; Taxoids; Treatment Outcome	2017
Expression of both poly r(C) binding protein 1 (PCBP1) and miRNA-3978 is suppressed in peritoneal gastric cancer metastasis. Scientific reports, 2017, 11-14, Volume: 7, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cysteine Endopeptidases; DNA-Binding Proteins; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Male; MicroRNAs; Middle Aged; Peritoneal Neoplasms; Peritoneum; RNA-Binding Proteins; Stomach Neoplasms	2017
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer. Journal of experimental & clinical cancer research : CR, 2017, Nov-15, Volume: 36, Issue:1 Topics: Aged; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; China; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Humans; Male; Microinjections; Middle Aged; Neoplasm Invasiveness; Neoplasm Transplantation; Pyridines; Stomach Neoplasms; Taxoids; Translational Research, Biomedical; Treatment Outcome; Zebrafish	2017
[Laparoscopic Total Gastrectomy with Pancreatosplenectomy after Neoadjuvant Chemotherapy for Advanced Gastric Cancer with Adjacent Organs Invasion]. Gan to kagaku ryoho. Cancer & chemotherapy, 2017, Volume: 44, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Laparoscopy; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Pancreatectomy; Splenectomy; Stomach Neoplasms; Taxoids; Tegafur	2017
Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use. The Kaohsiung journal of medical sciences, 2018, Volume: 34, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Fluorouracil; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Nail Diseases; Nails; Neoplasm Recurrence, Local; Oxaloacetates; Stomach Neoplasms	2018
[Progress in study on the treatment of gastric cancer with docetaxel]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2018, Feb-28, Volume: 43, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2018
Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy? Cancer biomarkers : section A of Disease markers, 2018, Volume: 22, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Survivin; Taxoids	2018
[A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2018
The Chemotherapeutic Effect of Docetaxel, Cisplatin and Fluorouracil Regimen on Gastric Cancer Stem Cells. Journal of nanoscience and nanotechnology, 2017, Volume: 17, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cisplatin; Docetaxel; Electrochemical Techniques; Fluorouracil; Humans; Mice; Models, Biological; Neoplastic Stem Cells; Stomach Neoplasms; Taxoids; Tissue Scaffolds; Xenograft Model Antitumor Assays	2017
Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study. PloS one, 2018, Volume: 13, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Databases, Factual; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Stomach Neoplasms; Treatment Outcome	2018
Timed‑flat infusion of 5‑fluorouracil with docetaxel and oxaliplatin as first‑line treatment of gastroesophageal adenocarcinoma: A single institution experience with the FD/FOx regimen. Oncology reports, 2018, Volume: 40, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Taxoids	2018
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis. BMC cancer, 2018, Jun-28, Volume: 18, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Drug Combinations; Female; Fluorouracil; Humans; Male; Middle Aged; Oxaliplatin; Oxaloacetates; Oxonic Acid; Propensity Score; Retrospective Studies; Stomach Neoplasms; Tegafur	2018
[A Case of Advanced Gastric Cancer Treated with Curative Resection after Preoperative Secondary Chemotherapy with Irinotecan after Primary Chemotherapy with Docetaxel, Cisplatin, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:6 Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy; Humans; Irinotecan; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2018
[Pulmonary Metastasis of Gastric Cancer as Carcinomatous Lymphangiosis at Five and Half Years after Surgery;Report of a Case]. Kyobu geka. The Japanese journal of thoracic surgery, 2018, Volume: 71, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Docetaxel; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Oxaliplatin; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed	2018
Let-7a Could Serve as A Biomarker for Chemo-Responsiveness to Docetaxel in Gastric Cancer. Anti-cancer agents in medicinal chemistry, 2019, Volume: 19, Issue:3 Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; MicroRNAs; Molecular Structure; Stomach Neoplasms; Structure-Activity Relationship	2019
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study. Journal of geriatric oncology, 2019, Volume: 10, Issue:4 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma; Chemotherapy, Adjuvant; Cohort Studies; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Italy; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Peritoneal Neoplasms; Platinum Compounds; Progression-Free Survival; Proportional Hazards Models; Receptor, ErbB-2; Retrospective Studies; Stomach Neoplasms; Treatment Failure	2019
Two steps forward and one step back. Nature reviews. Clinical oncology, 2019, Volume: 16, Issue:2 Topics: Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Epirubicin; Humans; Perioperative Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Standard of Care; Stomach Neoplasms; Treatment Outcome	2019
PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells. International journal of nanomedicine, 2019, Volume: 14 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; B7-H1 Antigen; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Microtubules; Nanoparticles; Particle Size; Photoelectron Spectroscopy; Polyesters; Polyethylene Glycols; Stomach Neoplasms; Treatment Outcome	2019
Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy. International journal of biological macromolecules, 2019, Apr-01, Volume: 126 Topics: Animals; Antineoplastic Agents; Blood Vessels; Cell Death; Chitosan; Deoxycholic Acid; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Liberation; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Nanoparticles; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Stomach Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2019
Synergistic Beneficial Effect of Docosahexaenoic Acid (DHA) and Docetaxel on the Expression Level of Matrix Metalloproteinase-2 (MMP-2) and MicroRNA-106b in Gastric Cancer. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Docetaxel; Docosahexaenoic Acids; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 2; MicroRNAs; Stomach Neoplasms; Talin; Up-Regulation	2020
[Three Cases of Advanced Gastric Cancer with Peritoneal Dissemination Successfully Treated with S-1 and Docetaxel Combination Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Neoplasm Recurrence, Local; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur	2018
[A Case of Peritoneal Dissemination of Metastatic Gastric Cancer with Successful Docetaxel and S-1 Combination Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2018, Volume: 45, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur	2018
PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer. Journal of biomaterials applications, 2019, Volume: 33, Issue:10 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chromones; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Enzyme Inhibitors; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Morpholines; Nanoparticles; Polylactic Acid-Polyglycolic Acid Copolymer; Stomach Neoplasms	2019
Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus. Anticancer research, 2019, Volume: 39, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Clinical Decision-Making; Computational Biology; Databases, Genetic; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Oxonic Acid; Precision Medicine; Protein Interaction Maps; Stomach Neoplasms; Tegafur; Transcriptome; Treatment Outcome	2019
Pregabalin for Treatment of Docetaxel-Related Hand-Foot Syndrome. Journal of pain and symptom management, 2019, Volume: 58, Issue:1 Topics: Adenocarcinoma; Analgesics; Antineoplastic Agents; Docetaxel; Hand-Foot Syndrome; Humans; Male; Middle Aged; Pregabalin; Stomach Neoplasms; Treatment Outcome	2019
Perioperative FLOT: new standard for gastric cancer? Lancet (London, England), 2019, 05-11, Volume: 393, Issue:10184 Topics: Adenocarcinoma; Capecitabine; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Leucovorin; Oxaliplatin; Stomach Neoplasms	2019
More is not always better: triplet chemotherapy and advanced gastric cancer. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Stomach Neoplasms	2019
ASO Author Reflections: Induction Systemic Chemotherapy for Peritoneal Metastasis of Gastric Cancer. Annals of surgical oncology, 2019, Volume: 26, Issue:Suppl 3 Topics: Cisplatin; Docetaxel; Humans; Induction Chemotherapy; Peritoneal Neoplasms; Stomach Neoplasms	2019
[A Case of Advanced Gastric Cancer with Bone Marrow Metastasis Treated with Low-Dose Combination Chemotherapy Containing S-1 and Docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2019, Volume: 46, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Neoplasms; Docetaxel; Drug Combinations; Female; Humans; Oxonic Acid; Stomach Neoplasms; Tegafur	2019
Altered Expression of CD44, SIRT1, CXCR4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel Treatment. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:2 Topics: Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Gene Expression; Humans; Hyaluronan Receptors; Inhibitory Concentration 50; MicroRNAs; Receptors, CXCR4; Signal Transduction; Sirtuin 1; Stomach Neoplasms; Transcriptome	2020
Efficacy of trastuzumab combined with cisplatin and docetaxel on gastric cardia carcinoma and its influence on HER2 and cyclin D1 expressions. Minerva medica, 2021, Volume: 112, Issue:3 Topics: Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cardia; Cisplatin; Cyclin D1; Docetaxel; Humans; Neoplasm Proteins; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab	2021
The Role of Human Epidermal Growth Factor Receptor (HER2/neu) in the Prognosis of Patients with Gastric Cancer. Asian Pacific journal of cancer prevention : APJCP, 2019, 07-01, Volume: 20, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Case-Control Studies; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Receptor, ErbB-2; Stomach Neoplasms; Survival Rate	2019
DHA Abolishes the Detrimental Effect of Docetaxel on Downregulation of the MICA via Decreasing the Expression Level of MicroRNA-20a in Gastric Cancer. Journal of gastrointestinal cancer, 2020, Volume: 51, Issue:2 Topics: Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Docosahexaenoic Acids; Down-Regulation; Drug Interactions; Histocompatibility Antigens Class I; Humans; MicroRNAs; Stomach Neoplasms	2020
Effect of lentinan combined with docetaxel and cisplatin on the proliferation and apoptosis of BGC823 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2013, Volume: 34, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cisplatin; Docetaxel; Flow Cytometry; Humans; Lentinan; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured	2013
[A case of progressive gastric carcinoma accompanied by disseminated carcinomatosis of bone marrow (DCBM)due to bone metastasis, with DIC recovery by administration of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Disease Progression; Disseminated Intravascular Coagulation; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[Gastric metastasis from breast cancer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2013, Jan-25, Volume: 61, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Breast Neoplasms; Carrier Proteins; Docetaxel; Doxorubicin; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Glycoproteins; Humans; Mastectomy, Modified Radical; Membrane Transport Proteins; Multimodal Imaging; Positron-Emission Tomography; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2013
FGFR2 gene amplification in gastric cancer predicts sensitivity to the selective FGFR inhibitor AZD4547. Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, May-01, Volume: 19, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Camptothecin; Case-Control Studies; Cell Line, Tumor; Cisplatin; Docetaxel; Drug Synergism; Female; Fluorouracil; Gene Amplification; Gene Knockdown Techniques; Humans; Inhibitory Concentration 50; Irinotecan; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Piperazines; Pyrazoles; Receptor, Fibroblast Growth Factor, Type 2; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays; Young Adult	2013
Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma. American journal of clinical oncology, 2015, Volume: 38, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Feasibility Studies; Female; Fluorouracil; Gastrectomy; Heart Arrest; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Sepsis; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
New advances in the treatment of gastric cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 2004, Volume: 2 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Docetaxel; Doxorubicin; Drug Combinations; Etoposide; Fluorouracil; Humans; Leucovorin; Levoleucovorin; Methotrexate; Organoplatinum Compounds; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2004
Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment. Journal of drug targeting, 2013, Volume: 21, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrophobic and Hydrophilic Interactions; Materials Testing; Mice; Mice, Inbred BALB C; Mice, Nude; Organophosphorus Compounds; Polyethylene Glycols; Polymers; Solubility; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2013
Chemotherapy and resection for gastric cancer with synchronous liver metastases. World journal of gastroenterology, 2013, Apr-07, Volume: 19, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Fluorouracil; Glycosylation; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Pilot Projects; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2013
[Regional chemotherapy in locally advanced and metastatic gastric cancer]. Voprosy onkologii, 2012, Volume: 58, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Deoxycytidine; Docetaxel; Drug Administration Schedule; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Gemcitabine; Humans; Infusions, Intra-Arterial; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Radiotherapy, Adjuvant; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Acute arterial thrombosis following chemotherapy in a patient with a gastric carcinoma. Cardiovascular journal of Africa, 2013, Mar-23, Volume: 24, Issue:2 Topics: Acute Disease; Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Carcinoma; Cisplatin; Docetaxel; Fluorouracil; Humans; Male; Popliteal Artery; Risk Factors; Stomach Neoplasms; Taxoids; Thrombectomy; Thrombosis; Treatment Outcome; Ultrasonography, Doppler	2013
Design of precise third-line therapy for gastric cancer: target or chemotherpy? The Korean journal of internal medicine, 2013, Volume: 28, Issue:3 Topics: Adenocarcinoma; Antineoplastic Agents; Docetaxel; Female; Humans; Male; Neoplasm Recurrence, Local; Stomach Neoplasms; Taxoids	2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, Volume: 17, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2014
A patient with scirrhous stomach cancer treated with combination of hyperthermotherapy and 5-aminolevulinic acid (ALA). Anticancer research, 2013, Volume: 33, Issue:7 Topics: Adenocarcinoma, Scirrhous; Adult; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Cisplatin; Combined Modality Therapy; Dichloroacetic Acid; Docetaxel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hyperthermia, Induced; Irinotecan; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Photosensitizing Agents; Prognosis; Silicates; Stomach Neoplasms; Taxoids; Tegafur; Titanium	2013
Esophageal mucosal metastasis from adenocarcinoma of the distal stomach. World journal of gastroenterology, 2013, Jun-21, Volume: 19, Issue:23 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cisplatin; Disease Progression; Docetaxel; Endoscopy, Digestive System; Endosonography; Esophageal Neoplasms; Esophagus; Gastrectomy; Humans; Immunohistochemistry; Male; Middle Aged; Mucin 5AC; Mucous Membrane; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles. Biomaterials, 2013, Volume: 34, Issue:29 Topics: Animals; Antineoplastic Agents; Docetaxel; Drug Delivery Systems; Gastric Mucosa; Gelatinases; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanoparticles; Neoplastic Stem Cells; Stomach; Stomach Neoplasms; Taxoids; Tubulin	2013
[An 84-year-old man with highly advanced gastric cancer showing good response after chemotherapy with docetaxel, cisplatin and S-1 combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:4 Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer diagnosed as stage IV responding to combined modality therapy and surviving for a long duration]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Middle Aged; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Time Factors	2013
Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). International journal of molecular sciences, 2013, Aug-06, Volume: 14, Issue:8 Topics: Antineoplastic Agents; Carcinogenesis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Early Growth Response Protein 2; Female; Gene Expression; Humans; Male; MicroRNAs; Neoplasm Invasiveness; RNA, Messenger; Stomach Neoplasms; Taxoids	2013
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Genetic Predisposition to Disease; Genotype; Humans; Leucovorin; Male; MicroRNAs; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polymorphism, Single Nucleotide; Prognosis; Stomach Neoplasms; Survival; Taxoids; Vitamin B Complex; Young Adult	2013
Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. Journal of translational medicine, 2013, Sep-03, Volume: 11 Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; Microtubules; Middle Aged; Multivariate Analysis; Neoplasm Staging; Phenotype; Postoperative Care; Prognosis; RNA, Messenger; Stomach Neoplasms; Taxoids; Thiostrepton; Up-Regulation	2013
[Relationship between the expression level of miR-29c and biological behavior of gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2013, Volume: 35, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Microarray Analysis; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Staging; RNA, Messenger; Stomach Neoplasms; Taxoids; Transcriptome; Tumor Burden	2013
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere. Journal of translational medicine, 2013, Oct-02, Volume: 11 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asian People; Cell Line, Tumor; Cell Proliferation; China; Disease Models, Animal; Docetaxel; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Mutation; Nuclear Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidines; Pyrroles; Stomach Neoplasms; Taxoids; Transcription Factors; Treatment Outcome; Xenograft Model Antitumor Assays	2013
Retrospective analysis of docetaxel, oxaliplatin plus fluorouracil compared with epirubicin, cisplatin and fluorouracil as first-line therapy for advanced gastric cancer. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Taxoids	2014
[Assessment of the vulnerable elders survey as a predictive test for elderly patients with advanced or metastatic gastric cancer treated with combined S-1 and docetaxel therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Data Collection; Docetaxel; Drug Combinations; Female; Humans; Male; Neoplasm Metastasis; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
Efficacy and safety of docetaxel plus oxaliplatin and capecitabine in the first line treatment of advanced gastric adenocarcinoma. BioMed research international, 2013, Volume: 2013 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Capecitabine; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Sequential chemotherapies for advanced gastric cancer: a retrospective analysis of 111 patients. Oncology, 2013, Volume: 85, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Epirubicin; Etoposide; Female; Fluorouracil; Gemcitabine; Germany; Hospitals, University; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
[A case of locally advanced gastric cancer in which the patient underwent curative gastrectomy after treatment with systemic chemotherapy with bi-weekly s-1/docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer with regional lymph node metastasis showing pathological complete response after preoperative chemotherapy with docetaxel, cisplatin, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort. Journal of experimental & clinical cancer research : CR, 2013, Sep-17, Volume: 32 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cohort Studies; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Taxoids	2013
Second-line chemotherapy for patients with oesophagogastric adenocarcinoma. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Male; Stomach Neoplasms; Taxoids	2014
Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer. Cancer letters, 2014, Apr-28, Volume: 346, Issue:1 Topics: Animals; Antineoplastic Agents; Blotting, Western; Docetaxel; Gelatinases; Humans; Mice; Nanoconjugates; Neoplasms, Experimental; Polyesters; Polyethylene Glycols; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2014
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Annals of surgical oncology, 2014, Volume: 21, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Hyperthermia, Induced; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2014
[Strategy for the treatment of Stage IV gastric cancer with preoperative chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Salvage Therapy; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of paclitaxel-resistant recurrent gastric cancer responsive to S-1 plus docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Oxonic Acid; Paclitaxel; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2013
[A case of advanced gastric cancer exhibiting pathological complete response after neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2013
A case of gastric cancer with perforation caused by chemotherapy with docetaxel and S-1. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Intestinal Perforation; Male; Oxonic Acid; Radiography, Abdominal; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2013
[Chemotherapy and targeted therapy in liver metastasis from gastric cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery, 2014, Volume: 17, Issue:2 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Hepatectomy; Humans; Irinotecan; Liver Neoplasms; Molecular Targeted Therapy; Stomach Neoplasms; Taxoids; Trastuzumab	2014
FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin. Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:5 Topics: Apoptosis; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Forkhead Transcription Factors; Gastrectomy; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Kinesins; Microtubules; Multivariate Analysis; Phenotype; Prognosis; Promoter Regions, Genetic; Proportional Hazards Models; Stathmin; Stomach Neoplasms; Taxoids; Thiostrepton; Up-Regulation	2014
Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer. World journal of gastroenterology, 2014, Mar-28, Volume: 20, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Cisplatin; Disease-Free Survival; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2014
[A case of advanced gastric cancer treated with curative resection after preoperative combined chemotherapy with docetaxel, cisplatin, and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2014
Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer. British journal of cancer, 2014, May-27, Volume: 110, Issue:11 Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Cell Cycle Proteins; Docetaxel; Female; Fluorouracil; Gene Expression; Histone-Lysine N-Methyltransferase; Humans; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Nuclear Proteins; Organoplatinum Compounds; Proportional Hazards Models; Repressor Proteins; RNA, Messenger; Stomach Neoplasms; Taxoids; Trans-Activators; Tumor Suppressor p53-Binding Protein 1; Ubiquitin-Conjugating Enzymes; Young Adult	2014
Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma. World journal of surgical oncology, 2014, May-19, Volume: 12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Remission Induction; Stomach Neoplasms; Taxoids	2014
Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling. Journal of cellular and molecular medicine, 2014, Volume: 18, Issue:12 Topics: Animals; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Movement; Cell Survival; DNA Methylation; Docetaxel; Dose-Response Relationship, Drug; Epigenesis, Genetic; Eye Proteins; Female; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Stomach Neoplasms; Taxoids; Transcription Factors; Transforming Growth Factor beta; Xenograft Model Antitumor Assays	2014
Survival and recurrence patterns after neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophagogastric adenocarcinoma. Annals of surgical oncology, 2015, Volume: 22, Issue:1 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2015
Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation. PloS one, 2014, Volume: 9, Issue:7 Topics: Activating Transcription Factor 6; Antineoplastic Agents; Apoptosis; Benzamides; Camptothecin; Cell Line; Cell Line, Tumor; Docetaxel; eIF-2 Kinase; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Irinotecan; MCF-7 Cells; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Sirtuin 1; Stomach Neoplasms; Taxoids; Transcription Factor CHOP; Tumor Suppressor Protein p53; Up-Regulation	2014
Inhibition of histone deacetylase 4 increases cytotoxicity of docetaxel in gastric cancer cells. Proteomics. Clinical applications, 2014, Volume: 8, Issue:11-12 Topics: Acetylation; Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Biomarkers; Cell Line, Tumor; Cell Survival; Cisplatin; Docetaxel; Drug Synergism; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Immunohistochemistry; Male; Middle Aged; Pyrroles; Repressor Proteins; Stomach Neoplasms; Taxoids	2014
Evaluation of docetaxel- and oxaliplatin-based adjuvant chemotherapy in postgastrectomy gastric cancer patients reveals obvious survival benefits in docetaxel-treated mixed signet ring cell carcinoma patients. Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Docetaxel; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2014
[A case of gastric cancer with N2 lymph node metastasis and pancreatic invasion effectively treated with docetax-el/S-1 as a neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Oxonic Acid; Pancreas; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2014
Modified administration schedule of docetaxel, cisplatin, and fluorouracil for advanced or recurrent gastric cancer with gastrointestinal stenosis. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Gastric Outlet Obstruction; Gastrointestinal Diseases; Humans; Intestinal Obstruction; Male; Middle Aged; Recurrence; Stomach Neoplasms; Taxoids	2014
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer. Asian Pacific journal of cancer prevention : APJCP, 2014, Volume: 15, Issue:20 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Cohort Studies; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Retrospective Studies; Risk Assessment; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome; Turkey; Young Adult	2014
Retrospective evaluation of the efficacy of first-line treatment of advanced gastric cancer with docetaxel and oxaliplatin. Cancer investigation, 2015, Volume: 33, Issue:1 Topics: Adult; Aged; China; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2015
Porous microspheres of amorphous calcium phosphate: block copolymer templated microwave-assisted hydrothermal synthesis and application in drug delivery. Journal of colloid and interface science, 2015, Apr-01, Volume: 443 Topics: Adenosine Triphosphate; Antineoplastic Agents; Calcium Phosphates; Cell Survival; Docetaxel; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Microscopy, Electron, Scanning; Microspheres; Microwaves; Polymers; Porosity; Stomach Neoplasms; Surface Properties; Taxoids; X-Ray Diffraction	2015
Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma. Anticancer research, 2015, Volume: 35, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Esophagogastric Junction; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
Ramucirumab combination improves OS and PFS in NSCLC. The American journal of managed care, 2014, Volume: 20, Issue:5 Spec No. Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Drug Therapy, Combination; Humans; Lung Neoplasms; Paclitaxel; Ramucirumab; Stomach Neoplasms; Survival Analysis; Taxoids	2014
Chemotherapy-Induced miRNA-29c/Catenin-δ Signaling Suppresses Metastasis in Gastric Cancer. Cancer research, 2015, Apr-01, Volume: 75, Issue:7 Topics: Animals; Antineoplastic Agents; Catenins; Cell Line, Tumor; Cell Movement; Cisplatin; Delta Catenin; Docetaxel; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Mice, Nude; MicroRNAs; Neoplasm Invasiveness; Neoplasm Transplantation; rho GTP-Binding Proteins; RNA Interference; Stomach Neoplasms; Taxoids	2015
[Treatment of type four gastric cancer in our institution]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2014
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; Male; Oxonic Acid; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2014
Efficacy and tolerability of weekly docetaxel, cisplatin, and 5-fluorouracil for locally advanced or metastatic gastric cancer patients with ECOG performance scores of 1 and 2. Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2015
Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo. PloS one, 2015, Volume: 10, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Proliferation; Docetaxel; Drug Synergism; Growth Inhibitors; Humans; Mice; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Receptors, Opioid; Stomach Neoplasms; Taxoids	2015
Preoperative systemic and intraperitoneal chemotherapy consisting of S-1, cisplatin and docetaxel in patients with marginally resectable gastric cancer. Anticancer research, 2015, Volume: 35, Issue:4 Topics: Adult; Aged; Cisplatin; Docetaxel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur	2015
Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil. Chemotherapy, 2014, Volume: 60, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Gastrectomy; Humans; Induction Chemotherapy; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Taxoids	2014
Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:11 Topics: Adult; Aged; Amine Oxidase (Copper-Containing); Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Docetaxel; Drug Combinations; Duodenum; Female; Gastrointestinal Diseases; Humans; Intestinal Mucosa; Male; Malnutrition; Middle Aged; Oxonic Acid; Prospective Studies; Sensitivity and Specificity; Stomach Neoplasms; Taxoids; Tegafur	2015
Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer. International journal of clinical oncology, 2016, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Febrile Neutropenia; Female; Gastrectomy; Humans; Male; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2016
Efficacy of conversion gastrectomy following docetaxel, cisplatin, and S-1 therapy in potentially resectable stage IV gastric cancer. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Cohort Studies; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Liver Neoplasms; Lymph Nodes; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2015
Bladder and gastric metastases from lung adenocarcinoma harboring codon 13 KRAS mutation: a case report with unusual clinical outcome. Tumori, 2015, Sep-09, Volume: 101, Issue:5 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Codon; Cystoscopy; Disease Progression; Docetaxel; Fatal Outcome; Female; Gastroscopy; Humans; Lung Neoplasms; Mutation; Neoplasms, Second Primary; Pemetrexed; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; Salvage Therapy; Stomach Neoplasms; Taxoids; Urinary Bladder Neoplasms	2015
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PloS one, 2015, Volume: 10, Issue:6 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Mice; Neoplastic Stem Cells; Receptors, CXCR4; Stomach Neoplasms; Taxoids; Transforming Growth Factor beta	2015
Systemic Chemotherapy using FLOT - Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of Peritoneal Metastasized Gastric Cancer. . Hepato-gastroenterology, 2014, Volume: 61, Issue:131 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Hypothermia, Induced; Infusions, Parenteral; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2014
Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:1 Topics: Antineoplastic Agents; beta Karyopherins; Biomarkers; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Immunohistochemistry; Male; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Proportional Hazards Models; Protein Binding; Signal Transduction; STAT1 Transcription Factor; Stomach Neoplasms; Taxoids; Up-Regulation	2016
Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Hypoalbuminemia; Logistic Models; Male; Middle Aged; Multivariate Analysis; Oxonic Acid; Peritoneal Lavage; Peritoneal Neoplasms; Preoperative Period; Prognosis; Proportional Hazards Models; Retrospective Studies; Serum Albumin; Stomach Neoplasms; Taxoids; Tegafur	2015
Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2015, Volume: 41, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Databases, Factual; Docetaxel; Epirubicin; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Kaplan-Meier Estimate; Leucovorin; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Postoperative Period; Prospective Studies; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
Perioperative chemotherapy in locally advanced gastric cancer. A retrospective study about 25 cases. La Tunisie medicale, 2015, Volume: 93, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tunisia	2015
[A Case of Resected Gastric Cancer Invading the Esophagus with Esophageal Recurrence That Responded to Weekly Docetaxel／Cisplatin Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophageal Neoplasms; Esophagectomy; Esophagus; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Recurrence; Stomach Neoplasms; Taxoids; Treatment Outcome	2015
The α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016, Volume: 37, Issue:4 Topics: alpha7 Nicotinic Acetylcholine Receptor; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Humans; Nicotinic Agonists; Nicotinic Antagonists; Paclitaxel; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Taxoids	2016
Modified gastric cancer chemotherapy: more effective, less toxic. The Lancet. Oncology, 2015, Volume: 16, Issue:16 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Dosage Calculations; Fluorouracil; Humans; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2015
[Characteristics of recurrence in patients with gastric cancer after radical gastrectomy and adjuvant chemotherapy]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Fluorouracil; Gastrectomy; Humans; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Organoplatinum Compounds; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Time Factors	2015
Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation. Antioxidants & redox signaling, 2016, 05-20, Volume: 24, Issue:15 Topics: Adult; Aged; Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Epigenesis, Genetic; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Male; Metallothionein; Mice, Nude; Middle Aged; NF-kappa B; Stomach Neoplasms; Sulfides; Taxoids; Transcriptional Activation; Up-Regulation; Xenograft Model Antitumor Assays; Young Adult	2016
Enhancement of Chemosensitivity by Stathmin-1 Silencing in Gastric Cancer Cells In Situ and In Vivo. Oncology research, 2016, 01-21, Volume: 23, Issue:1-2 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Gene Silencing; Humans; Mice, Nude; RNA Interference; Stathmin; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2016
[A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neoplasms; Docetaxel; Drug Combinations; Fatal Outcome; Female; Humans; Oxonic Acid; Recurrence; Stomach Neoplasms; Taxoids; Tegafur	2015
[A Case of Resected Advanced Gastric Cancer Exhibiting Pathological Complete Response after Neoadjuvant Che-motherapy(DTX/CDDP/S-1:DCS)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Oxonic Acid; Prognosis; Stomach Neoplasms; Taxoids; Tegafur	2015
[A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Metals; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stents; Stomach Neoplasms; Taxoids; Tegafur	2015
[A Case of Advanced Gastric Cancer with Peritoneal Dissemination Effectively Treated with S-1 and Docetaxel Combination Chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:12 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2015
Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer. Cellular oncology (Dordrecht), 2016, Volume: 39, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplasm Proteins; Promoter Regions, Genetic; Stomach Neoplasms; Stress, Physiological; Survival Analysis; Taxoids; Tumor Stem Cell Assay	2016
Integration of in silico modeling, prediction by binding energy and experimental approach to study the amorphous chitin nanocarriers for cancer drug delivery. Carbohydrate polymers, 2016, May-20, Volume: 142 Topics: Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chitin; Curcumin; Docetaxel; Drug Carriers; Fluorouracil; Humans; Molecular Docking Simulation; Nanoparticles; Stomach; Stomach Neoplasms; Taxoids; Thermodynamics	2016
Jackhammer oesophagus in a case of linitis plastica. BMJ case reports, 2016, May-12, Volume: 2016 Topics: Cisplatin; Colonoscopy; Diagnosis, Differential; Docetaxel; Esophagus; Fatal Outcome; Female; Fluorouracil; Humans; Linitis Plastica; Middle Aged; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2016
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2016, Volume: 42, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; China; Cyclobutanes; Cytoreduction Surgical Procedures; Databases, Factual; Docetaxel; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Sample Size; Stomach Neoplasms; Taxoids; Treatment Outcome	2016
[A Case of Recurred Gastric Cancer of the Anastomosis Completely Responding to Docetaxel, Cisplatin, and S-1 Triplet Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:4 Topics: Anastomosis, Surgical; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Recurrence; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2016
[A Case of Gastric Cancer with Diffuse Intra-Tumoral Calcifications Showing Pathological Complete Response to Chemotherapy with S-1 plus Docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Calcinosis; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Neoplasm Staging; Oxonic Acid; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2016
Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2017, Volume: 43, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; France; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2017
[Pathological Complete Response of Advanced Gastric Cancer after Docetaxel and S-1 Combination Neoadjuvant Chemotherapy-A Case Report]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Docetaxel; Drug Combinations; Humans; Male; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2016
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer. British journal of cancer, 2016, 09-06, Volume: 115, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gastrectomy; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2016
[A Case of Synchronous Esophageal and Gastric Cancer Successfully Treated Using Multimodal Therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:10 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gastrectomy; Humans; Male; Neoplasms, Multiple Primary; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2016
[Second-line treatment for metastatic or locally advanced gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2016, Oct-23, Volume: 38, Issue:10 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Humans; Irinotecan; Molecular Targeted Therapy; Paclitaxel; Ramucirumab; Salvage Therapy; Stomach Neoplasms; Taxoids	2016
Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies. The pharmacogenomics journal, 2017, Volume: 17, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Pharmacogenomic Testing; Pharmacogenomic Variants; Prospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2017
Exclusive neoadjuvant chemotherapy in locally advanced resectable gastric and gastro-esophageal junction adenocarcinoma. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2017, Volume: 49, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Postoperative Period; Preoperative Period; Retrospective Studies; Stomach Neoplasms; Surgical Procedures, Operative; Survival Analysis; Switzerland; Taxoids; Young Adult	2017
The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma. Bosnian journal of basic medical sciences, 2017, May-20, Volume: 17, Issue:2 Topics: Adenocarcinoma; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome; Young Adult	2017
Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China. BMC gastroenterology, 2017, Mar-14, Volume: 17, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Cisplatin; Disease-Free Survival; Docetaxel; Drug Combinations; Esophagogastric Junction; Female; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Proportional Hazards Models; Pyridines; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur; Treatment Outcome; Tumor Burden	2017
Is there an optimal chemotherapy regimen for the treatment of advanced gastric cancer that will provide a platform for the introduction of new biological agents? The oncologist, 2008, Volume: 13, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Drug Combinations; Fluorouracil; Humans; Immunologic Factors; Irinotecan; Meta-Analysis as Topic; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Randomized Controlled Trials as Topic; Stomach Neoplasms; Taxoids; Tegafur	2008
Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer. Anti-cancer drugs, 2008, Volume: 19, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2008
[Docetaxel-Cisplatin-5-Fu Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2007, Volume: 50, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
The combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer. Surgical oncology, 2010, Volume: 19, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; China; Cisplatin; Docetaxel; Duodenoscopy; Female; Fluorouracil; Gastrectomy; Gastroscopy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Retrospective Studies; Stomach Neoplasms; Taxoids	2010
Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line. Oncology reports, 2008, Volume: 20, Issue:6 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Orotate Phosphoribosyltransferase; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Stomach Neoplasms; Taxoids; Tetrazolium Salts; Thiazoles	2008
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis responding remarkably to combination chemotherapy of docetaxel, CDDP and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Gastroscopy; Humans; Lung Neoplasms; Lymphangitis; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed; Treatment Failure	2008
[Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Survivin; Taxoids; X-Linked Inhibitor of Apoptosis Protein	2008
Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Gastrectomy; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. Anticancer research, 2009, Volume: 29, Issue:3 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Docetaxel; Drug Synergism; Electrophoretic Mobility Shift Assay; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Survival Rate; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2009
Docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer. Anticancer research, 2009, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Recurrence; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur	2009
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:4 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Vomiting; Young Adult	2009
[A case of nonresected gastric cancer with peritoneal dissemination effectively treated by S-1/DOC and PTX/ CDDP combination chemotherapy with good QOL]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:7 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneum; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2009
The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Fever; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Middle Aged; Neutropenia; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2010
Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy. Anticancer research, 2009, Volume: 29, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Feasibility Studies; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2009
Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery. Journal of surgical oncology, 2009, Sep-15, Volume: 100, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Selection; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids	2009
[A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
[A case of gastric cancer with peritoneal dissemination-efficacy of combination therapy with S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2009
[A case of advanced cancer of the gastric remnant with complete response to S-1 plus docetaxel chemotherapy as confirmed histopathologically]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:9 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastric Stump; Humans; Male; Middle Aged; Oxonic Acid; Pancreatectomy; Splenectomy; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome	2009
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:3 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Failure	2010
[Efficacy and safety of S-1 plus docetaxel combination therapy for patients with advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
[A case of advanced gastric cancer effectively treated on an outpatient basis by biweekly S-1 and docetaxel combination chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:10 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Drug Combinations; Gastroscopy; Humans; Male; Neoplasm Staging; Outpatients; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed; Treatment Outcome	2009
Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells. International journal of cancer, 2010, Jun-01, Volume: 126, Issue:11 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Docetaxel; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Signal Transduction; Sirolimus; Stomach Neoplasms; Taxoids	2010
Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Remission Induction; Stomach Neoplasms; Survival Rate; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2010
[Comparison of therapeutic effects of chemotherapy combined with radiotherapy versus chemotherapy alone in initial treatment of advanced gastric adenocarcinoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2009, Volume: 31, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Disease Progression; Docetaxel; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Radiotherapy, Conformal; Remission Induction; Stomach Neoplasms; Taxoids	2009
Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study. Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Preoperative Care; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2010
[A case report of complete response by S-1/docetaxel combination chemotherapy for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:13 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. Journal of cellular and molecular medicine, 2011, Volume: 15, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Synergism; Humans; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Pyridines; Rhodamines; Sorafenib; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2011
[Intra-peritoneal chemotherapy for scirrhous gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Adenocarcinoma, Scirrhous; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Infusions, Parenteral; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
[A case of unresectable cardiac gastric cancer patient who maintained a long-term QOL with chemotherapy and detention of metallic stent]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Humans; Male; Oxonic Acid; Quality of Life; Stents; Stomach Neoplasms; Taxoids; Tegafur	2009
[Three scirrhous gastric cancer cases with CY negativity in second-look staging laparoscopy after chemotherapy to whom curative surgery was carried out]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Humans; Laparoscopy; Male; Middle Aged; Oxonic Acid; Second-Look Surgery; Stomach Neoplasms; Taxoids; Tegafur	2009
[A case of recurrence gastric cancer patient who was post operated and multi drug chemotherapy was effective for administration of S-1 and docetaxel combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2009, Volume: 36, Issue:12 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2009
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:1 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Ascites; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Tegafur	2010
Weekly docetaxel, cisplatin, and 5-fluorouracil as initial therapy for patients with advanced gastric and esophageal cancer. Cancer, 2010, Mar-15, Volume: 116, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids	2010
PSK enhances the efficacy of docetaxel in human gastric cancer cells through inhibition of nuclear factor-kappaB activation and survivin expression. International journal of oncology, 2010, Volume: 36, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Mice; Mice, SCID; Microtubule-Associated Proteins; Neoplasm Transplantation; NF-kappa B; Proteoglycans; Repressor Proteins; Stomach Neoplasms; Survivin; Taxoids	2010
[Adjuvant surgery for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2010
[Histological complete response in a case of primary squamous cell carcinoma of the stomach treated by chemotherapy with docetaxel and cisplatin plus 5-fluorouracil]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Endoscopy, Gastrointestinal; Fluorouracil; Humans; Male; Stomach Neoplasms; Taxoids	2010
The unusual presentation of gastric adenocarcinoma as a testicular mass: a favorable response to docetaxel and Cisplatin plus oral tegafur/uracil and leucovorin. Journal of the Chinese Medical Association : JCMA, 2010, Volume: 73, Issue:2 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Leucovorin; Male; Stomach Neoplasms; Taxoids; Tegafur; Testicular Neoplasms; Uracil	2010
Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diarrhea; Docetaxel; Greece; Humans; Kaplan-Meier Estimate; Neutropenia; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
Cutaneous metastasis as first clinical manifestation of signet ring cell gastric carcinoma. Dermatology online journal, 2010, Mar-15, Volume: 16, Issue:3 Topics: Aged; Antineoplastic Agents; Capecitabine; Carcinoma, Signet Ring Cell; Deoxycytidine; Docetaxel; Fluorouracil; Humans; Male; Skin Neoplasms; Stomach Neoplasms; Taxoids	2010
Severe interstitial pneumonitis associated with the administration of taxanes. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2010, Volume: 16, Issue:5 Topics: Adrenal Cortex Hormones; Aged; Breast Neoplasms; Docetaxel; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2010
Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysis. World journal of surgical oncology, 2010, May-19, Volume: 8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Oxonic Acid; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2010
Images in clinical medicine. Multiple Beau's lines. The New England journal of medicine, 2010, May-20, Volume: 362, Issue:20 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Male; Nail Diseases; Nails; Stomach Neoplasms; Taxoids	2010
Neoadjuvant treatment of adenocarcinomas of the gastroesophageal junction and stomach - a feasibility trial combining cisplatin and docetaxel with either 5-fluorouracil or capecitabine. International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Cisplatin; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Male; Middle Aged; Neoadjuvant Therapy; Stomach Neoplasms; Taxoids	2010
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with multiple liver metastases and esophageal invasion]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Esophageal Neoplasms; Esophagoscopy; Gastroscopy; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2010
[A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck; Neoplasm Staging; Oxonic Acid; Positron-Emission Tomography; Recurrence; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2010
CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer. Anticancer research, 2010, Volume: 30, Issue:6 Topics: Benzylamines; Biomarkers; Cell Line, Tumor; Cyclams; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Profiling; Heterocyclic Compounds; Humans; Receptors, CXCR4; Stomach Neoplasms; Taxoids	2010
[A very elderly case of recurrent gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of docetaxel (DOC) and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Liver Neoplasms; Male; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2010
[Bi-weekly docetaxel and doxifluridine combination therapy in pretreated patients with unresectable and/or advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Stomach Neoplasms; Survival Rate; Taxoids	2010
Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2010, Volume: 11, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Camptothecin; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Genotype; Humans; Irinotecan; Male; Middle Aged; Paclitaxel; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Stomach Neoplasms; Survival Rate; Taxoids	2010
New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer. Acta oncologica (Stockholm, Sweden), 2011, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Clinical Trials, Phase II as Topic; Denmark; Deoxycytidine; Diarrhea; Docetaxel; Drug Administration Schedule; Esophageal Neoplasms; Fever; Fluorouracil; Humans; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Practice Guidelines as Topic; Stomach Neoplasms; Survival Analysis; Taxoids; Treatment Outcome	2011
[A successful resected case of far-advanced cancer at the esophagogastric junction by chemoradiotherapy with docetaxel, nedaplatin and 5-fluorouracil]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatal Outcome; Fluorouracil; Humans; Male; Neoplasm Staging; Organoplatinum Compounds; Stomach Neoplasms; Taxoids	2010
Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer. BMC cancer, 2010, Oct-26, Volume: 10 Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
[Analysis of four patients with advanced gastric cancer undergoing gastrectomy after pre-operative combination chemotherapy using docetaxel, cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Male; Middle Aged; Neutropenia; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2/neu positive gastric tumor xenografts. International journal of oncology, 2011, Volume: 38, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Cycle; Cell Survival; Disease Models, Animal; Docetaxel; Female; Humans; Immunoconjugates; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron, Transmission; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab; Xenograft Model Antitumor Assays	2011
[A case of type 4 advanced gastric cancer with aplastic anemia successfully treated with neoadjuvant chemotherapy and surgical resection]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Anemia, Aplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Infusions, Parenteral; Lymph Node Excision; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
[Three cases of gastric cancer treated by S-1 combined with docetaxel in place of cisplatin]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
[Highly advanced gastric cancer that responded to neoadjuvant combination chemotherapy with docetaxel/CDDP/S-1 (DCS)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Splenectomy; Stomach Neoplasms; Taxoids; Tegafur	2010
[A long-term survival case of bilateral ovarian metastasis of progressive gastric cancer treated by chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Adenocarcinoma, Scirrhous; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Irinotecan; Krukenberg Tumor; Ovarian Neoplasms; Ovariectomy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
[Report of two cases successfully treated by chemo-radiation against lymph node metastasis after gastric cancer surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
[A case of synchronous double cancer of stomach and lung responding to neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:12 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Combinations; Humans; Irinotecan; Lung Neoplasms; Male; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2010
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cohort Studies; Disease Progression; Docetaxel; Esophageal Neoplasms; Female; Humans; Irinotecan; Male; Middle Aged; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2011
Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model. Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Docetaxel; Endothelial Cells; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Polymerase Chain Reaction; Stomach Neoplasms; Taxoids; Umbilical Veins; Xenograft Model Antitumor Assays	2011
Mestastatic gastric cancer from malignant fibrous histiocytoma. Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dioxoles; Docetaxel; Epirubicin; Fatal Outcome; Gemcitabine; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Lung Neoplasms; Male; Soft Tissue Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Taxoids; Tetrahydroisoquinolines; Thigh; Thoracic Vertebrae; Trabectedin	2011
[Improvement of drug therapy for advanced gastric cancer used at a municipal clinical dispensary]. Voprosy onkologii, 2010, Volume: 56, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cancer Care Facilities; Carboplatin; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Russia; Stomach Neoplasms; Taxoids; Treatment Outcome	2010
[Palliative anti-cancer chemotherapy is safely executable in a hemodialytic patient with unresectable advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Humans; Irinotecan; Kidney Failure, Chronic; Male; Neoplasm Staging; Palliative Care; Renal Dialysis; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2011
[A case report of bi-weekly docetaxel and S-1 combination chemotherapy for gastric cancer with carcinomatous lymphangitis of the lung]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2011, Volume: 108, Issue:4 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lung Neoplasms; Lymphangitis; Male; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2011
Second-line docetaxel plus cisplatin for advanced gastric cancer showing resistance to S-1. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Female; Humans; Leukopenia; Male; Middle Aged; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Watchful Waiting	2011
Paclitaxel-resistant recurrent gastric cancer responsive to docetaxel: a case report. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:4 Topics: Antineoplastic Agents; Carcinoembryonic Antigen; Clinical Trials, Phase III as Topic; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Recurrence; Salvage Therapy; Stomach Neoplasms; Taxoids	2011
Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma. BMC cancer, 2011, Apr-24, Volume: 11 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; China; Disease Progression; Disease-Free Survival; Docetaxel; Female; Follow-Up Studies; Humans; Male; Matrix Metalloproteinase 11; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Stomach Neoplasms; Taxoids; Treatment Outcome	2011
Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Annals of surgical oncology, 2011, Volume: 18, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gastrectomy; Humans; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Postoperative Complications; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2011
Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer. Chemotherapy, 2011, Volume: 57, Issue:3 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids	2011
Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel. International journal of cancer, 2012, Apr-01, Volume: 130, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Remission Induction; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma. Molecules and cells, 2011, Volume: 32, Issue:2 Topics: Carcinoma; Cell Line, Transformed; Cyclin-Dependent Kinase Inhibitor p21; Docetaxel; Drug Resistance, Neoplasm; Epstein-Barr Virus Infections; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Inhibitor of Apoptosis Proteins; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Survivin; Taxoids	2011
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna. Anticancer research, 2011, Volume: 31, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Esophagogastric Junction; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Taxoids	2011
Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012, Volume: 15, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Esophageal Neoplasms; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2012
mRNA expression of BRCA1, PIAS1, and PIAS4 and survival after second-line docetaxel in advanced gastric cancer. Journal of the National Cancer Institute, 2011, Oct-19, Volume: 103, Issue:20 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Signet Ring Cell; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Odds Ratio; Poly-ADP-Ribose Binding Proteins; Protein Inhibitors of Activated STAT; Retrospective Studies; RNA, Messenger; Small Ubiquitin-Related Modifier Proteins; Stomach Neoplasms; Taxoids	2011
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. Journal of surgical oncology, 2012, Volume: 105, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur; Treatment Outcome	2012
[A case of locally advanced non-small-cell lung cancer complicated with chronic renal failure and gastric cancer, successfully treated with weekly docetaxel and concurrent thoracic radiotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:9 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Humans; Kidney Failure, Chronic; Lung Neoplasms; Male; Neoplasm Staging; Neoplasms, Second Primary; Stomach Neoplasms; Taxoids	2011
[A case of advanced gastric cancer showing pathological CR after neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 combination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:10 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2011
Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes. Journal of surgical oncology, 2012, Volume: 105, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Combinations; Female; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Oxonic Acid; Postoperative Complications; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids; Tegafur	2012
In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2012, Volume: 15, Issue:3 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cell Line, Tumor; Cell Proliferation; Cetuximab; Docetaxel; ErbB Receptors; Genes, ras; Humans; Irinotecan; Male; Mice; Mice, Nude; Mutation; Proto-Oncogene Proteins B-raf; Stomach Neoplasms; Taxoids; Xenograft Model Antitumor Assays	2012
Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile. International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2 Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Docetaxel; Drug Carriers; Drug Compounding; Drug Stability; Female; Humans; Injections, Intravenous; Lethal Dose 50; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Micelles; Peptides; Photolysis; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Taxoids; Technology, Pharmaceutical; Tumor Burden; Xenograft Model Antitumor Assays	2012
Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Docetaxel; Female; G2 Phase Cell Cycle Checkpoints; Humans; Hyperthermia, Induced; Injections, Intralesional; Liposomes; Magnetics; Magnetite Nanoparticles; Mice; Mice, Inbred BALB C; Mice, Nude; Stomach Neoplasms; Taxoids; Time Factors; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays	2012
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; ErbB Receptors; Female; Fluorouracil; Gene Expression; Humans; Kaplan-Meier Estimate; Leucovorin; Male; Matrix Metalloproteinase 9; Middle Aged; Multivariate Analysis; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A	2012
Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma. International journal of radiation oncology, biology, physics, 2012, Jun-01, Volume: 83, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherapy; Dehydration; Deoxycytidine; Docetaxel; Female; Fluorouracil; Gastrectomy; Heart; Humans; Induction Chemotherapy; Kidney; Male; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Preoperative Care; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome	2012
Adjuvant chemoradiotherapy with or without intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2012, Volume: 102, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Docetaxel; Female; Fluorouracil; Gastrectomy; Humans; Intraoperative Care; Leucovorin; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Care; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2012
Posttherapy nodal status, not graded histologic response, predicts survival after neoadjuvant chemotherapy for advanced gastric cancer. Annals of surgical oncology, 2012, Volume: 19, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Follow-Up Studies; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Time Factors	2012
[Comparison of the toxicities and efficacies of the combination chemotherapy regimens in advanced gastric cancer patients who achieved complete response after chemotherapy]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2011, Volume: 58, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docetaxel; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Male; Middle Aged; Mucositis; Nausea; Neoplasm Staging; Organoplatinum Compounds; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tomography, X-Ray Computed; Vomiting	2011
Genome-wide identification of chemosensitive single nucleotide polymorphism markers in gastric cancer. Anticancer research, 2011, Volume: 31, Issue:12 Topics: Adult; Aged; Alleles; Cell Survival; Docetaxel; Drug Screening Assays, Antitumor; Female; Genome-Wide Association Study; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Polymorphism, Single Nucleotide; Receptors, Serotonin; Stomach Neoplasms; Taxoids; Transfection	2011
[Combination chemotherapy using docetaxel, cisplatin, and S-1 for far advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2011
[A case report-highly advanced gastric cancer leading to perforation during neoadjuvant chemotherapy with docetaxel, cisplatin and S-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cisplatin; Docetaxel; Drug Combinations; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Stomach Rupture; Taxoids; Tegafur; Tomography, X-Ray Computed	2011
[Peritoneal lavage cytology under local anesthesia for detection of peritoneal recurrence after surgery]. Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12 Topics: Aged; Anesthesia, Local; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Peritoneal Lavage; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2011
Unusual course of an abdominal aortic aneurysm in a patient treated with chemotherapy for gastric cancer. Journal of vascular surgery, 2012, Volume: 55, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aortic Aneurysm, Abdominal; Aortography; Blood Vessel Prosthesis Implantation; Cisplatin; Docetaxel; Endovascular Procedures; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Taxoids; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2012
[A case of advanced gastric cancer with peritoneal dissemination successfully treated with S-1 and intraperitoneal docetaxel administration]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Docetaxel; Drug Combinations; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
Magnetic nanoparticles for treatment of gastric cancer. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Humans; Hyperthermia, Induced; Magnetics; Magnetite Nanoparticles; Stomach Neoplasms; Taxoids	2012
Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunoenzyme Techniques; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2012
[Support of hematological homeostasis during chemotherapy with taxanes]. Voprosy onkologii, 2011, Volume: 57, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Docetaxel; Female; Fever; Follow-Up Studies; Homeostasis; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Protective Agents; Severity of Illness Index; Stomach Neoplasms; Taxoids; Tongue Neoplasms	2011
[A case of gastric cancer treated with modified docetaxel, cisplatin and 5-fluorouracil(mDCF)with ingestion inability]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Feeding and Eating Disorders; Fluorouracil; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2012
Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Docetaxel; Drug Synergism; Fluorouracil; Gene Expression; Humans; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids; Xanthones	2012
The impact of cross-resistance between paclitaxel and docetaxel for metastatic gastric cancer. Onkologie, 2012, Volume: 35, Issue:4 Topics: Aged; Antineoplastic Agents; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Japan; Male; Paclitaxel; Prevalence; Risk Assessment; Risk Factors; Stomach Neoplasms; Survival Analysis; Survival Rate; Taxoids; Treatment Outcome	2012
[A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Multiple Primary; Stomach Neoplasms; Taxoids	2012
[A case of advanced gastric cancer successfully treated with docetaxel and S-1 combined therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Neoplasm Metastasis; Oxonic Acid; Positron-Emission Tomography; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2012
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines. BMC complementary and alternative medicine, 2012, Apr-30, Volume: 12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Docetaxel; Drug Synergism; Herb-Drug Interactions; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Phytotherapy; Plant Extracts; RNA, Messenger; Stomach Neoplasms; Survivin; tau Proteins; Taxoids; Tubulin; Xanthones	2012
Gastrointestinal cancer: Salvage chemotherapy in gastric cancer--more than a straw? Nature reviews. Clinical oncology, 2012, May-01, Volume: 9, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Docetaxel; Drug Resistance, Neoplasm; Humans; Irinotecan; Prognosis; Salvage Therapy; Stomach Neoplasms; Taxoids	2012
[A case report of advanced gastric cancer with peritoneal dissemination effectively treated by combination chemotherapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
[A case of gastric cancer with peritoneal dissemination who achieved long survival from control of ascites for over 2 years by successive treatments with S-1 in combination with docetaxel as first-line followed by irinotecan in combination with cisplatin Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Camptothecin; Cisplatin; Docetaxel; Drug Combinations; Fatal Outcome; Humans; Irinotecan; Male; Oxonic Acid; Peritoneal Neoplasms; Salvage Therapy; Stomach Neoplasms; Taxoids; Tegafur	2012
Overexpression of cyclin L2 inhibits growth and enhances chemosensitivity in human gastric cancer cells. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclins; Docetaxel; Down-Regulation; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Proto-Oncogene Proteins c-bcl-2; Resting Phase, Cell Cycle; Stomach Neoplasms; Survivin; Taxoids; Transcription Factors; Transfection; Up-Regulation	2012
Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report. BMC gastroenterology, 2012, Jul-31, Volume: 12 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinations; Fatal Outcome; Female; Humans; Immunohistochemistry; Leiomyosarcoma; Liver Neoplasms; Neoplasm Recurrence, Local; Oxonic Acid; Sigmoid Neoplasms; Stomach Neoplasms; Taxoids; Tegafur	2012
Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy. Oncology, 2012, Volume: 83, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Clinical Trials, Phase II as Topic; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Humans; Inflammation; Male; Middle Aged; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Tegafur	2012
The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Follow-Up Studies; Humans; Keratin-18; Leucovorin; Male; Middle Aged; Neoplasm Staging; Peptide Fragments; Prognosis; Stomach Neoplasms; Survival Rate; Taxoids	2012
Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Phosphatidylinositol 3-Kinases; Polymorphism, Single Nucleotide; Prognosis; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Stomach Neoplasms; Survival Rate; Taxoids; TOR Serine-Threonine Kinases; Vinblastine; Vinorelbine	2012
[A case of advanced gastric cancer with recurrence-free long survival showing disappearance of distant lymph node metastases by S-1/docetaxel therapy followed by curative resection]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphatic Metastasis; Male; Oxonic Acid; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur; Time Factors; Tomography, X-Ray Computed	2012
[A case of gastric cancer with peritoneal dissemination and massive ascites successfully treated with S-1/docetaxel therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Biopsy; Docetaxel; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2012
A case of synchronous esophagus and stomach cancer successfully treated by combined chemotherapy. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:2 Topics: Aged, 80 and over; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal Neoplasms; Humans; Male; Positron-Emission Tomography; Stomach Neoplasms; Taxoids; Tomography, X-Ray Computed	2012
Second-line irinotecan after cisplatin, fluoropyrimidin and docetaxel for chemotherapy of metastatic gastric cancer. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Turkey	2012
Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases. Onkologie, 2012, Volume: 35, Issue:9 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Trastuzumab; Treatment Outcome	2012
Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Annals of surgical oncology, 2013, Volume: 20, Issue:3 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Follow-Up Studies; Forkhead Box Protein M1; Forkhead Transcription Factors; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Neoplasm Staging; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Stomach Neoplasms; Survival Rate; Taxoids; Tumor Cells, Cultured	2013
Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2013, Volume: 15, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Taxoids	2013
Efficacy of docetaxel in patients with paclitaxel-resistant advanced gastric cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:10 Topics: Adult; Aged; Antineoplastic Agents; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Middle Aged; Paclitaxel; Retrospective Studies; Stomach Neoplasms; Taxoids	2012
Pathological complete response and two-year disease-free survival in a primary gastric choriocarcinoma patient with advanced liver metastases treated with germ cell tumor-based chemotherapy: a case report. Japanese journal of clinical oncology, 2012, Volume: 42, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Disease-Free Survival; Docetaxel; Etoposide; Fluorouracil; Humans; Liver Neoplasms; Male; Neoplasm, Residual; Stomach Neoplasms; Survival Analysis; Taxoids	2012
Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013, Volume: 16, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2013
Prognostic factors in first-line chemotherapy treated metastatic gastric cancer patients: a retrospective study. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:8 Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Young Adult	2012
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:11 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coagulation; Docetaxel; Drug Combinations; Fatal Outcome; Female; Humans; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2012
Docetaxel-loaded thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel for the suppression of peritoneal metastasis of gastric cancer. Biomaterials, 2013, Volume: 34, Issue:4 Topics: Animals; Antineoplastic Agents; Delayed-Action Preparations; Docetaxel; Hot Temperature; Hydrogels; Linoleic Acid; Male; Mice; Mice, Inbred BALB C; Nanocapsules; Peritoneal Neoplasms; Poloxamer; Stomach Neoplasms; Taxoids; Treatment Outcome	2013
Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2013, Volume: 16, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed; Validation Studies as Topic	2013
[A case of HER2-positive and AFP-producing gastric cancer successfully treated by trastuzumab/docetaxel/S-1 combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:13 Topics: Aged; alpha-Fetoproteins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Male; Oxonic Acid; Receptor, ErbB-2; Stomach Neoplasms; Taxoids; Tegafur; Trastuzumab	2012
Clinical safety and efficacy of Kanglaite® (Coix Seed Oil) injection combined with chemotherapy in treating patients with gastric cancer. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Case-Control Studies; Coix; Deoxycytidine; Docetaxel; Drugs, Chinese Herbal; Female; Fluorouracil; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Phytotherapy; Prognosis; Quality of Life; Remission Induction; Seeds; Stomach Neoplasms; Taxoids; Young Adult	2012
[Adjuvant chemotherapy with S-1 plus docetaxel for highly advanced gastric cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:12 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Female; Humans; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur	2012
Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites. Cancer chemotherapy and pharmacology, 2013, Volume: 71, Issue:3 Topics: Aged; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Injections, Intravenous; Male; Middle Aged; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Taxoids	2013
[A case of multiple skin metastases from gastric cancer successfully treated with docetaxel combined with doxifluridine]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:8 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Floxuridine; Gastrectomy; Humans; Male; Paclitaxel; Skin Neoplasms; Splenectomy; Stomach Neoplasms; Taxoids	2002
[A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:9 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Floxuridine; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2002
[Pharmacologic study of intraperitoneal docetaxel in gastric cancer patients with peritoneal dissemination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:10 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Taxoids; Vindesine	2002
Effectiveness of doxifluridine (5'-DFUR)/docetaxel against advanced/recurrent gastric cancer showing resistance to various anticancer drug regimens. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2002, Volume: 5, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Resistance, Neoplasm; Fatal Outcome; Floxuridine; Gastrectomy; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms; Taxoids	2002
In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Paclitaxel; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Tumor Stem Cell Assay	2003
Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. Molecular cancer therapeutics, 2003, Volume: 2, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Cyclin B; Cyclin B1; Docetaxel; Drug Synergism; Enzyme Inhibitors; Flavonoids; Flow Cytometry; Humans; Immunoblotting; In Vitro Techniques; Mitosis; Neoplasm Transplantation; Piperidines; Propidium; Retinoblastoma Protein; Stomach Neoplasms; Taxoids; Time Factors	2003
Potentiation of docetaxel antitumor activity by batimastat against mouse forestomach carcinoma. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2001, Volume: 16, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Synergism; Male; Mice; Neoplasm Transplantation; Phenylalanine; Stomach Neoplasms; Taxoids; Thiophenes; Tumor Cells, Cultured	2001
High incidence of severe hand-foot syndrome during capecitabine-docetaxel combination chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Incidence; Male; Severity of Illness Index; Stomach Neoplasms; Syndrome; Taxoids	2003
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Nov-01, Volume: 9, Issue:14 Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Chromatography, High Pressure Liquid; Colonic Neoplasms; Cyclosporine; Docetaxel; Drug Combinations; Enzyme Inhibitors; Female; Humans; Mice; Mice, Inbred BALB C; NF-kappa B; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured	2003
[Weekly docetaxel therapy is useful for gastric carcinoma as a second-line chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12 Topics: Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Male; Middle Aged; Pleural Effusion, Malignant; Stomach Neoplasms; Taxoids	2003
[A case of advanced gastric cancer that responded to docetaxel with low-dose 5-FU and cisplatin combination chemotherapy after becoming chemoresistant to M-FLP]. Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:12 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Fluorouracil; Humans; Leucovorin; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms; Taxoids	2003
Modified pharmacokinetic modulating chemotherapy using 5-fluorouracil, UFT, and taxotere (docetaxel) for advanced gastric cancer. International journal of clinical oncology, 2003, Volume: 8, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Docetaxel; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Stomach Neoplasms; Taxoids; Tegafur; Treatment Outcome; Uracil	2003
Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer research, 2003, Dec-15, Volume: 63, Issue:24 Topics: Acetylation; Antineoplastic Agents, Phytogenic; Cell Cycle Proteins; Cell Line, Tumor; DNA Methylation; DNA Mutational Analysis; Docetaxel; Gene Expression Regulation, Neoplastic; Gene Silencing; Histones; Humans; Microtubules; Mitosis; Neoplasm Proteins; Paclitaxel; Poly-ADP-Ribose Binding Proteins; Stomach Neoplasms; Taxoids; Ubiquitin-Protein Ligases	2003
Docetaxel regimen provides survival benefits in advanced stomach cancer patients. Oncology (Williston Park, N.Y.), 2003, Volume: 17, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Stomach Neoplasms; Survival Analysis; Taxoids	2003
[A case of recurrent pleural effusion and positive cytology of advanced gastric cancer treated by TS-1 plus weekly taxane as second-line chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; CA-19-9 Antigen; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Oxonic Acid; Pleural Effusion, Malignant; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2004
Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer letters, 2004, Jul-16, Volume: 210, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Docetaxel; Female; Infusions, Parenteral; Mice; Mice, Nude; Neoplasms, Experimental; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis; Taxoids	2004
Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism. Cancer science, 2004, Volume: 95, Issue:8 Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cisplatin; Docetaxel; Drug Interactions; Humans; Platinum; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Up-Regulation	2004
Treatment issues in pediatric gastric adenocarcinoma. Journal of pediatric surgery, 2004, Volume: 39, Issue:8 Topics: Anastomosis, Roux-en-Y; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Signet Ring Cell; Catheter Ablation; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Gastrectomy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Irinotecan; Liver Neoplasms; Lymph Node Excision; Neoplasm Recurrence, Local; Neoplastic Syndromes, Hereditary; Pancreatectomy; Prognosis; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Remission Induction; Reoperation; Splenectomy; Stomach Neoplasms; Taxoids	2004
Nail changes during docetaxel containing combination chemotherapy. The Korean journal of internal medicine, 2004, Volume: 19, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Lymphatic Diseases; Middle Aged; Nail Diseases; Stomach Neoplasms; Taxoids	2004
[A case of recurrent gastric cancer tolerant to TS-1 therapy successfully treated by TS-1 combined with docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Pancreatectomy; Pyridines; Splenectomy; Stomach Neoplasms; Taxoids; Tegafur	2004
[Experimental study for a combination chemo-immunotherapy using dendritic cells]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11 Topics: Adult; Antineoplastic Agents, Phytogenic; Apoptosis; Dendritic Cells; Docetaxel; Humans; Immunotherapy; In Vitro Techniques; Leukocytes, Mononuclear; Lymphocyte Activation; Membrane Glycoproteins; Paclitaxel; Receptors, Cell Surface; Stomach Neoplasms; T-Lymphocytes, Cytotoxic; Taxoids; Toll-Like Receptor 4; Toll-Like Receptors; Tumor Cells, Cultured	2004
[A case report of the 8 year survivor--unresectable liver metastases from advanced gastric cancer (Stage IV) were completely responsive, after 4 years from a total sequential gastrectomy, combining docetaxel treatment to regress the recurrence]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Fluorouracil; Gastrectomy; Hepatectomy; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2004
[A case of scirrhous carcinoma of the stomach with malignant pleural and peritoneal carcinomatosis responding to the local administration of docetaxel (TXT)]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:11 Topics: Adenocarcinoma, Scirrhous; Adult; Antineoplastic Agents, Phytogenic; Ascites; Docetaxel; Female; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Peritoneal Neoplasms; Peritonitis; Pleural Effusion; Pleural Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Thoracic Cavity	2004
[Measurement of docetaxel concentration in blood and ascites after drip infusion into each vessel and intraperitoneal cavity of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Ascites; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Gastrectomy; Humans; Infusions, Intravenous; Infusions, Parenteral; Lymph Node Excision; Male; Middle Aged; Stomach Neoplasms; Taxoids	2004
[Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance]. Zhonghua yi xue za zhi, 2004, Dec-17, Volume: 84, Issue:24 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Middle Aged; Mitomycin; Neoplasm Proteins; RNA, Messenger; Stomach Neoplasms; Survivin; Taxoids	2004
[A case of a nonresected gastric cancer with peritoneal dissemination maintained on TS-1 and docetaxel combination chemotherapy with good QOL]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Male; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2005
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Oxonic Acid; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts. Oncology, 2005, Volume: 68, Issue:2-3 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Male; Oxonic Acid; Pyridines; Rats; Rats, Inbred F344; Rats, Nude; Stomach Neoplasms; Taxoids; Tegafur; Transplantation, Heterologous	2005
[A case of remnant gastric cancer with multiple bone metastasis and peritoneal dissemination; efficacy of combination therapy of docetaxel and TS-1]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:7 Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin. Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Digestive System Surgical Procedures; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiography; Remission Induction; Retroperitoneal Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome	2005
[Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:11 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carboplatin; Cisplatin; Docetaxel; Drug Combinations; Drug Screening Assays, Antitumor; Fluorouracil; Infusions, Parenteral; Mice; Mice, Nude; Neoplasm Seeding; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Stomach Neoplasms; Taxoids; Tegafur	2005
Clinical significance of class III beta-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer. International journal of oncology, 2006, Volume: 28, Issue:2 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Biopsy; Docetaxel; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Male; Middle Aged; Predictive Value of Tests; Stomach Neoplasms; Taxoids; Treatment Outcome; Tubulin	2006
Vitamin K2-induced antitumor effects via cell-cycle arrest and apoptosis in gastric cancer cell lines. International journal of molecular medicine, 2006, Volume: 17, Issue:2 Topics: Antibodies; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Line, Tumor; Docetaxel; Humans; Stomach Neoplasms; Taxoids; Vitamin K 2	2006
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy. International journal of cancer, 2006, Jul-15, Volume: 119, Issue:2 Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colorectal Neoplasms; Docetaxel; Drug Carriers; Esophageal Neoplasms; Feasibility Studies; Gene Expression Regulation, Neoplastic; Green Fluorescent Proteins; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasms; Polymerase Chain Reaction; Stomach Neoplasms; Taxoids; Telomerase; Transplantation, Heterologous; Vinblastine; Vinorelbine	2006
[A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Female; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2006
Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines. International journal of cancer, 2006, Aug-15, Volume: 119, Issue:4 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Dihydrouracil Dehydrogenase (NADP); Docetaxel; Drug Combinations; Drug Synergism; Female; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Multienzyme Complexes; Orotate Phosphoribosyltransferase; Orotidine-5'-Phosphate Decarboxylase; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Thymidylate Synthase; Xenograft Model Antitumor Assays	2006
Neoadjuvant treatment of gastric cancer with peritoneal dissemination. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2006, Volume: 32, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Docetaxel; Female; Fluorouracil; Humans; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Survival Rate; Taxoids; Treatment Outcome	2006
Cytotoxicity of docetaxel (Taxotere) used as a single agent and in combination with radiation in human gastric, cervical and pancreatic cancer cells. Chemotherapy, 2006, Volume: 52, Issue:5 Topics: Cell Nucleus; Cell Survival; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Microscopy, Fluorescence; Mitotic Index; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Uterine Cervical Neoplasms; X-Rays	2006
Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells. Cancer biology & therapy, 2006, Volume: 5, Issue:10 Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cisplatin; Docetaxel; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Taxoids	2006
[In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ascites; Camptothecin; Cell Survival; Colorectal Neoplasms; Docetaxel; Female; Humans; Injections, Intraperitoneal; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured	2006
[A partial response to combined TS-1 and docetaxel chemotherapy enabling a curative resection after the failure of combined TS-1 and CDDP chemotherapy in a patient with unresectable gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Gastrectomy; Humans; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed; Treatment Outcome	2006
[A case report of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Combinations; Fluorouracil; Humans; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Taxoids; Tegafur	2007
[A case of recurrent gastric cancer with obstructive jaundice successfully treated by docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Docetaxel; Drug Administration Schedule; Gastrectomy; Humans; Jaundice, Obstructive; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Quality of Life; Stents; Stomach Neoplasms; Taxoids	2007
[A case of advanced gastric cancer with liver metastases successfully treated by combination therapy of TS-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:2 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Male; Oxonic Acid; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2007
[Long survival and effective treatment of unresectable gastric cancer by TS-1 based chemotherapy with a sequential combination]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:2 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Middle Aged; Peritoneal Neoplasms; Quality of Life; Silicates; Stomach Neoplasms; Survivors; Taxoids; Titanium	2007
Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration. Yonsei medical journal, 2007, Feb-28, Volume: 48, Issue:1 Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Female; Hemorrhage; Humans; Male; Middle Aged; Nail Diseases; Stomach Neoplasms; Suppuration; Taxoids	2007
[A case of adenosquamous gastric carcinoma successfully treated with TS-1, low-dose CDDP and docetaxel as neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Drug Combinations; Humans; Male; Oxonic Acid; Remission Induction; Stomach Neoplasms; Taxoids; Tegafur	2007
[Combination therapy with bi-weekly docetaxel and 5'-deoxy-5-fluorouridine for advanced gastric cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Floxuridine; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Stomach Neoplasms; Taxoids	2007
Chemoimmunotherapy in the treatment of metastatic gastric cancer. Anti-cancer drugs, 2007, Volume: 18, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antidotes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; CD4-CD8 Ratio; Combined Modality Therapy; Deoxycytidine; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Endpoint Determination; Female; Fluorouracil; Humans; Immunotherapy; Killer Cells, Natural; Leucovorin; Lymphocyte Count; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Survival Analysis; Taxoids; Vascular Endothelial Growth Factor A	2007
[Complete regression after neoadjuvant chemotherapy in locally advanced gastric cancer causing peritonitis carcinomatosa--a case report]. Magyar sebeszet, 2006, Volume: 59, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Fluorouracil; Gastrectomy; Humans; Male; Middle Aged; Neoadjuvant Therapy; Peritoneal Neoplasms; Peritonitis; Stomach Neoplasms; Taxoids; Treatment Outcome	2006
Possible pitfall in diagnosis: mitotic arrest of gastric epithelium after docetaxel therapy for hormone-refractory prostatic cancer. Histopathology, 2007, Volume: 51, Issue:1 Topics: Aged; Antineoplastic Agents; Docetaxel; Epithelial Cells; False Positive Reactions; Gastric Mucosa; Humans; Male; Mitosis; Prostatic Neoplasms; Stomach Neoplasms; Taxoids	2007
Docetaxel for advanced gastric cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Jun-10, Volume: 25, Issue:17 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Fluorouracil; Humans; Research Design; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
Melanoma-associated antigen-A1 expression predicts resistance to docetaxel and paclitaxel in advanced and recurrent gastric cancer. Oncology reports, 2007, Volume: 18, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasm Recurrence, Local; Paclitaxel; Polymerase Chain Reaction; Predictive Value of Tests; Prognosis; Stomach Neoplasms; Taxoids; Transfection	2007
[Exploration on the increased sensitivity to docetaxel and reversing mechanism of drug resistance of antisense survivin RNA in gastric cancer cell line SGC7901 cells]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:2 Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Electroporation; Humans; Inhibitor of Apoptosis Proteins; Inhibitory Concentration 50; Microtubule-Associated Proteins; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Antisense; RNA, Messenger; Stomach Neoplasms; Survivin; Taxoids; Transfection	2007
Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Aug-01, Volume: 25, Issue:22 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Esophageal Neoplasms; Fluorouracil; Humans; Neoplasm Metastasis; Quality of Life; Stomach Neoplasms; Taxoids; Treatment Outcome	2007
A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1. International journal of clinical oncology, 2007, Volume: 12, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Combinations; Humans; Liver Neoplasms; Male; Middle Aged; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2007
Docetaxel in gastric cancer: a viewpoint by David Wilson. Drugs, 2007, Volume: 67, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2007
Docetaxel in gastric cancer: a viewpoint by Andre M. Murad. Drugs, 2007, Volume: 67, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Stomach Neoplasms; Taxoids	2007
[Docetaxel-cisplatin-5-FU combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric cancer]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2007, Volume: 50, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Taxoids	2007
[A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10 Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Humans; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur	2007
[Two cases of advanced gastric cancer in which paclitaxel proved effective after resistance to docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Middle Aged; Paclitaxel; Salvage Therapy; Stomach Neoplasms; Taxoids	2007
Enhanced efficiency of thermally targeted taxanes delivery in a human xenograft model of gastric cancer. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:8 Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Humans; Lethal Dose 50; Mice; Micelles; Neoplasm Transplantation; Paclitaxel; Stomach Neoplasms; Taxoids	2008
Doubts about whether docetaxel, cisplatin, plus fluorouracil has any benefit in advanced gastric cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Dec-01, Volume: 25, Issue:34 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Docetaxel; Fluorouracil; Humans; Quality of Life; Stomach Neoplasms; Taxoids	2007
Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. Biochimica et biophysica acta, 2008, Volume: 1783, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Docetaxel; Gene Expression; Humans; Phosphatidic Acids; Phospholipase D; Proto-Oncogene Proteins c-bcl-2; RNA Interference; Stomach Neoplasms; Taxoids; Transfection	2008
Docetaxel monotherapy as a second-line treatment after failure of fluoropyrimidine and platinum in advanced gastric cancer: experience of 154 patients with prognostic factor analysis. Japanese journal of clinical oncology, 2007, Volume: 37, Issue:12 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Medical Records; Middle Aged; Multivariate Analysis; Platinum Compounds; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Stomach Neoplasms; Taxoids; Treatment Failure; Treatment Outcome	2007
[A case report of inoperable gastric cancer demonstrating a clinical CR after chemo-radiation therapy employing weekly DOC]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:12 Topics: Aged; Docetaxel; Gastroscopy; Humans; Male; Neoplasm Staging; Radiation-Sensitizing Agents; Stomach Neoplasms; Taxoids; Time Factors	2007
Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer letters, 2008, Apr-18, Volume: 262, Issue:2 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Stomach Neoplasms; Survivin; Taxoids; Xanthones	2008
[A case of advanced gastric cancer successfully treated by combination therapy of S-1 and docetaxel]. Gan to kagaku ryoho. Cancer & chemotherapy, 2008, Volume: 35, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Docetaxel; Drug Combinations; Female; Gastroscopy; Humans; Male; Neoplasm Staging; Oxonic Acid; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed	2008
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines. Oncology reports, 2008, Volume: 19, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Docetaxel; Humans; Proteasome Inhibitors; Pyrazines; Stomach Neoplasms; Taxoids; Tumor Suppressor Protein p53	2008
[FOLFOX4 regimen versus DP(O)F regimen for advanced gastric cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2008, Volume: 27, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Stomach Neoplasms; Taxoids	2008
Dual anti-cancer effects of weekly intraperitoneal docetaxel in treatment of advanced gastric cancer patients with peritoneal carcinomatosis: a feasibility and pharmacokinetic study. Oncology reports, 2008, Volume: 19, Issue:5 Topics: Antineoplastic Agents; Area Under Curve; Capillaries; Docetaxel; Feasibility Studies; Female; Humans; Kinetics; Lymphatic Metastasis; Male; Peritoneal Neoplasms; Recurrence; Stomach Neoplasms; Taxoids; Time Factors; Treatment Outcome	2008
Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:2 Topics: Animals; Antineoplastic Agents, Phytogenic; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Stomach Neoplasms; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured	1996
Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells. International journal of oncology, 1999, Volume: 15, Issue:4 Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cisplatin; DNA Fragmentation; Docetaxel; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Signal Transduction; Stomach Neoplasms; Taxoids; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation	1999
Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer. International journal of oncology, 2001, Volume: 18, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Cation Exchange Resins; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Genetic Therapy; Humans; Indicators and Reagents; Lipids; Mice; Mice, Nude; Paclitaxel; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2001
Potentiation of docetaxel antitumor activity by batimastat against mouse forestomach carcinoma. Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2000, Volume: 19, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Male; Mice; Paclitaxel; Phenylalanine; Stomach Neoplasms; Taxoids; Thiophenes	2000